
<html lang="en"     class="pb-page"  data-request-id="b97947f6-e4ea-4d8d-8d41-dde94705fc7f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-5;article:article:10.1021/jm500297k;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection" /></meta><meta name="dc.Creator" content="Paul M.  Scola" /></meta><meta name="dc.Creator" content="Li-Qiang  Sun" /></meta><meta name="dc.Creator" content="Alan Xiangdong  Wang" /></meta><meta name="dc.Creator" content="Jie  Chen" /></meta><meta name="dc.Creator" content="Ny  Sin" /></meta><meta name="dc.Creator" content="Brian L.  Venables" /></meta><meta name="dc.Creator" content="Sing-Yuen  Sit" /></meta><meta name="dc.Creator" content="Yan  Chen" /></meta><meta name="dc.Creator" content="Anthony  Cocuzza" /></meta><meta name="dc.Creator" content="Donna M.  Bilder" /></meta><meta name="dc.Creator" content="Stanley V.  D’Andrea" /></meta><meta name="dc.Creator" content="Barbara  Zheng" /></meta><meta name="dc.Creator" content="Piyasena  Hewawasam" /></meta><meta name="dc.Creator" content="Yong  Tu" /></meta><meta name="dc.Creator" content="Jacques  Friborg" /></meta><meta name="dc.Creator" content="Paul  Falk" /></meta><meta name="dc.Creator" content="Dennis  Hernandez" /></meta><meta name="dc.Creator" content="Steven  Levine" /></meta><meta name="dc.Creator" content="Chaoqun  Chen" /></meta><meta name="dc.Creator" content="Fei  Yu" /></meta><meta name="dc.Creator" content="Amy K.  Sheaffer" /></meta><meta name="dc.Creator" content="Guangzhi  Zhai" /></meta><meta name="dc.Creator" content="Diana  Barry" /></meta><meta name="dc.Creator" content="Jay O.  Knipe" /></meta><meta name="dc.Creator" content="Yong-Hae  Han" /></meta><meta name="dc.Creator" content="Richard  Schartman" /></meta><meta name="dc.Creator" content="Maria  Donoso" /></meta><meta name="dc.Creator" content="Kathy  Mosure" /></meta><meta name="dc.Creator" content="Michael W.  Sinz" /></meta><meta name="dc.Creator" content="Tatyana  Zvyaga" /></meta><meta name="dc.Creator" content="Andrew C.  Good" /></meta><meta name="dc.Creator" content="Ramkumar  Rajamani" /></meta><meta name="dc.Creator" content="Kevin  Kish" /></meta><meta name="dc.Creator" content="Jeffrey  Tredup" /></meta><meta name="dc.Creator" content="Herbert E.  Klei" /></meta><meta name="dc.Creator" content="Qi  Gao" /></meta><meta name="dc.Creator" content="Luciano  Mueller" /></meta><meta name="dc.Creator" content="Richard J.  Colonno" /></meta><meta name="dc.Creator" content="Dennis M.  Grasela" /></meta><meta name="dc.Creator" content="Stephen P.  Adams" /></meta><meta name="dc.Creator" content="James  Loy" /></meta><meta name="dc.Creator" content="Paul C.  Levesque" /></meta><meta name="dc.Creator" content="Huabin  Sun" /></meta><meta name="dc.Creator" content="Hong  Shi" /></meta><meta name="dc.Creator" content="Lucy  Sun" /></meta><meta name="dc.Creator" content="William  Warner" /></meta><meta name="dc.Creator" content="Danshi  Li" /></meta><meta name="dc.Creator" content="Jialong  Zhu" /></meta><meta name="dc.Creator" content="Nicholas A.  Meanwell" /></meta><meta name="dc.Creator" content="Fiona  McPhee" /></meta><meta name="dc.Description" content="The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clinical trials for the treatment of hepatitis ..." /></meta><meta name="Description" content="The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clinical trials for the treatment of hepatitis ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 5, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500297k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500297k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500297k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500297k" /></link>
        
    
    

<title>The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500297k" /></meta><meta property="og:title" content="The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0021.jpeg" /></meta><meta property="og:description" content="The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clinical trials for the treatment of hepatitis C virus infection. The discovery of 24 was enabled by employing an isolated rabbit heart model to screen for the cardiovascular (CV) liabilities (changes to HR and SNRT) that were responsible for the discontinuation of an earlier lead from this chemical series, BMS-605339 (1), from clinical trials. The structure–activity relationships (SARs) developed with respect to CV effects established that small structural changes to the P2* subsite of the molecule had a significant impact on the CV profile of a given compound. The antiviral activity, preclincial PK profile, and toxicology studies in rat and dog supported clinical development of BMS-650032 (24)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500297k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500297k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500297k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500297k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500297k&amp;href=/doi/10.1021/jm500297k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1730-1752</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401840s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400164c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+M.++Scola">Paul M. Scola</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Qiang++Sun">Li-Qiang Sun</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+Xiangdong++Wang">Alan Xiangdong Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Chen">Jie Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ny++Sin">Ny Sin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+L.++Venables">Brian L. Venables</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sing-Yuen++Sit">Sing-Yuen Sit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Chen">Yan Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Cocuzza">Anthony Cocuzza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna+M.++Bilder">Donna M. Bilder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanley+V.++D%E2%80%99Andrea">Stanley V. D’Andrea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Zheng">Barbara Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piyasena++Hewawasam">Piyasena Hewawasam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Tu">Yong Tu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacques++Friborg">Jacques Friborg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Falk">Paul Falk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis++Hernandez">Dennis Hernandez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Levine">Steven Levine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chaoqun++Chen">Chaoqun Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Yu">Fei Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy+K.++Sheaffer">Amy K. Sheaffer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guangzhi++Zhai">Guangzhi Zhai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Barry">Diana Barry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+O.++Knipe">Jay O. Knipe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong-Hae++Han">Yong-Hae Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Schartman">Richard Schartman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Donoso">Maria Donoso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Mosure">Kathy Mosure</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+W.++Sinz">Michael W. Sinz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatyana++Zvyaga">Tatyana Zvyaga</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+C.++Good">Andrew C. Good</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramkumar++Rajamani">Ramkumar Rajamani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Kish">Kevin Kish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey++Tredup">Jeffrey Tredup</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herbert+E.++Klei">Herbert E. Klei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Gao">Qi Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luciano++Mueller">Luciano Mueller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+J.++Colonno">Richard J. Colonno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+M.++Grasela">Dennis M. Grasela</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+P.++Adams">Stephen P. Adams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Loy">James Loy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+C.++Levesque">Paul C. Levesque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huabin++Sun">Huabin Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Shi">Hong Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucy++Sun">Lucy Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++Warner">William Warner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danshi++Li">Danshi Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jialong++Zhu">Jialong Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+A.++Meanwell">Nicholas A. Meanwell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fiona++McPhee">Fiona McPhee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Clinical Development Infectious Disease, Bristol-Myers Squibb Research and Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Department of Lead Discovery and Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">Department of Mechanistic Biochemistry, Bristol-Myers Squibb Research and Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Department of Pharmaceutical Development, Bristol-Myers Squibb Research and Development, 1 Squibb Drive, New Brunswick, New Jersey, 08903, United States</span></div><div class="aff-info" id="aff9"><span class="aff-symbol">◆</span> <span class="aff-text">Department of Protein Science and Structure, Bristol-Myers Squibb Research and Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div><div class="corresp-info"><strong>*</strong>For P.M.S.: phone, 203-677-7870; fax, 203-677-7804; E-mail, <a href="/cdn-cgi/l/email-protection#f4a4958198daa7979b9895b4969987da979b99"><span class="__cf_email__" data-cfemail="5a0a3b2f3674093935363b1a38372974393537">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For L.Q.S.: phone, 203-677-7460; fax, 203-677-7804; E-mail, <a href="/cdn-cgi/l/email-protection#45092c142c242b226b16302b052728366b262a28"><span class="__cf_email__" data-cfemail="04486d556d656a632a57716a446669772a676b69">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500297k&amp;href=/doi/10.1021%2Fjm500297k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1730–1752</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 24, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 February 2014</li><li><span class="item_label"><b>Published</b> online</span>5 March 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500297k" title="DOI URL">https://doi.org/10.1021/jm500297k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1730%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BM.%2BScola%252C%2BLi-Qiang%2BSun%252C%2BAlan%2BXiangdong%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D5%26contentID%3Djm500297k%26title%3DThe%2BDiscovery%2Bof%2BAsunaprevir%2B%2528BMS-650032%2529%252C%2BAn%2BOrally%2BEfficacious%2BNS3%2BProtease%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BC%2BVirus%2BInfection%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1752%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500297k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2803</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">83</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500297k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;M. Scola&quot;},{&quot;first_name&quot;:&quot;Li-Qiang&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Xiangdong Wang&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Ny&quot;,&quot;last_name&quot;:&quot;Sin&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;L. Venables&quot;},{&quot;first_name&quot;:&quot;Sing-Yuen&quot;,&quot;last_name&quot;:&quot;Sit&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Cocuzza&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;M. Bilder&quot;},{&quot;first_name&quot;:&quot;Stanley&quot;,&quot;last_name&quot;:&quot;V. D’Andrea&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Piyasena&quot;,&quot;last_name&quot;:&quot;Hewawasam&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;Jacques&quot;,&quot;last_name&quot;:&quot;Friborg&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Falk&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;Hernandez&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Levine&quot;},{&quot;first_name&quot;:&quot;Chaoqun&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;K. Sheaffer&quot;},{&quot;first_name&quot;:&quot;Guangzhi&quot;,&quot;last_name&quot;:&quot;Zhai&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Barry&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;O. Knipe&quot;},{&quot;first_name&quot;:&quot;Yong-Hae&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Schartman&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Donoso&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Mosure&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;W. Sinz&quot;},{&quot;first_name&quot;:&quot;Tatyana&quot;,&quot;last_name&quot;:&quot;Zvyaga&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;C. Good&quot;},{&quot;first_name&quot;:&quot;Ramkumar&quot;,&quot;last_name&quot;:&quot;Rajamani&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Kish&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;Tredup&quot;},{&quot;first_name&quot;:&quot;Herbert&quot;,&quot;last_name&quot;:&quot;E. Klei&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Luciano&quot;,&quot;last_name&quot;:&quot;Mueller&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;J. Colonno&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;M. Grasela&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;P. Adams&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Loy&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;C. Levesque&quot;},{&quot;first_name&quot;:&quot;Huabin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Lucy&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Warner&quot;},{&quot;first_name&quot;:&quot;Danshi&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jialong&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;A. Meanwell&quot;},{&quot;first_name&quot;:&quot;Fiona&quot;,&quot;last_name&quot;:&quot;McPhee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1730-1752&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500297k&quot;},&quot;abstract&quot;:&quot;The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clinical trials for the treatment of hepatitis C virus infection. The discovery of 24 was enabled by employing an isolated rabbit heart model to screen for the cardiovascular (CV) liabilities (changes to HR and SNRT) that were responsible for the discontinuation of an earlier lead from this chemical series, BMS-605339 (1), from clinical trials. The structure–activity relationships (SARs) developed with respect to CV effects established that small structural changes to the P2* subsite of the molecule had a significant impact on the CV profile of a given compound. The antiviral activity, preclincial PK profile, and toxicology studies in rat and dog supported clinical development of BMS-650032 (24).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500297k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500297k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500297k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500297k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500297k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500297k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500297k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500297k&amp;href=/doi/10.1021/jm500297k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500297k" /></input><a href="/doi/pdf/10.1021/jm500297k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500297k%26sid%3Dliteratum%253Aachs%26pmid%3D24564672%26genre%3Darticle%26aulast%3DScola%26date%3D2014%26atitle%3DThe%2BDiscovery%2Bof%2BAsunaprevir%2B%2528BMS-650032%2529%252C%2BAn%2BOrally%2BEfficacious%2BNS3%2BProtease%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BC%2BVirus%2BInfection%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D5%26spage%3D1730%26epage%3D1752%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jmcmar.2014.57.issue-5/production/jmcmar.2014.57.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of asunaprevir (BMS-650032, <b>24</b>) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clinical trials for the treatment of hepatitis C virus infection. The discovery of <b>24</b> was enabled by employing an isolated rabbit heart model to screen for the cardiovascular (CV) liabilities (changes to HR and SNRT) that were responsible for the discontinuation of an earlier lead from this chemical series, BMS-605339 (<b>1</b>), from clinical trials. The structure–activity relationships (SARs) developed with respect to CV effects established that small structural changes to the P2* subsite of the molecule had a significant impact on the CV profile of a given compound. The antiviral activity, preclincial PK profile, and toxicology studies in rat and dog supported clinical development of BMS-650032 (<b>24</b>).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/57/5"><issue-title>HCV Therapies</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have described the discovery of the hepatitis C virus (HCV) NS3/4A protease inhibitor BMS-605339 (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which was derived from a tripeptidic acylsulfonamide chemotype.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This chemical series introduced the cyclopropyl acylsulfonamide P1′ moiety, a structural element that confers improved potency in the whole cell replicon assays compared to the corresponding carboxylic acid progenitor, an observation that has led to its broad application in NS3/4A inhibitor design.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Clinical evaluation of <b>1</b> in genotype (GT) 1 HCV-infected subjects revealed that at the highest single dose (120 mg) a mean reduction in viral load of 1.8 log<sub>10</sub> IU/mL was observed. However, this trial was ultimately discontinued due to the observation of cardiovascular (CV) events considered to be drug-related. Specifically, mild bradycardia, PR interval prolongation, and junctional escape rhythms occurred in 2 of 12 subjects dosed with 120 mg of <b>1</b>, one of whom was a normal healthy volunteer (NHV) while the other was infected with HCV. Effects in the electrocardiogram were observed 4 h following dosing and persisted for up to 18.5 h, although both patients remained asymptomatic throughout the observation period. Similar drug-induced CV effects had been observed preclinically in both the dog and rabbit but only in the presence of significantly higher drug concentrations. Thus, humans appeared to be more sensitive to the CV effects of <b>1</b>, and the potential toxicological ramifications of these findings could not be adequately predicted based on preclinical models.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of BMS-605339 (<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Described herein are the results of efforts that culminated in the identification of a second clinical compound from this tripeptidic acylsulfonamide series. Given the favorable antiviral activity associated with <b>1</b> in HCV-infected patients and the circumscribed nature of the preclinical and clinical toxicology findings, the objective of the present work was the identification of a compound with preclinical antiviral and pharmacokinetic properties similar to <b>1</b> but with a CV profile that held minimal risk for side effects. More specifically, the immediate research objective was the identification of a clinical candidate with high potency toward GT 1a and 1b subtype replicons (EC<sub>50</sub> <10 nM), a pharmacokinetic profile predictive of BID or QD dosing, and no evidence of significant CV liabilities in preclinical models.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The maximum total plasma exposure of <b>1</b> in the patients experiencing CV effects was 113 nM in the NHV and 206 nM in the HCV-infected subject, with both occurring 1 h postdosing. In conscious, telemeterized dogs administered a dose of 15 mg/kg BID of <b>1</b>, CV effects were limited to decreases in blood pressure and increases in PR interval, electrophysiological findings generally similar to those observed in humans. These effects in the dogs were limited in magnitude and considered to be manageable. The maximal total drug concentration in plasma was estimated to be ∼12 μM based on parallel studies in nontelemetrized animals. Plasma protein binding of <b>1</b> in dog and human plasma, measured by equilibrium dialysis, was found to be 98.2% and 99.1%, respectively, values that are similar and hence do not rationalize the significantly different in vivo concentrations in dog versus human that resulted in the observation of CV effects.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The increased sensitivity of humans to the CV effects of <b>1</b> compared to dogs meant that using this species to identify compounds free of these CV findings in humans would be challenging and was, therefore, not pursued. The rabbit was explored as an alternative model with heart rate (HR), sinus node recovery time (SNRT), and blood pressure (BP) monitored following intravenous administration (IV) of <b>1</b> to anesthetized animals at doses of 1, 3, and 10 mg/kg. Each dose was administered incrementally over a 5 min period, and effects were correlated with total plasma concentration of drug (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). A mild HR decrease of 32 bpm from baseline was observed 60 min after the last infusion. This HR observation was most significant, as it occurred in the presence of a mild decrease in blood pressure (BP) (−14 to −23 mmHg from baseline), which normally drives a compensatory, reflex HR increase. The observed BP effects were not considered to be drug-related because a similar effect occurred in control animals infused with vehicle. SNRT was slightly prolonged but not significantly different from control and <b>1</b> did not affect PR or QT intervals, QRS duration, or AH and HV intervals in the His bundle electrocardiogram. The maximum total drug in plasma in this experiment was 27 μM, while 60 min after the last drug infusion the total plasma concentration was 1.65 μM and the mean drug concentration in cardiac tissue was 0.25 μM. These results indicated that rabbits were also markedly less sensitive than humans to the CV effects of <b>1</b> and that this in vivo rabbit model was not a viable toxicology screen for the identification of a second clinical candidate.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of BMS-605339 (<b>1</b>) on heart rate (A), sinus node recovery time (B), and PR interval (C) in anesthetized rabbits administered 1, 3, and 10 mg/kg by IV infusion. Plasma concentrations are depicted in (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Testing of <b>1</b> for in vitro activity at a broad panel of CV receptors, including adrenergic and muscarinic receptors, revealed no significant biological activities that might underlie the observed cardiocasular findings. Ion channels that are predictive of in vivo effects on heart rate, PR interval, or junctional escape rhythms were also explored as a potential source of the CV effects, but <b>1</b> produced only weak inhibitory activity in these evaluations. Specifically, at a protein-free concentration of 30 μM, <b>1</b> inhibited L- and T-type calcium channels by 36% and 27%, respectively. Inhibition of HCN4, an ion channel thought to play a role in SA node heart rate regulation, was also weak, with 34% inhibition observed. Similar results were found in a sodium channel assay where <b>1</b>, at a concentration of 30 μM, was associated with only 11% inhibition, a result confirmed in a Purkinje fiber assay where a <i>V</i><sub>max</sub> reduction of only 8.4% was observed at a drug concentration of 30 μM. In addition, <b>1</b> produced only a weak inhibitory effect (<17%) toward the human ether-à-go-go-related gene (hERG) in a patch clamp assay at 30 μM, suggesting low potential for QT-related ECG findings.</div><div class="NLM_p">To assess the effects of <b>1</b> on cardiac function further and to gather additional insight into the potential mechanism of these observations, studies were conducted in isolated rabbit hearts (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The Langendorff isolated heart model enables testing for direct effects on SA node function through measurement of sinus node recovery time (SNRT).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Hearts were perfused with protein-free, Krebs–Henseleit solutions containing <b>1</b> for approximately 12 min each at concentrations of 0.3, 1, 3, and 10 μM. A mild, concentration-dependent decrease in HR was observed of −15 and −23 bpm from baseline at 3 and 10 μM, respectively, that reflected moderate, concentration-dependent increases in SNRT of ≥+425 ms. Following perfusion with 10 μM of <b>1</b>, the effects on HR and SNRT continued to increase during a 10 min washout period (−46 bpm in HR and +1250 ms in SNRT). At that time, there were still no significant effects on atrioventricular (A–V) conduction time, QRS duration, or coronary blood flow.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of BMS-605339 (<b>1</b>) on HR and SNRT in a isolated rabbit heart preparation perfused with 0.3, 1, 3, and 10 μM of drug in protein-free medium. Hearts were perfused with each concentration of <b>1</b> (unbound) for ∼12 min. Mean ± SEM, <i>n</i> = 4 hearts/group. *<i>P</i> < 0.05, **<i>P</i> < 0.01 versus vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Isolated rabbit hearts were also perfused with <b>1</b> at single concentrations for 60 min to assess the time dependency of the CV effects (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). At 1 μM, time-dependent effects on HR and SNRT were observed, with a decrease in HR and an increase in SNRT. At a concentration of 0.3 μM, the effects of <b>1</b> on HR and SNRT were reduced significantly compared to those at 1 μM, while reducing the concentration further to 0.1 μM resulted in no significant effects when compared to vehicle.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect on HR and SNRT in an isolated rabbit heart preparation perfused with a single concentration ≤1 μM of BMS-605339 (<b>1</b>) for 60 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Collectively, the results of these experiments suggested that the effect of <b>1</b> may be a consequence of a direct action on the SA node, which is located in the right atrium of the heart and functions as the primary cardiac pacemaker. Moreover, the similarity of the drug-induced CV effects observed in the Langendorff rabbit heart model with those observed in rabbits, dogs, and humans in vivo was suggestive of a common mechanism operating across species albeit with different sensitivities. The protein-free environment associated with the Langendorff rabbit heart model allowed evaluation of BMS-605339 (<b>1</b>) at free drug concentrations difficult to achieve in vivo in the rabbit or dog, overcoming the differential sensitivity issue, and this model was adopted as a tool with which to evaluate analogues of <b>1</b> in an effort to identify those free of CV liabilities.</div><div class="NLM_p">The initial series of compounds evaluated in the isolated rabbit heart model (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were selected in an effort to develop structure–activity relationships (SARs) with respect to the CV findings observed with <b>1</b>. Truncating the terminal cyclopropyl acylsulfonamide group of <b>1</b> to the corresponding carboxylic acid <b>2</b> resulted in a compound with significant effects on heart rate and SNRT in the rabbit model, although these effects were less severe than those observed with <b>1</b>. Nonetheless, this observation exonerated the acylsulfonamide functionality as causative of the CV effects in <b>1</b>. Given the established value of the acylsulfonamide moiety as a means to drive potency and favorably modulate pharmacokinetic properties, this group was retained as a structural element.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Interestingly, analogues of <b>1</b> with structural modifications at the P3 and P4 subsites (compounds <b>3</b> and <b>4</b>) also produced effects in the Langendorff model. Furthermore, a reduction in sinus rhythm (HR) and a concomitant increase in SNRT was observed across disparate functionality at P2* (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Representative analogues bearing a pyrimidine (<b>5</b>) and a carbamate (<b>6</b>) at P2* induced a CV signal and, hence, a structurally distinct P2* ring system that fundamentally circumvented CV effects was unlikely to be identified in an expedient fashion. These findings, coupled with our understanding of the opportunities within the isoquinoline series to optimize potency and PK properties, provided direction, and immediate attention was given to expanding the SARs surrounding the isoquinoline nucleus of this tripeptidic acylsulfonamide chemotype.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Analogues of <b>1</b>: HCV Inhibitory Potency and CV Profile<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compounds were dosed at 10 μM for 20 min. When vehicle only was perfused for 20 min, % change in HR and SNRT were −3 and 4, respectively.</p></div></div><div></div></div><div class="NLM_p">The unsubstituted isoquinoline <b>7</b> described previously served as a structural template for optimization, a process that ultimately provided <b>1</b>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Upon testing in the isolated heart model, <b>7</b> elicited effects similar to the 6-methoxy isoquinoline <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Importantly, the corresponding 5-methoxy isoquinoline <b>8</b> demonstrated a significantly improved HR and SNRT profile. A comparison of the results between regioisomers <b>1</b> and <b>8</b> in the isolated heart model was most significant because it established that marked improvements in the CV profile of compounds were possible via simple structural changes to the isoquinoline ring system. However, while the CV profile of <b>8</b> was promising, the activity of this isoquinoline analogue (EC<sub>50</sub> = 25 nM) in the replicon assay did not meet the criteria (EC<sub>50</sub> < 10 nM) established for further consideration and additional modifications to this ring system were explored. The addition of a second alkoxy substituent to the 5-alkoxy isoquinoline, as in <b>9</b>, resulted in a decline in activity both in the biochemical assay as well as the whole cell replicon screen.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This loss in intrinsic activity in the biochemical assay was attributed to a local conformational preference between the C5 and C6-methoxy groups (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a), which in the binding pocket of NS3/4A directs the alkyl terminus of the C5-methoxy away from the binding site while projecting the lone pair of the oxygen toward the EF loop carbonyls in a nonpreferential position. In an effort to retrieve the potency lost by the addition of a second substituent, an annulation strategy was considered which restrained the C5 and C6 substituents (<b>10</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b) in the bound mode observed for parent analogues <b>1</b> and <b>8</b>, as shown in parts c and d of Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, respectively. In this event, the simple dioxolane analogue <b>10</b> proved to be more potent than the acyclic <b>9</b> in both the biochemical assay as well as the whole-cell replicon screen. However, the metabolic and toxicological liabilities associated with the methylene acetal ring system present in <b>10</b> prompted the synthesis of the corresponding dihydrofuran and dihydropyran analogues.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Compound <b>11</b>, which incorporates a C5-dihydrofuran motif, provided excellent activity in the biochemical screen but with modest results in the whole-cell replicon assay. Upon testing in the CV model, <b>11</b> proved to be free of the CV liabilities associated with <b>1</b>. Consistent with this observation the one carbon homologue of <b>11</b>, dihydropyran analogue <b>12</b>, which similarly bears a C5-ethereal oxygen, was also free of a CV signal in the isolated heart model. However, the regiosomeric analogues <b>13</b> and <b>14</b>, in which the ethereal oxygen is located at position 6 of the isoquinoline ring system, each elicited a significant signal in the isolated heart model. This SAR was compelling and seemed to implicate the C6 ethereal oxygen present in <b>1</b>, <b>13</b>, and <b>14</b>, as responsible for the CV signal observed with these analogues. Consistent with these findings, the addition of a C6 ethereal oxygen to <b>12</b> provided dioxane <b>16</b> which, upon testing in the Langendorff model, induced bradycardia and an increase in SNRT. However, not all C5-alkoxy analogues proved to be free of CV liabilities as deannulation of the dihydrofuran ring found in <b>11</b> provided the C5-methoxy, C6-methyl analogue, <b>15</b>, which in the isolated heart model elicited significant bradycardia (−59%) and a substantial increase in SNRT (7296%). Thus, consistent SAR in the CV model was limited to clusters of compounds which were structurally similar with respect to the steric and electronic effects of the isoquinoline substituents. As this balance was easily disturbed, the utility of these findings to predict the profile of related compounds was limited.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a–d) Compounds <b>9</b>, <b>10</b>, <b>1</b>, and <b>8</b> bound to NS3/4A. (c) Crystal structure representation of the P2* region of compound <b>1</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> with the NS3/4A enzyme, whereas (a), (b), and (d) are computationally derived models of the bound modes of compounds <b>9</b>, <b>10</b>, and 8.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. P2* Analogues of <b>1</b>: HCV Inhibitory Potency, PK, and CV Profiles<a class="ref internalNav" href="#t2fn2" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0016.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0017.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0018.gif" alt="" id="GRAPHIC-d8688e1238-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn2"><div class="footnote" id="t2fn2"><sup>Table a</sup><p class="last">Compounds were dosed at 10 μM for 20 min. When vehicle only was perfused for 20 min, % change in HR and SNRT were –3 and 4, respectively.</p></div><div class="footnote" id="t2fn3"><sup>Table b</sup><p class="last">Compounds were dosed at 10 μM for 60 min. When vehicle only was perfused for 50 min, % change in HR and SNRT were –5 and 16, respectively.</p></div><div class="footnote" id="t2fn1"><sup>Table c</sup><p class="last">Compound <b>20</b> incorporates a valine in place of the <i>tert</i>-butyl glycine.</p></div></div><div></div></div><div class="NLM_p">From this seam of SARs in the isoquinoline series, <b>11</b> demonstrated a promising profile with acceptable antiviral activity and a favorable result in the Langendorff model. Upon IV dosing to rat, <b>11</b> demonstrated low clearance (1.4 mL/min/kg) and a half-life of 4 h. The plasma AUC of <b>11</b> after oral dosing at 15 mg/kg was 40 μM·h and 24 h plasma and liver concentrations were 0.11 and 0.80 μM, respectively. Hence, <b>11</b> was evaluated further with a specific emphasis on the CV profile of this analogue. Upon testing in the isolated heart model for a period of 60 min, <b>11</b> exerted only vehicle-like effects on HR and SNRT. In addition, in vivo evaluation of <b>11</b> in anesthetized rabbits provided a similar finding: minimal effects on HR and SNRT were observed and no substantial effects on PR, QRS, and QTc intervals, at plasma concentrations ≤177 μM. This plasma concentration of <b>11</b> is 6-fold higher than the concentration at which <b>1</b> induced bradycardia in this model. Thus, the CV profile demonstrated by <b>11</b> was noteworthy as it provided in vivo evidence that the CV effects observed with <b>1</b> could be eliminated by modifying the isoquinoline ring substituents. Moreover, a correlation was established between results obtained in the ex vivo isolated heart model with those in vivo. In dogs, <b>11</b> demonstrated acceptable oral bioavailability (66%) but high levels of the furan <b>17</b> were observed in plasma. In subsequent studies, <b>17</b> proved to be a potent inhibitor of CYP 3A4 (IC<sub>50</sub> = 69 nM), and further testing of this compound was discontinued.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Nonetheless, <b>17</b> was critical in establishing the isoquinoline ring system as a vehicle for the identification of compounds free of the CV effects observed with <b>1</b> in the rabbit.</div><div class="NLM_p">Structure–activity relationship studies in the isoquinoline series continued with the assessment and development of C4-alkoxy-substituted analogues. Initial interest in this series was based on the potency and in vivo distribution profile of the parent compound, <b>18</b>. This regioisomer of <b>1</b> exhibted an EC<sub>50</sub> of 19 nM in the GT-1b replicon screen. Moreover, after intraduodenal (ID) dosing to rats, a liver-to-plasma ratio of ∼3700 was observed at the 4 h time point.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the treatment of HCV, a hepatotropic distribution was considered a favorable property because viral replication is believed to occur predominantly in the liver.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Moreover, in the clinical evaluation of <b>1</b>, a significant decline in viral load (0.6 log<sub>10</sub> IU/mL) was observed after a 10 mg dose wherein the mean <i>C</i><sub>max</sub> was 5 nM, which was less than the EC<sub>50</sub> observed for this compound in GT-1 replicons. This observation provided indirect evidence suggesting that the liver levels of <b>1</b> played a role in mediating the antiviral response of this compound in infected patients. Consequently, the identification of a compound with a hepatotropic distribution was considered a favorable attribute and the profile of <b>18</b> was attractive from this perspective.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Full PK studies on <b>18</b> in rats further illustrated the hepatoselective distribution profile of this compound with liver levels at 24 h relatively high at 4.2 μM and an oral bioavailability of 19%. Upon perfusion of <b>18</b> in the isolated heart model at a concentration of 10 μM for 20 min, only mild effects were observed. Further perfusion for a 60 min period at 1 μM resulted in only vehicle-like effects, while escalating to 10 μM resulted in a more significant reduction in heart rate and a concomitant increase in SNRT. The mild CV effects observed for this compound prohibited its development, yet, given the observations made in the C5-alkoxy series wherein CV effects were optimized by further modifications to the isoquinoline ring system, an analogous strategy was adopted in the optimization of <b>18</b>.</div><div class="NLM_p">As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, potency was maintained by the addition of a second substituent to the isoquinoline ring system in <b>18</b>. However, the high liver exposure observed after dosing <b>18</b> to rats was not recapitulated with compounds incorporating an additional methoxy substituent. For example, both <b>19</b> (4,5-dimethoxy) and <b>20</b> (4,6-dimethoxy) showed poor exposure in both plasma and liver after oral dosing. Importantly, the addition of a C3-fluoro substituent to <b>20</b> provided <b>21</b>, a compound which displayed an in vivo distribution profile similar to that of the parent, <b>18</b>. For example, liver levels of <b>21</b> in rats 24 h postdose (15 mg/kg) were 3.4 μM. It should be noted that the CV profile of this set of bis-alkoxy isoquinolines did not meet criteria because significant effects on heart rate and SNRT were observed. However, the PK trend from this series suggested that the synthesis and evaluation of additional analogues of <b>18</b> which contained a halogen in the A- or B-ring system was warranted (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In the event, the C5, C6, and C7 chlorinated analogues of <b>18</b> proved to be potent inhibitors of the NS3/4A protease that extended to excellent inhibitory activity in the replicon. These compounds were subsequently evaluated in the Langendorff model, and while <b>22</b> and <b>23</b> each showed a mild to moderate CV signal, the C-7 chloro isomer <b>24</b> was free of CV effects in this model. Given the favorable CV and potency profile for <b>24</b> (EC<sub>50</sub> = 6 nM), the pharmacokinetic properties of the compound were assessed in the rat. After oral dosing to the rat, <b>24</b> demonstrated modest oral bioavailability and a plasma AUC of 1.0 μM·h. However, the 24 h liver levels of <b>24</b> after PO dosing were high at 15.2 μM, suggesting a hepatotropic distribution in vivo. Thus, <b>24</b> was an important lead, demonstrating on-target potency with a clean CV profile and a favorable hepatotropic distribution.</div><div class="NLM_p">A number of close structural analogues of <b>24</b> were synthesized in an effort to further optimize the molecule and to systematically evaluate SARs for CV effects. To this end, modifications were made to the C4 and C7 positions of the isoquinoline ring system and to subsites along the peptidic backbone of the molecule (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Most interesting was the observation that the C7-chloro isoquinoline analogue <b>25</b> demonstrated mild CV effects in the Langendorff model. As previously mentioned, the C4-methoxy derivative <b>18</b> also elicited a CV signal in this model. Thus, a C7-chloro group and a C4-methoxy moiety as individual entities gave rise to a measurable CV signal, yet, in combination, these substituents function to abrogate completely cardiac effects at the concentrations evaluated.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Analogues of <b>24</b>: HCV Inhibitory Potency, PK, and CV Profiles<a class="ref internalNav" href="#t3fn2" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0019.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0020.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn2"><div class="footnote" id="t3fn2"><sup>Table a</sup><p class="last">Compounds were dosed at 10 μM for 20 min. When vehicle only was perfused for 20 min, % change in HR and SNRT were −3 and 4, respectively.</p></div><div class="footnote" id="t3fn1"><sup>Table b</sup><p class="last">Compounds were dosed at 10 μM for 60 min. When vehicle only was perfused for 50 minutes, % change in HR and SNRT were −5 and 16, respectively.</p></div></div><div></div></div><div class="NLM_p">Further evaluation of the critical C7 position of the isoquinoline ring established that a chloro moiety was preferred at this site because replacement with fluorine (<b>26</b>) resulted in mild effects in the Langendorff model. In contrast, SARs at the C4 position of <b>24</b> suggested that the parent methoxy substituent could be further functionalized. For example, a MEM group, as found in <b>27</b>, proved to be a suitable replacement for the C4-methoxy in <b>24</b>. Compound <b>27</b> demonstrated a similar CV profile in the 20 min isolated heart model as observed for <b>24</b>; however, <b>27</b> was not advanced in the screening tier due to the relatively weak antiviral activity observed in the replicon assay. A dimethylamine moiety, as in <b>28</b>, also served as a useful replacement for the C4-methoxy group in <b>24</b> because this compound demonstrated a clean CV profile in the 20 min perfusion assay. However, perfusion of isolated hearts with <b>28</b> for 1 h resulted in mild effects on HR and SNRT that were significant compared to those with <b>24</b> under these conditions. Additional changes to the C4-position of <b>24</b> included incorporating a difluoromethoxy substituent, as exemplified by <b>29</b>, which resulted in a mild CV signal. This SAR point, albeit limited, suggested that in the context of the C7 chloro series, an electron donating C4 substituent was preferable.</div><div class="NLM_p">Modifications to the P1 and P4 subsites of <b>24</b> were also evaluated. Interestingly, relatively small structural changes to P1, such as saturation of the terminal olefin (<b>30</b>), resulted in very mild CV effects in isolated hearts. Supplementing this P1 change with a trifluorinated P4 Boc cap (<b>31</b>) gave a similar CV profile to <b>30</b> in the Langendorff model. The emergence of a CV signal from changes to the P1 subsite suggests that the peptidic core plays some role in affecting cardiac sinus rhythm. Consistent with this hypothesis, perfusion of isolated rabbit hearts with the ketone (<b>32</b>) elicited mild effects (17% HR reduction, 26% increase in SNRT after 20 min at 10 μM). Thus, it appears that CV effects that are pronounced with <b>1</b> and abrogated with <b>24</b> result from a complex interplay between backbone and P2* moieties.</div><div class="NLM_p">Hence, <b>24</b> emerged from an extensive SAR study in the isoquinoline series as an optimized compound in terms of potency, PK and initial CV profile and this compound was profiled more extensively. Perfusion of isolated rabbit hearts with <b>24</b> at a concentration of 10 μM for 60 min induced only vehicle-like effects on HR and SNRT. The tissue concentration of <b>24</b> in the atrium at the end of the experiment was 61 μM, demonstrating significant localization of compound in the region of the heart containing the SA node. The significant difference in outcome for <b>24</b> compared to <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) underscores the impact of small structural changes on CV profile. In rabbits, <b>24</b> induced only vehicle-like effects on HR and SNRT as well as PR, QRS, and QTc intervals at high plasma concentrations ≤240 μM (nearly 9-fold that where <b>1</b> caused significant effects), providing further confidence to advance this compound. Compound <b>24</b> was also tested in the battery of ion channel and cardiac receptor assays described previously; no significant inhibition was noted in these assays at a protein-free concentration of ≤30 μM.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A comparison of results in the isolated heart model for compounds <b>1</b> and <b>24</b>. Compounds were perfused for 60 min at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The clear distinction in CV profiles of <b>1</b> and <b>24</b> prompted an exploration of the relative solution conformation of these compounds, and this was accomplished by comparing various NMR parameters (chemical shifts, coupling constants, NOEs) acquired in aqueous buffer. The chemical shift of amide hydrogens are sensitive indicators of conformation. Little difference is observed for the chemical shifts of the amide hydrogens in either the <i>tert</i>-butyl glycine substructure (6.54 vs 6.62 ppm in <b>24</b> and <b>1</b>, respectively) or the P1 amino acid moiety (8.31 vs 8.28 ppm in <b>24</b> and <b>1</b>, respectively). In addition, the chemical shifts of other protons throughout <b>24</b> and <b>1</b> exhibit considerable similarity, the only exception being the shifts arising from the P2* moiety, which is a direct reflection of the altered substitution pattern. Each compound exhibits a preference for an extended conformer as indicated by the NOE pattern along the peptide backbone as well as the observation of large <i>J</i><sub>HN,Hα</sub> coupling constant in the <i>tert</i>-butyl glycine substructure (9.66 vs 9.31 Hz in <b>24</b> and <b>1</b>, respectively). All spectroscopic evidence points toward the backbones of <b>24</b> and <b>1</b> being conformationally similar. However, inspection of NOE cross peaks originating from aromatic protons in the P2* moiety suggests differences may exist in the side chain conformations of the two compounds; considerably more NOEs were observed in <b>24</b> than in <b>1</b> (Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a,b). NOE contacts are also observed between hydrogen atoms within the cyclopropyl ring of the P1 subsite and the Hβ hydrogens in the hydroxy proline of <b>24</b>, but analogous interactions were not found in <b>1</b>. These observations suggest an enhanced conformational mobility of the P2* in <b>1</b> compared to <b>24</b>. While the conformational differences between <b>1</b> and <b>24</b> are suggestive of a potential source of off-target effects, a direct correlation to CV properties can only be established after NMR analysis of a representative set of compounds and such efforts are ongoing.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Depiction of observed interproton NOE contacts in <b>24</b> (a) and <b>1</b> (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As noted, oral dosing (15 mg/kg) of <b>24</b> to rats resulted in plasma exposure of approximately 1 μM·h (<i>F</i> = 12%), with high clearance (38 mL/min/kg) and a moderate half-life of 4.2 h. The clearance of <b>24</b> in the rat was substantially higher than the 7 mL/min/kg reported for <b>1</b>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Consistent with this observation, the 24 liver levels measured for <b>24</b> after PO dosing were substantially greater than those observed for <b>1</b>. The liver levels of <b>24</b> measured at 4 h postdosing were 15.2 μM, while at that same time point the levels of <b>1</b> in the liver were 0.734 μM. Subsequent in vitro studies in hepatocytes indicated that <b>24</b> was taken up into cells by an active transport process, an observation that had also been made with <b>1</b>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Interestingly, while the hepatotropic distribution of both <b>1</b> and <b>24</b> appeared to be mediated, at least in part, by transporters, their half-lives in rat liver were significantly different. The <i>t</i><sub>1/2</sub> of <b>24</b> in rat liver was 13 h, while that for <b>1</b> was much shorter at 4 h. This differential in half-lives between these compounds in the liver may be a reflection of differences in their elimination rates. The PK performance of <b>24</b> in dogs was quite similar to that observed for <b>1</b>, with an oral bioavailability of >50%, and moderate clearance. Upon dosing to monkeys, the oral bioavailability of <b>24</b> was low, with moderate clearance observed which compared favorably to the profile observed for <b>1</b>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> An hepatotropic distribution of <b>24</b> was observed in both the dogs and monkeys as the liver-to-plasma AUC ratios for these compounds after PO dosing were 40 and 151, respectively. These AUC ratios were less than that observed in rat (359) for <b>24</b>; however, the result provided evidence of an hepatotropic distribution of <b>24</b> across species and provided confidence of a similar outcome in humans.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Hence, <b>24</b> demonstrated a similar PK profile to <b>1</b> across species but with a greater liver disposition observed in rat.</div><div class="NLM_p">In the cell-based replicon assay, <b>24</b> exhibited an EC<sub>50</sub> of 4.0 nM toward the GT-1a strain and 1.2 nM toward the GT-1b strain. The in vitro cytotoxicity profile of <b>24</b> in a hepatotoma-derived cell line was also favorable (CC<sub>50</sub> = 34 μM), providing a significant therapeutic index. The potency of <b>24</b> was approximately 2-fold higher than <b>1</b> in the GT 1a and 1b replicon assays. Not surprisingly, the X-ray cocrystal structures revealed the binding mode of these compounds with the NS3/4A enzyme to be quite similar, with only subtle changes in the EF-loop region and the D168-Arg155 interactions seen in response to the P2* group used (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). In the case of <b>1</b>, the isoquinoline C6 methoxy group projects into the solvent, whereas the C4 methoxy in <b>24</b> projects toward the EF loop. The subtle relocation of the EF loop suggests limited plasticity that is sufficient to accommodate the isoquinoline C4 methoxy substituent in <b>24</b>. This induces a shift in ring B of the isoquinoline group with the Cl substitution in the C7 position projecting toward Asp168. The impact, based on the co-crystal structure, is a rearrangement of the hydrogen-bond network between Asp168 and Arg155, shifting from a true bidentate salt bridge interaction in <b>1</b> to a shared interaction with Arg123 in <b>24</b>.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Crystal structure of <b>1</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and <b>24</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> bound to the HCV NS3/4A enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further profiling of <b>24</b> in vitro demonstrated that the compound was a P-glycoprotein (P-gp) substrate and a mild inhibitor of CYP 3A4 (not time-dependent). There was no evidence implicating <b>24</b> as an inducer of CYP 3A4 expression. Compound <b>24</b> was neither mutagenic (Ames assay) nor clastogenic (in vitro micronucleus assay in Chinese hamster ovary (CHO) cells). Selected in vitro profiling screens for inhibition of enzyme activities revealed no off-target activity for <b>24</b> at 10 μM. In conscious telemetered dogs, no significant CV effects were observed after oral administration of <b>24 </b>which provided <i>C</i><sub>max</sub> values ≤94 μM. In contrast, <b>1</b> produced significant CV effects at a plasma exposure of 12 μM. Additionally, GLP toxicity studies in rats and dogs with <b>24</b> supported clinical development of this compound based on <i>C</i><sub>max</sub> and AUC margins for a projected human dose.</div><div class="NLM_p">The antiviral activity of <b>24</b> (BMS-650032, asunaprevir) coupled with its pharmacokinetic properties and favorable toxicological profile qualified the compound for evaluation in pre-IND toxicology studies as a prelude to advancing into clinical trials.<a onclick="showRef(event, 'ref3 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref3 ref13 ref14 ref15 ref16">(3, 13-16)</a> The antiviral activity of <b>24</b> was established in a single ascending dose (SAD) study conducted in genotype 1-infected patients followed by a multiple ascending dose (MAD) study in which the drug was administered twice daily for 3 days.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> At doses of 200–1200 mg of <b>24</b>, plasma viral RNA declined rapidly with mean maximal reductions of 2.7 and 3.5 log<sub>10</sub> IU/mL in the SAD and MAD studies, respectively. Clinical trials designed to evaluate the efficacy and safety of <b>24</b> in combination with pegylated interferon-α (pegIFN) and ribavirin (RBV), as well as in combination with one or two direct-acting antiviral agents (DAAs) targeting different mechanisms of action in the HCV replication pathway, have been described.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17-22)</a> In the 2-DAA proof-of-concept trial, <b>24</b> was combined with the NS5A inhibitor daclatasvir<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with and without pegIFN/RBV and administered for 24 weeks to HCV GT-1 patients who had previously failed treatment with pegIFN/RBV.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In the sentinel cohorts of this trial, of the 11 patients (9 GT-1a and 2 GT-1b) receiving the 2-DAA-only combination, four (2 GT-1a and 2 GT-1b patients) achieved a sustained virological response (SVR) while all 10 patients (10 GT-1a and 1 GT-1b) in the cohort receiving the 2-DAA regimen combined with pegIFN/RBV achieved SVR. This study established for the first time that a chronic HCV infection could be cured by therapy with small molecule DAAs in the absence of the immunomodulatory effects of pegIFN.<a onclick="showRef(event, 'ref18 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref21">(18, 21)</a> These results have been confirmed in clinical trials in Japanese patients chronically infected with GT-1b who had previously failed to respond to pegIFN/RBV.<a onclick="showRef(event, 'ref19 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref22">(19, 22)</a></div><div class="NLM_p">The synthesis of <b>24</b> involved the coupling of three key intermediates <b>33</b>, <b>34</b>, and <b>35</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), and this general approach was employed in the preparation of tripeptide acylsulfonamide analogues described herein. The synthesis of <b>34</b> warrants description (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), while <b>35</b> has been previously described<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and <b>33</b> is a commercially available material. Treatment of cinnamic acid <b>36</b> with diphenylphosphoryl azide (DPPA) generated the acylazide <b>37</b> as an isolable compound. Thermolysis of <b>37</b> in refluxing diphenylmethane catalyzed a Curtius rearrangement followed by ring closure which secured the isoquinoline ring system found in <b>38</b> in 53% yield. Selective C4 oxygenation of the isoquinoline nucleus proceeded via a chemoselective ipso substitution that was followed by a halogen-metal exchange reaction and oxygenation. To this end, isoquinolone <b>38</b>, upon treatment with <i>N</i>-bromosuccinimide in CH<sub>3</sub>CN, was selectively brominated to provide 4-bromo-7-chloro-isoquinolone <b>39</b>. Isoquinolone <b>39</b> was converted to the C1-chloroisoquinoline <b>40</b> by exposure to POCl<sub>3</sub> at reflux. Oxygenation of the isoquinoline C4 position in <b>40</b> was accomplished in a single operation by a lithium-halogen exchange (<i>n</i>-BuLi, −78 °C), which selectively engaged the C4-bromo group in the presence of both the C1 and C7 chloro substituents. The intermediate aryl-lithium species was quenched by the addition of isopropylboronic acid ester which gave rise to the isoquinoline-4-boronate derivative. In the course of several experiments, this boronate derivative was isolated; however, such workup and characterization proved unnecessary as optimal yields were obtained by subjecting the crude boronate directly to the oxidizing conditions of aqueous H<sub>2</sub>O<sub>2</sub>. The process of lithiation, boronate ester formation, and oxidation provided the desired 4-hydroxy-1,7-dicholoroisoquinoline <b>41</b> in good overall yield (82%). Importantly, this transformation proved amenable to large scale preparative procedures. The final step in the formation of P2* intermediate <b>42</b> was the methylation of the hydroxyl group in <b>41</b>, which was conducted straightforwardly using either trimethylsilyldiazomethane or MeI in the presence of base. The final step in the synthesis of <b>34</b> involved the base-induced coupling of <i>N</i>-Boc-3-(<i>R</i>)-hydroxy-<span class="smallcaps smallerCapital">l</span>-proline and 1-chloro-4-methoxy-7-chloro-isoquinoline <b>42</b>, which proceeded in quantitative yield to provide the desired <i>N</i>-Boc-3-(<i>R</i>)-(4-methoxy-7-chloro-1-oxo-isoquinoline)-<span class="smallcaps smallerCapital">l</span>-proline <b>34</b>.</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Key Fragments in the Synthesis of <b>24</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fragment <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DPPA, Et<sub>3</sub>N, benzene, rt; (b) Ph<sub>2</sub>CH<sub>2</sub>, reflux, 53% overall for two steps; (c) NBS, MeCN, reflux, 90%; (d) POCl<sub>3</sub>, reflux, 73%; (e) (1) <i>n</i>-Bu-Li, THF, −78 °C, (2) (<i>i</i>-PrO)<sub>3</sub>B, −78 °C; (3) 50% H<sub>2</sub>O<sub>2</sub>, Na<sub>2</sub>SO<sub>3</sub> −78 °C, 82% overall three steps; (f) MeOH, MeCN, TMSCHN<sub>2</sub>, 0 °C–rt, 66% or MeI, NaH, DMF, 4 °C, 96%; (g) <i>N</i>-Boc-3-(<i>R</i>)-hydroxy-<span class="smallcaps smallerCapital">l</span>-proline, <i>t</i>-BuOK, DMSO, 10 °C.</p></p></figure><div class="NLM_p">The final sequence of reactions (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) involved coupling of (1<i>R</i>,2<i>S</i>)-1-amino-<i>N</i>-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide <b>35</b> with the functionalized proline derivative <b>34</b> to provide the <i>N</i>-Boc-protected dipeptide <b>43</b> as a crystalline compound in 88% yield. Intermediate <b>43</b> was deprotected to provide the free amine <b>44</b> as a crystalline solid, which was coupled with the commercially available <i>N</i>-Boc-<i>t</i>-butyl-<span class="smallcaps smallerCapital">l</span>-glycine <b>33</b> to provide the final compound <b>24</b> in 94% yield. The crystalline hydrate of <b>24</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) was readily generated in methanol with water as the antisolvent.</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Coupling of Fragments for the Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, Hunig’s base <i>i</i>-Pr<sub>2</sub>Net, (1<i>R</i>,2<i>S</i>)-1-amino-<i>N</i>-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide (TsOH salt, <b>35</b>), rt, 88%; (b) HCl (conc), MeOH, reflux, 100%; (c) HATU, Hunig’s base, <i>N</i>-Boc-<i>t</i>-butyl-<span class="smallcaps smallerCapital">l</span>-glycine (<b>33</b>), DCM, 0 °C–rt, 94%.</p></p></figure><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Single crystal X-ray structure of the hydrate of <b>24</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In the preparation of crystalline <b>24</b>, amorphous material was dissolved in methanol and water was added as an antisolvent. Prism or plate-shaped crystals were obtained which provided monohydrate crystals upon standing under ambient conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The cardiovascular effects observed in the clinic in subjects treated with <b>1</b> resulted in the discontinuation of clinical trials with this tripeptidic acylsulfonamide. These CV findings were noted in the presence of low plasma levels of <b>1</b>, an observation that was surprising given the preclinical CV toxicology profile conducted in both rabbits and dogs where the compound showed only mild CV effects at relatively high plasma levels. The cardiovascular effects of <b>1</b> were recapitulated in an isolated rabbit heart model that was utilized to profile and triage lead NS3/4A inhibitors. The CV effects observed for <b>1</b> were mitigated by modifications to the P2* isoquinolone ring system, which led to the identification of <b>24</b> (BMS-650032, asuanprevir) as a compound free of the cardiovascular liabilities found in the first clinical compound. The antiviral activity, PK, and toxicological profile of <b>24</b> met the targeted criteria, and this compound was advanced into clinical trials. Notable were the elevated levels of <b>24</b> found in the liver across species after IV or PO dosing in conjunction with its potency against GT 1a and 1b replicons which provided high EC<sub>50</sub> multiples 24 h after dosing. The activity of <b>24</b> translated into a robust antiviral response in early clinical trials. In an important proof-of-concept clinical trial, <b>24</b> was combined with the NS5A replication complex inhibitor daclatasvir as part of an interferon-free, RBV-free regimen. Not only was this the first study to show that patients infected with GT-1 could be cured with a DAA-only regimen, it was also the first study to show that difficult-to-treat prior nonresponders to IFN-based regimens could be cured of infection. Phase 3 studies with <b>24</b> and daclatasvir have now been completed, and if approved, this DAA-only regimen has the potential to provide GT-1b HCV-infected patients with therapy of superior safety and efficacy relative to the currently approved regimens.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Methods</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Sample Analysis for in Vitro and in Vivo Studies</h4><div class="NLM_p">Samples obtained from pharmacokinetic studies were analyzed by LC/MS/MS. Analysis was by multiple reaction monitoring using positive ion mode. Declustering potential and collision energy were optimized for each compound. Plasma samples were prepared by protein precipitation/filtration using organic solvent containing internal standard (IS) as follows. First, 200 μL of the IS solution was added to each well of a protein precipitation filter plate (Strata, Phenomenex, LA). Then biological samples (50 μL) were added to the filter plate, such that a 4:1 v/v solvent/sample ratio was achieved. The filter plate was placed atop a standard 96-well plate, and the entire unit was centrifuged at 1000 rpm for 2 min. The supernatant was collected in the 96-well plate, and an aliquot (10 μL) was first injected onto the TFC extraction column and then back-eluted onto a high-performance liquid chromatography (HPLC) column for LC/MS/MS-based analysis. For the analysis of liver samples, tissues were homogenized in phosphate buffer/CH<sub>3</sub>CN (80/20, v/v) and the resulting homogenates were prepared for analysis using protein-precipitation followed by online TFC extraction as described for plasma samples. If dilutions were required, an aliquot of the sample was diluted into the respective matrix. Analysis of samples from full PK studies were conducted against standard curves ranging from 2 to 10000 nM. Each standard curve was fitted with a linear regression weighted by reciprocal concentration (1/<i>x</i><sup>2</sup>). Standards were analyzed in duplicate. Quality control samples were prepared in blank biological matrix at concentration levels within the range of the standard curve and were analyzed as replicates within each analytical set.</div><div class="NLM_p last">All animal studies were performed under the approval of the Bristol-Myers Squibb Animal Care and Use Committee and in accordance with the American Association for Accreditation of Laboratory Animal Care (AAALAC).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Rat Pharmacokinetics</h4><div class="NLM_p last">Male Sprague–Dawley rats (300–350 g, Hilltop Lab Animals, Inc., Scottsdale, PA) with single or dual indwelling jugular cannulas were used (<i>N</i> = 3 per group). Rats dosed orally were fasted overnight, while those intravenously dosed were not fasted. Compounds were administered either IV (5 mg/kg, 10-min infusion) or orally (15 mg/kg, gavage) in PEG-400/ethanol (9:1). Serial blood samples were obtained from the jugular vein cannulas of all animals at 0 (predose) and at 0.17 (or 0.25 for oral), 0.5, 0.75, 1, 2, 4, 6, 8, 24 h post dose. These samples (∼0.3 mL) were collected into K3EDTA-containing tubes and then centrifuged at 4 °C (1500–2000<i>g</i>) to obtain plasma, which was stored at −20 °C until analysis by LC/MS/MS. Excised tissues were rinsed, blotted dry, weighed, and stored frozen until processed for analysis by LC/MS/MS. Screening studies were conducted as described above with truncated time points (0 (predose), 0.17 (IV only), 0.5, 1, 2, 4, and 6 h with livers were taken at terminal time point).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Data Analysis</h4><div class="NLM_p last">The pharmacokinetic parameters were obtained by noncompartmental analysis of plasma concentration versus time data (KINETICA software, version 2.4, InnaPhase Corporation, Philadephia, PA). The peak concentration (<i>C</i><sub>max</sub>) were recorded directly from experimental observations. The area under the curve from time zero to the last sampling time (AUC<sub>0-<i>t</i></sub>) was calculated using a combination of linear and log trapezoidal summations. The plasma clearance (CL = dose/AUC after IV dose) and elimination half-life (<i>T</i><sub>1/2</sub>) in plasma and livers calculated from following equation: <i>T</i><sub>1/2</sub> = 0.693 × volume/clearance.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Ion Channel and Purkinje Fiber</h4><div class="NLM_p">Test agents were evaluated in vitro for effects on potassium (hERG/IKr), L- and T-type calcium, sodium (SCN5A), and pacemaker (HCN4) channels, and rabbit Purkinje fiber action potentials. Ionic current measurements were performed using the whole cell patch clamp technique. Human ion channels (hERG, sodium, L- and T-type calcium, HCN4) stably expressed in human embryonic kidney cells (HEK 293) were used as test systems. In the hERG assay, effects on hERG currents were calculated by measuring inhibition of peak tail currents. In the sodium channel assay, effects were calculated by measuring inhibition of peak inward currents at two stimulation frequencies, 1 and 4 Hz, to assess rate-dependence of interaction. In the T-type and L-type calcium channel assays, and the HCN4 assay, effects were calculated by measuring inhibition of peak inward currents.</div><div class="NLM_p last">Action potential parameters were measured in isolated rabbit Purkinje fibers using a conventional intracellular technique. Action potential parameters measured included resting membrane potential, overshoot, maximal upstroke velocity (<i>V</i><sub>max</sub>), and time to 50% and 90% repolarization.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Isolated Perfused Rabbit Heart</h4><div class="NLM_p">Hearts were excised from anesthetized rabbits and perfused in a retrograde manner through the aorta at a constant pressure and temperature (37 ± 0.2 °C) with oxygenated Krebs–Henseleit bicarbonate buffer. A bipolar ECG was recorded via electrodes connected to an ECG amplifier. A pair of recording electrodes was placed on the epicardium of the left atrium and pair of stimulating electrodes was placed on the epicardium of the right atrium for atrial stimulation. Flow of the perfusate through the coronary arteries was monitored and recorded via an extracorporeal flow probe. The atrial electrogram, ECG, and coronary flow were continuously monitored and recorded via a Ponehmah physiology platform (Data Sciences International, St. Paul, MN). Data were expressed as mean ± SD and were compared using student <i>t</i> test.</div><div class="NLM_p">The primary end point of the studies was SA node function; the secondary end points were cardiac conduction (A–V conduction, QRS duration), QT interval, and coronary flow. SA node function was evaluated by measuring SA node recovery time (SNRT) and sinus rate (HR). SNRT was defined as the longest A<sub>1</sub>–A<sub>2</sub> cycle length after atrial pacing. In some experiments, test agents were perfused at different concentrations in ascending order in each heart. Each concentration was perfused for 10 min without washout between concentrations. All parameters were measured at baseline and after 10 min perfusion at each concentration. Data were averaged from 1 min recording at baseline and after 10 min perfusion at each dose. To study the effects of a single concentration of test agent over a longer time period, rabbit hearts were perfused for 1 h with test agent and data were analyzed every 10 min throughout the perfusion period.</div><div class="NLM_p last">At the end of the study, the atria were weighed and snap frozen in liquid nitrogen and were stored frozen at −20 °C until all studies were done. To measure tissue concentration, the atria were thawed at room temperature and 1 g of tissue was homogenized in 2 volumes of homogenization buffer (800 mL acetonitrile (HPLC grade no. 9017-03, JT Baker, Phillipsburg, NJ):200 mL Hank’s balanced salt solution (catalogue no. 14175-095, Invitrogen, Carlsbed, CA). Tissues were homogenized on ice at 13500–17500 rpm using short bursts of a T25 basic S1 generator (IKA Works, Wilmington, DE) with an S25N-8G dispersing tool until a uniform suspension is achieved. The suspension was centrifuged at 3000 rpm for 10 min at 4 °C, and the supernatant was analyzed for BMS-650032 concentrations as previously described.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Anesthetized Rabbit Electrophysiology</h4><div class="NLM_p last">Experiments were performed in propofol–fentanyl anesthetized closed-chest rabbits (<i>n</i> = 4). The primary end point was SA node function reflected by SA node recovery time (SNRT) and sinus rate (HR). SNRT is defined as the longest A<sub>1</sub>–A<sub>2</sub> cycle length after atrial pacing. A<sub>1</sub> represents the last beat of an atrial pacing train, and A<sub>2</sub> the first spontaneous sinus beat after pacing. The secondary end points were cardiac conduction (A–V conduction, QRS duration) and QT interval. The atrial and His bundle electrograms were continuously monitored and recorded via intracardiac leads that were connected to Prucka CardioLab 7000. Body surface ECG (lead II and III) and arterial blood pressure (BP) were continuously monitored and recorded at 500 Hz (Ponehmah) at a logging rate of 10 s. Compounds were intravenously infused at 1, 3, and 10 mg/kg via an infusion pump. PEG400:ethanol (9:1) was used as vehicle. Each dosage was achieved by 5 min infusions. SNRT was measured 2 min later. The interval between dosage escalations was 15 min. Blood (plasma) samples were taken 2 min after the end of the first two infusions and 5, 15, 30, and 60 min after the final infusion for determination of compound concentration. Data were averaged from a 1 min recording interval immediately before blood sampling and are expressed as mean ± SEM. Data were compared with vehicle control using student <i>t</i> test.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Dog Cardiovascular Telemetry</h4><div class="NLM_p last">The potential hemodynamic and electrocardiographic (ECG) effects of acute oral doses of test agents were evaluated in conscious dogs monitored by telemetry. Four instrumented beagle dogs (two of each sex) were given <b>1</b> at 30 mg/kg given as 15 mg/kg BID separated by 4 h dosed in gelatin capsules as a solution in 20% α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in 4 mM sodium bicarbonate (NaHCO<sub>3</sub>), pH 10.0. Six instrumented beagle dogs (three of each sex) were administered <b>1</b> at 100 mg/kg given in gelatin capsules as a solution in polyethylene glycol 400 (PEG-400) and TPGS (60:40 v/v). Each dog served as its own control and received the test article vehicle 1 day prior to and 5 days after test agent administration. Systemic blood pressure (systolic, diastolic, and mean), left ventricular end-diastolic pressure, lead II electrocardiogram, core body temperature, and activity were monitored via radiotelemetry implants (Integrated Telemetry Systems) for approximately 20 h after each vehicle or test article administration. The first derivative of left ventricular pressure signal, +d<i>P</i>/d<i>t</i>, was calculated as an index of left ventricular contractility. Additional parameters evaluated included clinical signs (through approximately 6 h after the initial BID dose via remote video monitoring, and during periods of animal handling) and toxicokinetics (4 and 6 h after the initial dose). Six instrumented beagle dogs (three of each sex) were administered <b>24</b> at 100 mg/kg given in gelatin capsules as a solution in PEG-400 and TPGS (60:40 v/v) and similarly evaluated by telemetry.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> CYP Inhibition Assay</h4><div class="NLM_p last">To assess the potential for a drug candidate to inhibit CYP450 enzymes, microsomes expressing individual human recombinant CYP450s and fluorogenic CYP probes that produce fluorescent metabolites were used. The CYP450 enzymes includes CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4-BFC, and CYP3A4-BzR and were conducted in duplicate in 384-well plates using a high-throughput assay format with robotic liquid handling. Briefly, test compounds are dissolved in DMSO (20 mM) with positive controls added along with compounds following the same dilution process as the compounds. Using a TECAN Genesis, the 100% DMSO/compound solutions are serially diluted, 1:3, to 10 concentrations. The 100% DMSO/compound solutions were then diluted with water to 0.6% DMSO. The final DMSO concentration in the assay is 0.2%. The top test concentration for the test compounds is 40 μM. After prewarming of the assay plates in an incubator (37 °C) for 10 min, a mixture of substrate and cofactors in the appropriate potassium phosphate assay buffer was added. The enzyme/substrate pairs are 1A2, 3-cyano-7-ethoxycoumarin (CEC), 2C9, 7-methoxy-4-trifluoromethylcoumarin (MFC), 2C19, 3-cyano-7-ethoxycoumarin (CEC), 2D6, 3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylamino)ethyl]-7-methoxy-4-methylcoumarin (AMMC), 3A4, 7-benzyloxy-4-trifluoromethylcoumarin (BFC), and 3A4, benzyloxyresorufin (BzR) . The final cofactor concentrations are 1.3 mM NADP+, 3.3 mM glucose-6-phosphate, and 0.4 U/mL glucose-6-phosphate dehydrogenase for all enzymes except 2D6. The 2D6 assay has final cofactor concentrations of 0.0081 mM NADP+, 0.41 mM glucose-6-phosphate, and 0.4 U/mL glucose-6-phosphate dehydrogenase. The reactions were initiated by the addition of enzyme in the appropriate potassium phosphate assay buffer. The enzyme source for the assays were cDNA-expressed isozymes prepared from baculovirus-infected insect cells supplied from BD Biosciences Corp (Woburn, MA). The assay plates were returned to the incubator (37 °C) until the appropriate times at which plates were removed for analysis. The reaction in each plate was quenched by the addition of 80% acetonitrile/20% 0.5 M TRIS base, except for the 3A4-BzR assay that was read immediately after the 45 min incubation. The amount of fluorescent product formed in each well was determined by analysis using a LJL Analyst plate reader. The data from the reader was exported and analyzed using Xlfit curve-fitting software to calculate the 50% inhibitory concentrations (IC<sub>50</sub>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> NMR</h4><div class="NLM_p">Expanded regions of 2d-NOE spectra for <b>24</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>a) and <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>b)</div><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0010.jpeg" id="GRAPHIC-d8688e2432-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Expanded regions of 2d-NOE spectra for <b>24</b> (a) and <b>1</b> (b). Sample solutions were ∼0.2 mM of compound 24 (a) and 1 (b) in 70% H<sub>2</sub>O (NaPO<sub>4</sub> buffer of 10 mM, pH = 6.3) and 30% DMSO-<i>d</i><sub>6</sub>. Spectra were acquired on a Bruker 700 MHz spectrometer equipped with a TCI cryo-probe, the sample temperature was 20.0 °C. The proton spectral traces along the borders of the NOESY spectral panel are from imported proton spectra. All spectra were processed in topspin with cosine apodizations in both time domains. NOESY spectra were acquired in a block-averaged mode of four times four scans per per t1-increment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Compound Synthesis</h4><div class="NLM_p">All reagents were purchased from commercial suppliers and used without purification unless otherwise noted. All anhydrous reactions were performed under a N<sub>2</sub> atmosphere using SureSeal solvents from Aldrich. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded on a Bruker AM FT 300 MHz spectrometer, a Bruker Avance<sup>III</sup> 500 MHz spectrometer, or a Bruker Ultrashield 400 MHz spectrometer, each equipped with a 5 mm TXI cryoprobe. All spectra were determined in the solvents indicated, and residual protio-solvent was used as internal standard for chemical shift assignments. Interproton coupling constants are reported in hertz (Hz). Multiplicity patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad; dd, doublet of doublets; dt, doublet of triplets; dq, doublet of quartets and most spectra were analyzed using the ACDLABS SpecManager 12.0 program software. Note: at ambient temperature in DMSO-<i>d</i><sub>6</sub>, most of the final products exist predominantly as a mixture of rotamers.</div><div class="NLM_p">All compounds were determined to be at a purity level of greater than 95% as detemined by liquid chromatography methodologies. Liquid chromatography/mass spectra (LCMS) were performed on a Shimadzu LC instrument coupled to a Water Micromass ZQ instrument and the LCMS conditions are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. LCMS Conditions Used in the Characterization of All Compounds Found in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">LCMS condition<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Col<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">GT<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">FR<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Sol A<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Sol B<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method A</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method B</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method C</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method D</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method E</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method F</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method G</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method H</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method I</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method J</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method K</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method L</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method M</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method N</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method O</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method P</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="center">A1</td><td class="colsep0 rowsep0" align="center">B1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Gradient = 0%B to 100%B; wavelength (λ) = 220 nm; injection volume = 5 μL unless otherwise stated.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Col = column where column 1 = Phenomenex-Luna C18 (4.6 mm × 30 mm, S10); column 2 = Phenomenex-Luna C18 (2.0 mm × 30 mm, 3 μm); column 3 = Xterra C18 (3.0 mm × 50 mm, S7); column 4 = Phenomenex-Luna C18 (3.0 mm × 50 mm, 5 μm); column 5 = Waters Aquity BEH C18 2.1 mm × 50 mm 1.7U; column 6 = Xterra C18 (4.6 mm × 50 mm, S7); column 7 = Phenomenex-Luna C18 (3.0 mm × 50 mm, S10); column 8 = Phenomenex-Luna C18 (3.0 mm × 50 mm, S10); column 9 = Xterra C18 (4.6 mm × 30 mm, S5); column 10 = Phenomenex-Luna C18 (3.0 mm × 50 mm, 10 μm).</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">GT = gradient time (min).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">FR = flow rate (mL/min).</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Sol A = solvent A where solvent A1 = 0.1% TFA/10% MeOH/90% H<sub>2</sub>O.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Sol B = solvent B where solvent B1 = 0.1% TFA/90% MeOH/10% H<sub>2</sub>O.</p></div></div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Preparation of 7-Chloroisoquinolin-1-ol (<b>38</b>)</h3><div class="NLM_p last">DPPA (27.5 g, 0.1 mol) was added dropwise to a solution of (<b>36</b> (18.3 g, 0.1 mol) and Et<sub>3</sub>N (20.2 g, 0.2 mol) in benzene (100 mL). After stirring for 2 h, the solution was concentrated and the residue purified by silica gel chromatography (20% EtOAc/hexanes) to give 16 g of <b>37</b> as a solid. Intermediate <b>37</b> was dissolved in Ph<sub>2</sub>CH<sub>2</sub> (100 mL) and the mixture slowly heated to 90 °C over a 30 min time period. The solution was heated to reflux and maintained at this temperature for 3 h. After cooling to room temperature, a solid precipitated which was collected by filtration and washed with toluene to provide <b>38</b> (9.5 g, 53%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.24 (d, <i>J</i> = 2.27 Hz, 1 H), 7.67 (d, <i>J</i> = 2.01 Hz, 1 H), 7.66 (s, 1 H), 7.18 (d, <i>J</i> = 7.05 Hz, 1 H), 6.66 (d, <i>J</i> = 7.05 Hz, 1 H). LCMS (method D): <i>t</i><sub>R</sub> = 1.86 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>6</sub>ClNO, 179.01; found, 179.92 (M + H)<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Preparation of 4-Bromo-7-chloroisoquinolin-1-ol (<b>39</b>)</h3><div class="NLM_p last">A slurry of <b>38</b> (36.33 g, 203 mmol) and <i>N</i>-bromosuccinimide, (39.74 g, 223.3 mmol) in anhydrous CH<sub>3</sub>CN (500 mL) was slowly heated to a gentle reflux over a period of approximately 2 h and maintained at a gentle reflux for 1.5 h. After cooling to room temperature over a period of 3 h, the precipitated solid was collected by filtration and washed with CH<sub>3</sub>CN (100 mL × 3) to provide <b>39</b> (47 g, 90%) as a solid. This material was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.27 (d, <i>J</i> = 2.00 Hz, 1 H), 7.88 (d, <i>J</i> = 8.8 Hz, 1 H), 7.81 (dd, <i>J</i> = 8.40, 2.00 Hz, 1 H), 7.46(s, 1H). LCMS (method D): <i>t</i><sub>R</sub> = 2.21 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>5</sub>BrClNO, 256.92; found, 257.80 (M + H)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Preparation of 4-Bromo-1,7-dichloroisoquinoline (<b>40</b>)</h3><div class="NLM_p last">A heterogeneous solution of <b>39</b> (47 g, 182 mmol) in POCl<sub>3</sub> (200 mL, 2.15 mol) was slowly heated to reflux over a period of 1 h and then was maintained at reflux for 4 h before being cooled to room temperature and concentrated in vacuo to remove excess POCl<sub>3</sub>. The residue was dissolved in of CH<sub>2</sub>Cl<sub>2</sub> (600 mL), cooled to −35 °C, neutralized, and subsequently basified carefully with 1 N NaOH (400 mL) until the mixture was pH = 8. The organic layer was separated, washed with H<sub>2</sub>O, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residual solid was crystallized from EtOAc (approximately 50 mL) to give 32 g of <b>40</b>. The mother liquor from the crystallization process was concentrated and purified by silica gel chromatography (16% EtOAc in hexanes) to provide an additional 4 g of <b>40</b> as a solid. In total, 36 g (73%) of <b>40</b> was obtained. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (s, 1 H), 8.34 (d, <i>J</i> = 1.76 Hz, 1 H), 8.14 (d, <i>J</i> = 9.06 Hz, 1 H), 7.80 (dd, <i>J</i> = 8.81, 2.01 Hz, 1 H). LCMS (method D): <i>t</i><sub>R</sub> = 2.55 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>4</sub>BrCl<sub>2</sub>N, 274.89; found, 275.76 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Preparation of 1,7-Dichloroisoquinolin-4-ol (<b>41</b>)</h3><div class="NLM_p last">To a slurry of <b>40</b> (22.16 g, 80 mmol) in THF (500 mL) maintained at −78 °C was added 1.6 M <i>n</i>-BuLi in hexanes (100 mL, 160 mmol) dropwise via cannula over 15 min (the internal temperature was maintained ←65 °C). The solution was stirred for 0.5 h, and (<i>i</i>-PrO)<sub>3</sub>B (37 mL, 160 mmol) added dropwise via syringe over 10 min (the internal temperature was maintained ←65 °C). The reaction mixture was stirred for 0.5 h, and 30% H<sub>2</sub>O<sub>2</sub> (80 mL, 776 mmol) was added dropwise via an addition funnel over 10 min (the internal temperature rose to −60 °C during this addition), followed by addition of 1 N NaOH solution (80 mL, 80 mmol). The cooling bath was removed, and the reaction mixture allowed to warm to room temperature and stirred for an additional 1 h. After confirming the completion of the reaction by LC/MS, the reaction mixture was cooled to −40 °C, and a solution of of Na<sub>2</sub>SO<sub>3</sub> (100 g, 0.793 mol) in of H<sub>2</sub>O (400 mL) was added dropwise over 30 min (the internal temperature was maintained between 5 and 10 °C). The resulting slurry was neutralized with 6N HCl (∼50 mL) at 0 °C to provide a pH ∼ 6 solution. The mixture was diluted with of EtOAc (500 mL) and transferred to a 2 L separatory funnel. To the remaining solid in the reaction vessel was added H<sub>2</sub>O (500 mL) and EtOAc (300 mL) and the mixture neutralized with 6N HCl (∼20 mL). The organic layers were combined and washed with brine (300 mL × 3) and H<sub>2</sub>O (200 mL × 3). The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated to give a crude product which was triturated with EtOAc (50 mL). The solid was collected by filtration, rinsed with EtOAc (3 × 25 mL), and dried to provide 11.8 g of <b>41</b>. The filtrate was concentrated and the residue purified by silica gel chromatography (35% EtOAc in hexanes) to give an additional 2.1 g of <b>41</b>. In total, 27.9 g (82%) of <b>41</b> was obtained. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.23 (d, <i>J</i> = 8.8 Hz, 1 H), 8.16 (d, <i>J</i> = 2 Hz, 1 H), 7.76 (dd, <i>J</i> = 8.8, 2, Hz, 1 H), 7.4 (s, 1 H). LCMS (method D): <i>t</i><sub>R</sub> = 2.32 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>5</sub>Cl<sub>2</sub>NO, 212.97; found, 213.88 (M + H)<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Preparation of 1,7-Dichloro-4-methoxyisoquinoline (<b>42</b>)</h3><div class="NLM_p last">To a slurry of <b>41</b> (16 g, 75.5 mmol) in MeOH/CH<sub>3</sub>CN (30 mL/300 mL) maintained at 0 °C was added dropwise a 2 M solution of TMSCHN<sub>2</sub> in hexanes (60 mL, 120 mmol). The reaction mixture was warmed to room temperature and stirred for 14 h. The solution was concentrated, and the residual solid was recrystallized from EtOAc (about 50 mL) to give 8.1 g of <b>42</b>, which was washed with 25% EtOAc in hexanes. The mother liquor was concentrated and the residue purified by silica gel chromatography (16% EtOAc in hexanes) to provide an additional 3.2 g of <b>42</b> as a solid. In total, 11.3 g (66%) of <b>42</b> was obtained. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.05 (s, 3 H), 7.67 (dd, <i>J</i> = 9.06, 2.01 Hz, 1 H), 7.80 (s, 1 H), 8.16 (d, <i>J</i> = 8.81 Hz, 1 H), 8.23 (d, <i>J</i> = 2.01 Hz, 1 H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Alternate Preparation of 1,7-Dichloro-4-methoxyisoquinoline (<b>42</b>)</h3><div class="NLM_p last">To a stirred solution of <b>41</b> (7.2 g, 33.6 mmol) in DMF (100 mL) maintained at 4 °C was added CH<sub>3</sub>I (4 mL, 64.2 mmol) followed by NaH (60% dispersion in mineral oil, 2.52 g, 63.0 mmol). The bright-yellow solution was stirred at 4 °C for 1 h. The reaction mixture was neutralized by the addition of 70 mL of 0.5N HCl, and 50 mL of brine was added to the mixture. An off-white solid precipitated that was collected by filtration and washed with 200 mL of H<sub>2</sub>O followed by 100 mL of pentane to provide 7.4 g (97%) of <b>42</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (d, <i>J</i> = 1.96 Hz, 1 H), 8.16 (d, <i>J</i> = 9.05 Hz, 1 H), 7.80 (s, 1 H), 7.67 (dd, <i>J</i> = 8.80, 1.96 Hz, 1 H), 4.05 (s, 3 H). LCMS (method D): <i>t</i><sub>R</sub> = 2.42 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>7</sub>Cl<sub>2</sub>NO, 226.99; found, 227.89 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Preparation of (2<i>S</i>,4<i>R</i>)-1-(<i>tert</i>-Butoxycarbonyl)-4-((7-chloro-4-methoxyisoquinolin-1-yl)oxy)pyrrolidine-2-carboxylic acid (<b>34</b>)</h3><div class="NLM_p last">DMSO (200 mL) was added to a mixture of <b>42</b> (4.52 g, 20 mmol), (2<i>S</i>,4<i>R</i>)-1-(<i>tert</i>-butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (5.08 g, 22 mmol), and <i>t</i>-BuOK (6.72 g, 60 mmol) with stirring at 10 °C. The resulting slurry was sonicated for 30 min to provide a homogeneous solution which was stirred at room temperature for 3 h. The reaction mixture was cooled to 0 °C and quenched by the addition of H<sub>2</sub>O (50 mL) The mixture was neutralized, then acidified, to a final pH of 5 by the careful addition of 1N HCl. The mixture was extracted with EtOAc (400 mL) and the organic layer washed with brine (200 mL), then H<sub>2</sub>O (2 × 200 mL), before being dried over MgSO<sub>4</sub> and concentrated in vacuo to provide 8.36 g of crude solid, <b>34</b>. This material was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.13–8.02 (m, 2 H), 7.68 (dd, <i>J</i> = 8.81, 2.01 Hz, 1 H), 7.54 (s, 1 H), 5.65 (brs, 1 H), 4.59–4.42 (m, 1 H), 3.98 (s, 3H), 3.92–3.70 (m, 2 H), 2.77–2.62 (m, 1 H), 2.47–2.34 (m, 1 H), 1.46 (s, 9 H). LCMS (method P): <i>t</i><sub>R</sub> = 2.35 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>6</sub>, 422.12; found, 423.17 (M + H)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Preparation of (2<i>S</i>,4<i>R</i>)-<i>tert</i>-Butyl 4-((7-Chloro-4-methoxyisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidine-1-carboxylate (<b>43</b>)</h3><div class="NLM_p last">To a solution of <b>34</b> (8.36 g, 19.8 mmol), the TsOH salt of <b>35</b> (9.64 g, 24 mmol), and iPr<sub>2</sub>EtN (17.4 mL, 100 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) was added HATU (11.4 g, 31 mmol). The reaction mixture was stirred for 16 h, concentrated in vacuo, and the residue dissolved in EtOAc (300 mL) and washed sequentially with 1N HCl (50 mL × 3), H<sub>2</sub>O (30 mL × 2), and brine (50 mL × 2). The organic phase was dried over MgSO<sub>4</sub>, concentrated, and the residue purified by silica gel chromatography (25% acetone in hexanes) to provide 11.5 g of product. This compound was further purified by crystallization from MeOH (40 mL) to afford <b>43</b> (11 g, 88%) as a crystalline solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.09 (d, <i>J</i> = 8.81 Hz, 1 H), 8.06 (d, <i>J</i> = 2.01 Hz, 1 H), 7.70 (dd, <i>J</i> = 8.94, 2.14 Hz, 1 H), 7.55 (s, 1 H), 5.93–5.65 (m, 2 H), 5.31 (d, <i>J</i> = 17.12 Hz, 1 H), 5.13 (d, <i>J</i> = 10.32 Hz, 1 H), 4.40 (dd, <i>J</i> = 9.69, 6.92 Hz, 1 H), 3.93–3.72 (m, 2 H), 3.03–2.90 (m, 1 H), 2.53 (dd, <i>J</i> = 13.72, 6.42 Hz, 1 H), 2.36–2.17 (m, 2 H), 1.88 (dd, <i>J</i> = 8.06, 5.54 Hz, 1 H), 1.43 (s, 9H), 1.03–1.31 (m, 8 H). LCMS (method P): <i>t</i><sub>R</sub> = 2.32 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>35</sub>ClN<sub>4</sub>O<sub>8</sub>S, 634.19; found, 635.23 (M + H)<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Preparation of (2<i>S</i>,4<i>R</i>)-4-((7-Chloro-4-methoxyisoquinolin-1-yl)oxy)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)pyrrolidine-2-carboxamide, HCl (<b>44</b>)</h3><div class="NLM_p last">A slurry of <b>43</b> (6.34 g, 10 mmol) in MeOH (50 mL) containing concentrated HCl (3 mL) was refluxed for 2 h. The solution was cooled to room temperature and concentrated in vacuo. The solid residue was taken up in dry Et<sub>2</sub>O (50 mL) and the solution concentrated in vacuo. This process, was repeated 5 times to ensure complete removal of H<sub>2</sub>O and the residue solubilized in HCl to provide <b>44</b> (6.07 g, 100%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.28 (d, <i>J</i> = 2.01 Hz, 1 H), 8.12 (d, <i>J</i> = 9.06 Hz, 1 H), 7.74 (dd, <i>J</i> = 8.81, 2.01 Hz, 1 H), 7.57 (s, 1 H), 5.88 (s, 1 H), 5.76–5.58 (m, 1 H), 5.33 (d, <i>J</i> = 17.12 Hz, 1 H), 5.20–5.10 (m, 1 H), 4.70 (dd, <i>J</i> = 10.32, 7.81 Hz, 1 H), 4.01 (s, 3 H), 3.90–3.75 (m, 2 H), 3.08–2.83 (m, 2 H), 2.46–2.25 (m, 2 H), 1.95 (dd, <i>J</i> = 8.06, 5.79 Hz, 1 H), 1.38 (dd, <i>J</i> = 9.57, 5.54 Hz, 1 H), 1.30–1.22 (m, 1 H), 1.21–0.96 (m, 3 H). LCMS (method D): <i>t</i><sub>R</sub> = 2.08 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>27</sub>ClN<sub>4</sub>O<sub>6</sub>S, 534.13; found, 534.98 (M + H)<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Preparation of <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Chloro-4-methoxyisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>24</b>)</h3><div class="NLM_p last">To a solution of <b>43</b> (6.07 g, 10 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) maintained at 0 °C was added <i>i</i>-Pr<sub>2</sub>EtN (8.7 mL, 50 mmol) followed by <i>N</i>-Boc-<i>t</i>-butyl-<span class="smallcaps smallerCapital">l</span>-glycine (2.772 g, 12 mmol) and HATU (5.7 g, 15 mmol). The reaction mixture was warmed to RT and stirred for 16 h before being concentrated in vacuo and the residue dissolved in EtOAc (300 mL). The EtOAc solution was washed sequentially with 1N HCl (50 mL × 3), H<sub>2</sub>O (30 mL × 2), and brine (50 mL × 2). The organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo and the residue purified by silica gel chromatography (33% acetone in hexanes) to provide <b>24</b> (7 g, 94%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1 H), 8.95 (s, 1 H), 8.07 (d, <i>J</i> = 8.77 Hz, 1 H), 8.00 (d, <i>J</i> = 1.72 Hz, 1 H), 7.80 (d, <i>J</i> = 8.77 Hz. 1 H), 7.68 (s, 1 H), 6.56 (d, <i>J</i> = 7.71 Hz, 1 H), 5.72 (m, 1 H), 5.62 (t-d, <i>J</i> = 16.79 Hz, 9.75 Hz, 1 H), 5.24 (d, <i>J</i> = 16.79 Hz, 1 H), 5.10 (d, <i>J</i> = 10.83 Hz, 1 H), 4.47 (t, <i>J</i> = 8.66 Hz, 1 H), 4.36 (d, <i>J</i> = 11.37 Hz, 1 H), 3.97 (s, 3 H), 3.96 (d, overlap, 1 H), 3.92 (d, <i>J</i> = 11.37 Hz, 1 H), 2.93 (m, 1 H), 2.52 (m, 1 H), 2.19 (m, 1 H), 2.16 (m, 1 H), 1.72 (d-d, <i>J</i> = 8.16 Hz, 5.35 Hz, 1 H), 1.36 (d-d, <i>J</i> = 9.18 Hz, 5.35 Hz, 1 H), 1.10 (s, 9 H), 1.04 (m, 4 H), 0.96 (s, 9 H). Anal. Calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>SCl: C, 55.84; H, 6.32; N, 9.10. Found: C, 56.02; H, 6.31; N, 9.04. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>SCl, 748.2783; found, 748.2810 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Preparation of <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Chloro-4-methoxyisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>R</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>30</b>)</h3><div class="NLM_p last">A suspension of compound <b>24</b> (100 mg) and 5% Pt(S)/C (10 mg) in EtOAc (15 mL) was hydrogenated under H<sub>2</sub> at 30 PSI for 0.5 h. After filtration through a Celite plug and washing with EtOAc, the filtrate was concentrated and the residue purified by prep HPLC to give <b>30</b> (70 mg, 70%) as a solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.15–8.00 (m, 1H), 7.66 (d, <i>J</i> = 8.6 Hz, 1H), 7.56 (s, 1H), 6.57 (d, <i>J</i> = 9.3 Hz, 1H), 5.78 (br s, 1H), 4.56 (dd, <i>J</i> = 10.2, 7.4 Hz, 1H), 4.42 (d, <i>J</i> = 11.3 Hz, 1H), 4.18 (d, <i>J</i> = 9.6 Hz, 1H), 4.10–3.94 (m, 4H), 3.01–2.89 (m, 1H), 2.56 (dd, <i>J</i> = 13.7, 6.9 Hz, 1H), 2.32–2.19 (m, 1H), 1.70–0.86 (m, 31H). LCMS (method E): <i>t</i><sub>R</sub> = 3.44 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>48</sub>ClN<sub>5</sub>O<sub>9</sub>S, 749.29; found, 750.5 (M + H)<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Preparation of 1,1,1-Trifluoro-2-methylpropan-2-yl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Chloro-4-methoxyisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>R</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>31</b>)</h3><div class="NLM_p last">A solution of <b>24</b> (747 mg) in 2.5% conc HCl in MeOH (10 mL) was refluxed for1 h. After concentration to give the HCl salt, half of the material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and <i>i</i>-Pr<sub>2</sub>EtN (2 mL) followed by the addition of 1,1,1-trifluoro-2-methylpropan-2-yl 1<i>H</i>-imidazole-1-carboxylate (222 mg) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL). After the solvents were removed, the residue was heated to 50 °C for 2 h, then cooled to room temperature and the residue purified by prep HPLC to give 1,1,1-trifluoro-2-methylpropan-2-yl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-chloro-4-methoxyisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (230 mg, 57.5%). A suspension of the compound above (40 mg) and 5% Pt(S)/C (10 mg) in EtOAc (10 mL) was hydrogenated under H<sub>2</sub> at 30 PSI for 0.6 h. After filtration through a Celite plug and washing with EtOAc, the filtrate was concentrated and the residue purified by prep HPLC to give <b>31</b> (30 mg, 75%) as a solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.14–7.96 (m, 2H), 7.68 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 7.57 (s, 1H), 5.77 (br s, 1H), 4.58 (dd, <i>J</i> = 10.7, 6.9 Hz, 1H), 4.43 (d, <i>J</i> = 11.6 Hz, 1H), 4.21–4.13 (m, 1H), 4.05–3.95 (m, 4H), 3.00–2.86 (m, 1H), 2.57 (dd, <i>J</i> = 13.6, 6.5 Hz, 1H), 2.34–2.15 (m, 1H), 1.69–1.47 (m, 5H), 1.38–0.91 (m, 22H). LCMS (method E): <i>t</i><sub>R</sub> = 3.54 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>45</sub>ClF<sub>3</sub>N<sub>5</sub>O<sub>9</sub>S, 803.26; found, 804.31 (M + H)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Preparation of <i>tert</i>-Butyl ((<i>S</i>)-1-((<i>S</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-oxopyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>32</b>)</h3><div class="NLM_p last">To a solution of Dess–Martin reagent (940 mg, 2.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added <i>tert</i>-butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-hydroxypyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (556 mg, 1.00 mmol). The solution was stirred at room temperature for 4 h and concentrated in vacuo. The residue was triturated with hot EtOAc (10 mL) and filtered through Celite. The filtrate was concentrated in vacuo. The residue was purified by flash column, eluting with 1:1 hexane–acetone, to yield <b>32</b> (550 mg, 99%) as a white foam. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.82–5.72 (m, 1H), 5.33 (d, <i>J</i> = 18.5 Hz, 1H), 5.16 (d, <i>J</i> = 12 Hz, 1H), 4.80–4.77 (m, 1H), 4.34–4.17 (m, 2H), 2.96–2.92 (m, 1H), 2.60–2.51 (m, 1H), 2.28–2.22 (m, 1H), 1.91–1.88 (m, 1H), 1.46–1.43 (m, 10H), 1.28–1.25 (m, 2H), 1.14–1.09 (m, 11H). LCMS (method B): <i>t</i><sub>R</sub> = 2.49 min). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>38</sub>N<sub>4</sub>O<sub>8</sub>S, 554.24; found, 455.10 (M – Boc)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 6-Chloro-1,2-dihydrofuro[3,2-<i>f</i>]isoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.25–8.15 (m, 1H), 7.33 (dd, <i>J</i> = 5.9, 0.7 Hz, 1H), 7.24 (d, <i>J</i> = 7.4 Hz, 1 H), 4.84 (t, <i>J</i> = 9.0 Hz, 2H), 3.47 (t, <i>J</i> = 9.0 Hz, 2H). LCMS (method D): <i>t</i><sub>R</sub> = 2.19 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>8</sub>ClNO, 205.03; found, 205.99 (M + H)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-Chloro-2,3-dihydrofuro[2,3-<i>f</i>]isoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.23 (d, <i>J</i> = 5.6 Hz, 1H), 7.90–7.84 (m, 1H), 7.70 (dd, <i>J</i> = 5.7, 0.9 Hz, 1H), 7.56 (d, <i>J</i> = 8.6 Hz, 1H), 4.86 (t, <i>J</i> = 9.0 Hz, 2H), 3.47 (t, <i>J</i> = 9.0 Hz, 2H). LCMS (method O): <i>t</i><sub>R</sub> = 1.44 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>8</sub>ClNO, 205.03; found, 206.09 (M + H)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 7-Chloro-2,3-dihydro-[1,4]dioxino[2,3-<i>f</i>]isoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (d, <i>J</i> = 5.8 Hz, 1H), 7.87 (dd, <i>J</i> = 9.3, 0.8 Hz, 1H), 7.81 (dd, <i>J</i> = 5.8, 0.8 Hz, 1H), 7.27 (d, <i>J</i> = 9.3 Hz, 1H), 4.53–4.40 (m, 4H). LCMS (method N): <i>t</i><sub>R</sub> = 2.60 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>8</sub>ClNO<sub>2</sub>, 219.04; found, 222.05 (M + H)<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-Chloro-4,6-dimethoxyisoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18 (d, <i>J</i> = 9.1 Hz, 1H), 7.77 (s, 1H), 7.46 (d, <i>J</i> = 2.5 Hz, 1H), 7.34 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 4.06 (s, 3H), 3.98 (s, 3H). LCMS (method C): <i>t</i><sub>R</sub> = 2.03 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>10</sub>ClNO<sub>2</sub>, 223.04; found, 224.11 (M + H)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 7-Chloro-3,4-dihydro-2<i>H</i>-pyrano[2,3-<i>f</i>]isoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (d, <i>J</i> = 5.8 Hz, 1H), 7.87 (dd, <i>J</i> = 5 0.8, 0.5 Hz, 1H), 7.76 (d, <i>J</i> = 8.6 Hz, 1H), 7.31 (d, <i>J</i> = 8.6 Hz, 1H), 4.41–4.33 (m, 2H), 2.92 (t, <i>J</i> = 6.4 Hz, 2H), 2.17–2.05 (m, 2H). LCMS (method E): <i>t</i><sub>R</sub> = 2.92 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>10</sub>ClNO, 219.04; found, 220.03 (M + H)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-Chloro-9,10-dihydro-8<i>H</i>-pyrano[3,2-<i>f</i>]isoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.19 (d, <i>J</i> = 5.8 Hz, 1H), 8.09 (d, <i>J</i> = 9.3 Hz, 1H), 7.50 (d, <i>J</i> = 5.8 Hz, 1H), 7.15 (d, <i>J</i> = 9.3 Hz, 1H), 4.32–4.25 (m, 2H), 2.99 (t, <i>J</i> = 6.5 Hz, 2H), 2.21–2.08 (m, 2H). LCMS (method E): <i>t</i><sub>R</sub> = 2.92 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>10</sub>ClNO, 219.04; found, 219.92 (M + H)<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-Chloro-5-methoxy-6-methylisoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.23 (d, <i>J</i> = 5.8 Hz, 1H), 7.98 (d, <i>J</i> = 8.8 Hz, 1H), 7.79 (dd, <i>J</i> = 5.8, 0.8 Hz, 1H), 7.46 (d, <i>J</i> = 8.8 Hz, 1H), 2.47 (s, 3H). LCMS (method E): <i>t</i><sub>R</sub> = 2.72 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>10</sub>ClNO, 207.04; found, 208.03 (M + H)<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-Chloro-4,5-dimethoxyisoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89 (d, <i>J</i> = 8.6 Hz, 1H), 7.80 (s, 1H), 7.65–7.55 (m, 1H), 7.11 (d, <i>J</i> = 8.1 Hz, 1H), 4.01 (s, 3H), 3.98 (s, 3H). LCMS (method E): <i>t</i><sub>R</sub> = 2.47 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>10</sub>ClNO<sub>2</sub>, 223.04; found, 224.03 (M + H)<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-Chloro-7-fluoro-4-methoxyisoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.23 (dd, <i>J</i> = 9.2, 5.4 Hz, 1H), 7.86 (dd, <i>J</i> = 9.6, 2.5 Hz, 1H), 7.78 (s, 1H), 7.49 (ddd, <i>J</i> = 9.1, 8.1, 2.6 Hz, 1H), 4.05 (s, 3H). LCMS (method E): <i>t</i><sub>R</sub> = 3.01 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>7</sub>ClFNO, 211.02; found, 212.05 (M + H)<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1,5-Dichloro-4-methoxyisoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.86 (s, 1H), 7.76 (dd, <i>J</i> = 7.6, 1.0 Hz, 1H), 7.55 (dd, <i>J</i> = 8.3, 7.6 Hz, 1H), 4.02 (s, 3H). LCMS (method E): <i>t</i><sub>R</sub> = 3.01 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>7</sub>Cl<sub>2</sub>FNO, 226.99; found, 227.99 (M + H)<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1,6-Dichloro-4-methoxyisoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27–8.14 (m, 2H), 7.80 (s, 1H), 7.61 (dd, <i>J</i> = 9.1, 2.0 Hz, 1H), 4.04 (s, 3H). LCMS (method E): <i>t</i><sub>R</sub> = 3.19 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>7</sub>Cl<sub>2</sub>FNO, 226.99; found, 228.05 (M + H)<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-Chloro-5,6-dimethoxy-2-phenylpyrimidine</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.48–8.27 (m, 2H), 7.49–7.35 (m, 3H), 4.21 (s, 3H), 3.96 (s, 3H). LCMS (method B): <i>t</i><sub>R</sub> = 2.99 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>2</sub>O<sub>2</sub>, 250.05; found, 250.86 (M + H)<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1,7-Dichloro-4-(2-methoxyethoxy)isoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.30–8.14 (m, 2H), 7.81 (s, 1H), 7.65 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.23 (s, 1H), 4.42–4.22 (m, 2H), 3.95–3.76 (m, 2H), 3.46 (s, 3H). LCMS (method B): <i>t</i><sub>R</sub> = 2.80 min). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>11</sub>Cl<sub>2</sub>NO<sub>2</sub>, 271.02; found, 271.85 (M + H)<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1,7-Dichloro-4-(difluoromethoxy)isoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 1.5 Hz, 1H), 8.16–8.02 (m, 2H), 7.82–7.68 (m, 1H), 6.97, 6.89–6.45 (s, 1H). LCMS (method B): <i>t</i><sub>R</sub> = 2.85 min). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>5</sub>Cl<sub>2</sub>FNO, 262.97; found, 263.78 (M + H)<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1,7-Dichloro-<i>N</i>,<i>N</i>-dimethylisoquinolin-4-amine</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31–8.28 (m, 1H), 8.28 (s, 1H), 8.00 (s, 1H), 7.74–7.68 (m, 1H), 2.99 (s, 6H). LCMS (method J): <i>t</i><sub>R</sub> = 2.958, min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>2</sub>, 240.02; found, 241.12 (M + H)<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-Bromo-3-fluoro-4,6-dimethoxyisoquinoline</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (d, <i>J</i> = 9.3 Hz, 1H), 7.36 (d, <i>J</i> = 2.5 Hz, 1H), 7.20 (dd, <i>J</i> = 9.3, 2.5 Hz, 1H), 4.11 (d, <i>J</i> = 3.0 Hz, 3H), 3.97 (s, 3H). LCMS (method J): <i>t</i><sub>R</sub> = 3.22 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>9</sub>BrFNO<sub>2</sub>, 284.98; found, 285.80 (M + H)<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>1</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.09 (d, <i>J</i> = 9.0 Hz, 1H), 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.25 (d, <i>J</i> = 6.0 Hz, 1H), 7.18 (s, 1H), 7.10–7.08 (m, 1H), 6.60 (d, <i>J</i> = 10.0 Hz, 1H), 5.81 (b, 1 H), 5.74–5.69 (m, 1H), 5.28 (d, <i>J</i> = 18.0 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.51–4.49 (m, 1H), 4.24–4.21 (m, 1H), 4.06–4.02 (m, 1H), 3.92 (s, 3H), 2.97–2.91 (m, 1H), 2.61–2.55 (m, 1H), 2.30–2.20 (m, 2H), 1.88–1.85 (m, 1H), 1.45–1.40 (m, 1H), 1.27 (s, 9H), 1.25–1.23 (m, 1H), 1.08–1.00 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.75 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S, 713.31; found, 714.11 (M + H) <sup>+</sup>. Anal. Calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·0.5H<sub>2</sub>O: C, 58.16; H, 6.69; N, 9.69. Found: C, 58.01; H, 6.46; N, 9.55.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (1<i>R</i>,2<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-1-((<i>S</i>)-2-((<i>tert</i>-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylic Acid (<b>2</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.89 (d, <i>J</i> = 5.8 Hz, 1H), 7.12 (d, <i>J</i> = 5.5 Hz, 1H), 7.10–7.02 (m, 2H), 6.98 (s, 1H), 5.85–5.66 (m, 2H), 5.23 (d, <i>J</i> = 17.1 Hz, 1H), 5.08 (d, <i>J</i> = 10.4 Hz, 1H), 4.55 (t, <i>J</i> = 7.8 Hz, 1H), 4.40 (d, <i>J</i> = 11.3 Hz, 1H), 4.32 (d, <i>J</i> = 9.5 Hz, 1H), 4.01 (d, <i>J</i> = 8.2 Hz, 1H), 3.90 (s, 3H), 2.61–2.48 (m, 2H), 2.11–2.03 (m, 1H), 1.93 (t, <i>J</i> = 6.4 Hz, 1H), 1.38–1.28 (m, 9H), 1.24–1.19 (m, 1H), 1.00 (s, 9H). LC-MS (method N): <i>t</i><sub>R</sub> = 3.09 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>42</sub>N<sub>4</sub>O<sub>8</sub>, 610.30; found, 611.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.10 (d, <i>J</i> = 9.0 Hz, 1H), 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.25 (d, <i>J</i> = 6.0 Hz, 1H), 7.18 (s, 1H), 7.10 (d, <i>J</i> = 9.0 Hz, 1H), 5.86 (b, 1 H), 5.81–5.74 (m, 1H), 5.32 (d, <i>J</i> = 18.1 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.55–4.47 (m, 1H), 4.06–4.03 (m, 2H), 3.92 (s, 3H), 2.97–2.94 (m, 1H), 2.61–2.57 (m, 1H), 2.35–2.22 (m, 2H), 1.89–1.88 (m, 1H), 1.43–1.40 (m, 1H), 1.25–1.21 (m, 10H), 1.09–1.07 (m, 3H), 0.98–0.94 (m, 6H). LCMS (method A): <i>t</i><sub>R</sub> = 1.71 min). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>9</sub>S, 699.23; found, 700.07 (M + H)<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (2<i>S</i>,4<i>R</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-1-((<i>S</i>)-2-((4,6-dimethylpyridin-2-yl)amino)-3-methylbutanoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidine-2-carboxamide (<b>4</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.90 (d, <i>J</i> = 6.1 Hz, 1H), 7.74 (d, <i>J</i> = 9.2 Hz, 1H), 7.26 (d, <i>J</i> = 5.8 Hz, 1H), 7.20 (d, <i>J</i> = 1.8 Hz, 1H), 7.00 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 6.13 (s, 1H), 6.07 (s, 1H), 5.96 (s, 1H), 5.85–5.75 (m, 1H), 5.31 (d, <i>J</i> = 17.4 Hz, 1H), 5.13 (d, <i>J</i> = 10.4 Hz, 1H), 4.89 (s, 1H), 4.60 (d, <i>J</i> = 8.9 Hz, 1H), 4.49 (dd, <i>J</i> = 10.4, 7.0 Hz, 1H), 4.15 (dd, <i>J</i> = 11.6, 3.7 Hz, 1H), 3.95 (s, 3H), 3.51 (q, <i>J</i> = 7.0 Hz, 1H), 3.03–2.96 (m, 1H), 2.58–2.50 (m, 1H), 2.39–2.31 (m, 1H), 2.24 (q, <i>J</i> = 9.0 Hz, 1H), 2.20–2.12 (m, 1H), 2.07 (s, 3H), 1.91 (dd, <i>J</i> = 7.8, 5.6 Hz, 1H), 1.81 (s, 3H), 1.42 (dd, <i>J</i> = 9.3, 5.3 Hz, 1H), 1.35–1.28 (m, 1H), 1.24 (dd, <i>J</i> = 10.1, 3.7 Hz, 1H), 1.20 (t, <i>J</i> = 7.2 Hz, 1H), 1.11 (s, 2H), 1.08 (d, <i>J</i> = 6.7 Hz, 3H), 1.06 (d, <i>J</i> = 6.7 Hz, 3H). LCMS (method M): <i>t</i><sub>R</sub> = 2.43 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>44</sub>N<sub>6</sub>O<sub>7</sub>S, 704.30; found, 705.20 (M + H)<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((5,6-dimethoxy-2-phenylpyrimidin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.39 (td, <i>J</i> = 3.8, 2.1 Hz, 2H), 7.56–7.40 (m, 3H), 6.67 (d, <i>J</i> = 9.5 Hz, 1H), 5.97 (br s, 1H), 5.86–5.71 (m, 1H), 5.33 (d, <i>J</i> = 1 7.4 Hz, 1H), 5.15 (d, <i>J</i> = 10.4 Hz, 1H), 4.63–4.50 (m, 1H), 4.39–4.21 (m, 2H), 4.20–4.08 (m, 5H), 3.90–3.72 (m, 3H), 2.96 (br s, 1H), 2.89–2.79 (m, 1H), 2.60 (dd, <i>J</i> = 13.6, 6.9 Hz, 1H), 2.44–2.21 (m, 2H), 2.10–2.00 (m, 1H), 1.96–1.85 (m, 1H), 1.53–1.44 (m, 1H), 1.49–1.36 (m, 1H), 1.37 (s, 9H), 1.31–1.08 (m, 4H), 1.04 (s, 9H). LCMS (method B): <i>t</i><sub>R</sub> = 3.29 min). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>50</sub>N<sub>6</sub>O<sub>10</sub>S, 770.33; found, 771.15 (M + H)<sup>+</sup>.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (3<i>R</i>,5<i>S</i>)-1-((S)-2-((<i>tert</i>-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-5-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-3-yl 4-fluoroisoindoline-2-carboxylate (<b>6</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.41 (s, 1H), 8.99, 8.83 (s, 1H), 7.40–7.27 (m, 1H), 7.21–7.02 (m, 2H), 6.66 (d, <i>J</i> = 7.3 Hz, 1H), 5.64–5.47 (m, 1H), 5.25–5.16 (m, 2H), 5.11–5.01 (m, 1H), 4.63 (br s, 4H), 4.41–4.27 (m, 1H), 4.13 (d, <i>J</i> = 11.5 Hz, 1H), 3.99–3.87 (m, 1H), 3.71 (d, <i>J</i> = 11.5 Hz, 1H), 2.95–2.81 (m, 1H), 2.52–2.48 (m, 1H), 2.33–2.21 (m, 1H), 2.18–1.94 (m, 1H), 1.68 (dd, <i>J</i> = 7.8, 5.3 Hz, 1H), 1.39–0.85 (m, 23H). LCMS (method D): <i>t</i><sub>R</sub> = 2.42 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>46</sub>FN<sub>5</sub>O<sub>9</sub>S, 719.30; found, 742.26 (M + Na)<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-(isoquinolin-1-yloxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 9.18 (b, 1H), 8.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.97 (d, <i>J</i> = 6 Hz, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 1H), 7.70 (t, <i>J</i> = 7.5 Hz, 1H), 7.52 (t, <i>J</i> = 7.4 Hz, 1H), 7.32 (d, <i>J</i> = 6 Hz, 1H), 5.88 (b, 1 H), 5.82–5.70 (m, 1H), 5.27 (d, <i>J</i> = 16.8 Hz, 1H), 5.12 (d, <i>J</i> = 10.2 Hz, 1H), 4.57–4.45 (m, 2H), 4.26 (b, 1H), 4.11–4.06 (m, 1H), 2.99–2.92 (m, 1H), 2.67–2.60 (m, 1H), 2.34–2.22 (m, 2H), 1.90–1.86 (m, 1H), 1.46–1.42 (m, 1H), 1.27–1.15 (m, 10H), 1.09–1.00 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.80 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>8</sub>S, 683.30; found, 684.07 (M + H)<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-carbamoyl)-4-((5-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89 (d, <i>J</i> = 5.9 Hz, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.54 (d, <i>J</i> = 5.9 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H), 7.08 (d, <i>J</i> = 7.6 Hz, 1H), 6.55 (d, <i>J</i> = 9.5 Hz, 1H), 5.79 (s, 1H), 5.81–5.70 (m, 1H), 5.23 (d, <i>J</i> = 16.9 Hz, 1H), 5.06 (d, <i>J</i> = 10.0 Hz, 1H), 4.47 (dd, <i>J</i> = 9.7, 7.0 Hz, 1H), 4.39 (d, <i>J</i> = 12.2 Hz, 1H), 4.20 (d, <i>J</i> = 9.1 Hz, 1H), 4.01 (dd, <i>J</i> = 11.9, 3.3 Hz, 1H), 3.93 (s, 3H), 2.98–2.90 (m, 1H), 2.56 (dd, <i>J</i> = 13.6, 6.7 Hz, 1H), 2.34–2.18 (m, 2H), 1.82 (dd, <i>J</i> = 8.1, 5.6 Hz, 1H), 1.47–1.40 (m, 1H), 1.30–1.19 (m, 1H), 1.25 (s, 9H), 1.10–0.99 (m, 3H), 1.03 (s, 9H). LC-MS (method C): <i>t</i><sub>R</sub> = 2.37 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S, 713.31; found, 714.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((5,6-dimethoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44 (br s, 1H), 8.91 (br s, 1H), 8.03–7.90 (m, 2H), 7.44–7.35 (m, 2H), 6.60 (d, <i>J</i> = 8.2 Hz, 1H), 5.78 (br s, 1H), 5.69–5.54 (m, 1H), 5.24 (d, <i>J</i> = 17.0 Hz, 1H), 5.11 (d, <i>J</i> = 11.7 Hz, 1H), 4.48–4.29 (m, 2H), 4.05 (d, <i>J</i> = 8.4 Hz, 1H), 3.96 (s, 4H), 3.86 (s, 3H), 2.98–2.91 (m, 1H), 2.50–2.48 (m, 1H), 2.26–2.06 (m, 2H), 1.72 (dd, <i>J</i> = 8.0, 5.3 Hz, 1H), 1.36 (dd, <i>J</i> = 9.1, 5.1 Hz, 1H), 1.25–0.88 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.42 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>N<sub>5</sub>O<sub>10</sub>S, 743.32; found, 744.16 (M + H)<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-([1,3]Dioxolo[4,5-<i>f</i>]isoquinolin-6-yloxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.89–7.76 (m, 2H), 7.21 (dd, <i>J</i> = 6.1, 0.7 Hz, 1H), 7.15 (d, <i>J</i> = 8.8 Hz, 1H), 6.19 (s, 2H), 5.82 (br s, 1H), 5.73 (dt, <i>J</i> = 16.9, 9.6 Hz, 1H), 5.28 (d, <i>J</i> = 17.1 Hz, 1H), 5.10 (dd, <i>J</i> = 10.4, 1.3 Hz, 1H), 4.51 (dd, <i>J</i> = 10.3, 7.1 Hz, 1H), 4.45 (d, <i>J</i> = 11.7 Hz, 1H), 4.21 (s, 1H), 4.04 (dd, <i>J</i> = 11.7, 3.2 Hz, 1H), 2.98–2.87 (m, 1H), 2.60 (dd, <i>J</i> = 13.6, 7.0 Hz, 1H), 2.35–2.16 (m, 2H), 1.86 (dd, <i>J</i> = 8.2, 5.5 Hz, 1H), 1.48–1.35 (m, 1H), 1.28–1.14 (m, 10H), 1.09–1.03 (m, 3H), 1.02–0.95 (m, 9H). LCMS (method G): <i>t</i><sub>R</sub> = 2.573 min. LCMS (ESI) <i>m</i>/<i>z</i>calcd for C<sub>35</sub>H<sub>45</sub>N<sub>5</sub>O<sub>10</sub>S, 727.29; found, 728.52 (M + H)<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((2,3-dihydrofuro[2,3-<i>f</i>]isoquinolin-6-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.37 (d, <i>J</i> = 8.3 Hz, 1H), 7.28 (d, <i>J</i> = 6.0 Hz, 1H), 5.83 (br s, 1H), 5.80–5.68 (m, 1H), 5.28 (d, <i>J</i> = 16.9 Hz, 1H), 5.11 (d, <i>J</i> = 11.6 Hz, 1H), 4.75 (t, <i>J</i> = 8.9 Hz, 2H), 4.55–4.47 (m, 1H), 4.42 (d, <i>J</i> = 11.8 Hz, 1H), 4.24 (d, <i>J</i> = 9.6 Hz, 1H), 4.05 (d, <i>J</i> = 12.8 Hz, 1H), 3.37 (t, <i>J</i> = 8.9 Hz, 2H), 2.97–2.88 (m, 1H), 2.60 (dd, <i>J</i> = 13.7, 6.9 Hz, 1H), 2.32–2.16 (m, 2H), 1.86 (dd, <i>J</i> = 8.1, 5.5 Hz, 1H), 1.47–1.38 (m, 1H), 1.30–0.96 (m, 22H). LCMS (method E): <i>t</i><sub>R</sub> = 3.21 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S, 725.31; found, 726.29 (M + H)<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((3,4-dihydro-2<i>H</i>-pyrano[2,3-<i>f</i>]isoquinolin-7-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.6 Hz, 1H), 7.48 (d, <i>J</i> = 6.0 Hz, 1H), 7.15 (d, <i>J</i> = 8.6 Hz, 1H), 5.85–5.63 (m, 2H), 5.28 (d, <i>J</i> = 17.1 Hz, 1H), 5.10 (d, <i>J</i> = 11.6 Hz, 1H), 4.50 (dd, <i>J</i> = 9.9, 7.2 Hz, 1H), 4.41 (d, <i>J</i> = 11.6 Hz, 1H), 4.36–4.31 (m, 3H), 4.24 (d, <i>J</i> = 9.6 Hz, 1H), 4.09–4.00 (m, 1H), 2.98–2.84 (m, 3H), 2.59 (dd, <i>J</i> = 13.6, 7.1 Hz, 1H), 2.33–2.16 (m, 2H), 2.12–2.03 (m, 2H), 1.86 (dd, <i>J</i> = 8.2, 5.4 Hz, 1H), 1.46–1.37 (m, 1H), 1.29–0.96 (m, 22H). LCMS (method E): <i>t</i><sub>R</sub> = 3.26 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S, 739.33; found, 740.23 (M + H)<sup>+</sup>.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((1,2-dihydrofuro[3,2-<i>f</i>]isoquinolin-6-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.41 (s, 1H), 8.84 (s, 1H), 8.02 (d, <i>J</i> = 8.8 Hz, 1H), 7.93 (d, <i>J</i> = 6.0 Hz, 1H), 7.12 (d, <i>J</i> = 5.8 Hz, 1H), 7.03 (d, <i>J</i> = 8.8 Hz, 1H), 6.63 (d, <i>J</i> = 8.0 Hz, 1H), 5.73 (br s, 1H), 5.64–5.50 (m, 1H), 5.19 (d, <i>J</i> = 17.1 Hz, 1H), 5.10–5.02 (m, 1H), 4.73 (t, <i>J</i> = 9.0 Hz, 2H), 4.41–4.29 (m, 2H), 4.02 (d, <i>J</i> = 8.3 Hz, 1H), 3.92–3.85 (m, 1H), 3.42–3.35 (m, 2H), 2.94–2.85 (m, 1H), 2.52–2.48 (m, 1H), 2.19–2.05 (m, 2H), 1.67 (dd, <i>J</i> = 7.9, 5.4 Hz, 1H), 1.31 (dd, <i>J</i> = 9.3, 5.3 Hz, 1H), 1.26–0.87 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.42 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S, 725.31; found, 726.26 (M + H)<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((9,10-dihydro-8<i>H</i>-pyrano[3,2-<i>f</i>]isoquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 8.84 (s, 1H), 8.00–7.90 (m, 2H), 7.26 (d, <i>J</i> = 6.0 Hz, 1H), 6.92 (d, <i>J</i> = 9.0 Hz, 1H), 6.62 (d, <i>J</i> = 8.0 Hz, 1H), 5.71 (br s, 1H), 5.64–5.49 (m, 1H), 5.19 (d, <i>J</i> = 17.1 Hz, 1H), 5.10–5.01 (m, 1H), 4.40–4.28 (m, 2H), 4.20 (t, <i>J</i> = 5.0 Hz, 2H), 4.02 (d, <i>J</i> = 8.3 Hz, 1H), 3.87 (d, <i>J</i> = 8.5 Hz, 1H), 2.92–2.82 (m, 3H), 2.52–2.48 (m, 1H), 2.20–1.97 (m, 4H), 1.67 (dd, <i>J</i> = 7.9, 5.1 Hz, 1H), 1.31 (dd, <i>J</i> = 9.0, 5.0 Hz, 1H), 1.25–0.88 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.46 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S, 739.33; found, 740.29 (M + H)<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (3<i>R</i>,5<i>S</i>)-1-((<i>S</i>)-2-((<i>tert</i>-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-5-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-3-yl 4-fluoroisoindoline-2-carboxylate (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 8.85 (s, 1H), 7.98 (d, <i>J</i> = 6.0 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 1H), 7.40 (d, <i>J</i> = 6.0 Hz, 1H), 7.35 (d, <i>J</i> = 8.3 Hz, 1H), 6.62 (d, <i>J</i> = 8.3 Hz, 1H), 5.74 (br s, 1H), 5.64–5.51 (m, 1H), 5.19 (d, <i>J</i> = 17.1 Hz, 1H), 5.10–5.03 (m, 1H), 4.41–4.31 (m, 2H), 4.00 (d, <i>J</i> = 8.3 Hz, 1H), 3.93–3.85 (m, 1H), 3.79 (s, 3H), 2.95–2.85 (m, 1H), 2.52–2.48 (m,1H), 2.38 (s, 3H), 2.12 (q, <i>J</i> = 8.7 Hz, 2H), 1.67 (dd, <i>J</i> = 7.8, 5.3 Hz, 1H), 1.32 (dd, <i>J</i> = 9.2, 5.1 Hz, 1H), 1.24–0.88 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.52 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S, 727.33; found, 728.20 (M + H)<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((2,3-dihydro-[1,4]dioxino[2,3-<i>f</i>]isoquinolin-7-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 8.84 (s, 1H), 7.92 (d, <i>J</i> = 5.8 Hz, 1H), 7.67 (d, <i>J</i> = 9.0 Hz, 1H), 7.34 (d, <i>J</i> = 5.8 Hz, 1H), 7.03 (d, <i>J</i> = 9.0 Hz, 1H), 6.62 (d, <i>J</i> = 8.3 Hz, 1H), 5.71 (br s, 1H), 5.64–5.50 (m, 1H), 5.19 (d, <i>J</i> = 17.1 Hz, 1H), 5.06 (d, <i>J</i> = 11.8 Hz, 1H), 4.45–4.27 (m, 6H), 4.01 (d, <i>J</i> = 8.3 Hz, 1H), 3.87 (d, <i>J</i> = 8.8 Hz, 1H), 2.96–2.86 (m, 1H), 2.52–2.48 (m, 1H), 2.21–2.05 (m, 2H), 1.67 (dd, <i>J</i> = 7.8, 5.3 Hz, 1H), 1.31 (dd, <i>J</i> = 8.8, 4.8 Hz, 1H), 1.26–0.88 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.45 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>47</sub>N<sub>5</sub>O<sub>10</sub>S, 741.30; found, 742.29 (M + H)<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-(furo[2,3-<i>f</i>]isoquinolin-6-yloxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 8.88 (s, 1H), 8.29 (d, <i>J</i> = 2.0 Hz, 1H), 8.18 (d, <i>J</i> = 5.8 Hz, 1H), 8.05 (d, <i>J</i> = 8.5 Hz, 1H), 7.80 (d, <i>J</i> = 8.5 Hz, 1H), 7.72 (d, <i>J</i> = 5.8 Hz, 1H), 7.21 (d, <i>J</i> = 1.9 Hz, 1H), 6.63 (d, <i>J</i> = 7.9 Hz, 1H), 5.83 (br s, 1H), 5.69–5.56 (m, 1H), 5.23 (d, <i>J</i> = 17.0 Hz, 1H), 5.10 (d, <i>J</i> = 11.8 Hz, 1H), 4.51–4.38 (m, 2H), 4.07 (d, <i>J</i> = 8.4 Hz, 1H), 3.96 (d, <i>J</i> = 9.1 Hz, 1H), 2.98–2.89 (m, 1H), 2.52–2.48 (m, 1H), 2.27–2.09 (m, 2H), 1.72 (dd, <i>J</i> = 8.0, 5.2 Hz, 1H), 1.36 (dd, <i>J</i> = 9.1, 5.3 Hz, 1H), 1.24–0.93 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.48 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>5</sub>O<sub>9</sub>S, 723.29; found, 724.16 (M + H)<sup>+</sup>.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((4-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 8.87 (br s, 1H), 8.17 (d, <i>J</i> = 8.3 Hz, 1H), 8.07 (d, <i>J</i> = 8.3 Hz, 1H), 7.81 (t, <i>J</i> = 7.5 Hz, 1H), 7.69–7.55 (m, 2H), 6.62 (d, <i>J</i> = 8.3 Hz, 1H), 5.73 (br s, 1H), 5.70–5.55 (m, 1H), 5.24 (d, <i>J</i> = 16.8 Hz, 1H), 5.16–5.05 (m, 1H), 4.49–4.31 (m, 2H), 4.08 (d, <i>J</i> = 8.3 Hz, 1H), 3.99 (s, 3H), 3.97–3.82 (m, 1H), 2.99–2.87 (m, 1H), 2.48–2.70 (m, 1H), 2.24–2.10 (m, 2H), 1.72 (dd, <i>J</i> = 7.9, 5.4 Hz, 1H), 1.43–1.32 (m, 1H), 1.29–0.93 (m, 22H). LCMS (method H): <i>t</i><sub>R</sub> = 3.22 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S, 713.31; found, 736.29 (M + Na)<sup>+</sup>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((4,5-dimethoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.74 (d, <i>J</i> = 8.3 Hz, 1H), 7.55 (s, 1H), 7.44 (t, <i>J</i> = 8.2 Hz, 1H), 7.19 (d, <i>J</i> = 7.8 Hz, 1H), 5.83–5.66 (m, 2H), 5.28 (d, <i>J</i> = 17.6 Hz, 1H), 5.10 (d, <i>J</i> = 11.3 Hz, 1H), 4.54–4.46 (m, 1H), 4.41 (d, <i>J</i> = 11.6 Hz, 1H), 4.23 (d, <i>J</i> = 9.6 Hz, 1H), 4.03 (d, <i>J</i> = 9.3 Hz, 1H), 3.92 (s, 3H), 3.88 (s, 3H), 2.96–2.88 (m, 1H), 2.58 (dd, <i>J</i> = 13.6, 6.8 Hz, 1H), 2.32–2.16 (m, 2H), 1.86 (dd, <i>J</i> = 8.1, 5.8 Hz, 1H), 1.46–1.37 (m, 1H), 1.28–0.95 (m, 22H). LCMS (method E): <i>t</i><sub>R</sub> = 2.51 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>N<sub>5</sub>O<sub>10</sub>S, 743.32; found, 744.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((4,6-dimethoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04 (d, <i>J</i> = 9.1 Hz, 1H), 7.47 (s, 1H), 7.39 (d, <i>J</i> = 2.5 Hz, 1H), 7.12 (dd, <i>J</i> = 9.1, 2.3 Hz, 1H), 5.84–5.70 (m, 2H), 5.29 (d, <i>J</i> = 17.6 Hz, 1H), 5.10 (d, <i>J</i> = 10.8 Hz, 1H), 4.57–4.39 (m, 2H), 4.06–3.96 (m, 5H), 3.91 (s, 3H), 2.98–2.87 (m, 1H), 2.56 (dd, <i>J</i> = 13.3, 7.3 Hz, 1H), 2.35–2.13 (m, 2H), 2.09–1.97 (m, 1H), 1.87 (dd, <i>J</i> = 8.1, 5.3 Hz, 1H), 1.45–0.84 (m, 20H). LCMS (method H): <i>t</i><sub>R</sub> = 2.93 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>10</sub>S, 729.30; found, 730.35 (M + H)<sup>+</sup>.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>tert</i>-Butyl <i>N</i>-[(2<i>S</i>)-1-[(2<i>S</i>,4<i>R</i>)-2-{[(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl]carbamoyl}-4-[(3-fluoro-4,6-dimethoxyisoquinolin-1-yl)oxy]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.15 (br s, 1H), 8.02 (d, <i>J</i> = 9.3 Hz, 1H), 7.32 (d, <i>J</i> = 1.8 Hz, 1H), 7.03 (dd, <i>J</i> = 8.7, 1.4 Hz, 1H), 5.82–5.67 (m, 3H), 5.28 (d, <i>J</i> = 17.1 Hz, 1H), 5.11 (dd, <i>J</i> = 10.2, 1.1 Hz, 1H), 4.50 (dd, <i>J</i> = 10.1, 7.3 Hz, 1H), 4.43 (d, <i>J</i> = 11.8 Hz, 1H), 4.04 (br s, 1H), 3.96 (d, <i>J</i> = 1.3 Hz, 3H), 3.93 (s, 3H), 2.97–2.88 (m, 1H), 2.59 (dd, <i>J</i> = 13.7, 6.9 Hz, 1H), 2.33–2.16 (m, 2H), 1.87 (dd, <i>J</i> = 8.1, 5.3 Hz, 1H), 1.42 (dd, <i>J</i> = 9.3, 5.0 Hz, 1H), 1.22 (m, 3H), 1.22 (s, 9H), 1.09–1.03 (m, 2H), 1.01 (s, 9H). LCMS (method K): <i>t</i><sub>R</sub> = 3.34 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>48</sub>FN<sub>5</sub>O<sub>10</sub>S-BOC, 662.27; found, 662.22 (M – BOC + H)<sup>+</sup>.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((5-Chloro-4-methoxyisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>O) δ 8.14 (d, <i>J</i> = 8.3 Hz, 1H), 7.74 (d, <i>J</i> = 7.3 Hz, 1H), 7.65 (s, 1H), 7.44 (t, <i>J</i> = 7.8 Hz, 1H), 5.81–5.68 (m, 2H), 5.28 (d, <i>J</i> = 16.9 Hz, 1H), 5.11 (d, <i>J</i> = 11.6 Hz, 1H), 4.57–4.40 (m, 2H), 4.20 (d, <i>J</i> = 0.3 Hz, 1H), 4.03 (d, <i>J</i> = 8.8 Hz, 1H), 3.93 (s, 3H), 2.97–2.86 (m, 1H), 2.59 (dd, <i>J</i> = 13.8, 7.1 Hz, 1H), 2.33–2.16 (m, 2H), 1.86 (dd, <i>J</i> = 8.2, 5.4 Hz, 1H), 1.47–1.39 (m, 1H), 1.26–0.93 (m, 22H). LCMS (method E): <i>t</i><sub>R</sub> = 3.41 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>46</sub>ClN<sub>5</sub>O<sub>9</sub>S, 747.28; found, 748.35 (M + H)<sup>+</sup>.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((6-Chloro-4-methoxyisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.41 (s, 1H), 8.86 (s, 1H), 8.10 (d, <i>J</i> = 8.8 Hz, 1H), 7.98 (d, <i>J</i> = 1.8 Hz, 1H), 7.67 (s, 1H), 7.57 (dd, <i>J</i> = 8.9, 1.6 Hz, 1H), 6.61 (d, <i>J</i> = 8.3 Hz, 1H), 5.67 (br s, 1H), 5.64–5.48 (m, 1H), 5.28–5.15 (m, 1H), 5.12–5.02 (m, 1H), 4.45–4.25 (m, 2H), 4.01–3.81 (m, 5H), 2.99–2.85 (m, 1H), 2.52–2.48 (m, 1H), 2.12 (q, <i>J</i> = 8.8 Hz, 2H), 1.68 (dd, <i>J</i> = 8.0, 5.3 Hz, 1H), 1.41–1.28 (m, 1H), 1.17–0.87 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.59 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>46</sub>ClN<sub>5</sub>O<sub>9</sub>S, 747.28; found, 748.20 (M + H)<sup>+</sup>.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Chloroisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>25</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 8.92 (s, 1H), 8.09–7.99 (m, 2H), 7.94 (d, <i>J</i> = 8.8 Hz, 1H), 7.76 (dd, <i>J</i> = 8.7, 1.6 Hz, 1H), 7.43 (d, <i>J</i> = 6.0 Hz, 1H), 6.59 (d, <i>J</i> = 8.0 Hz, 1H), 5.77 (br s, 1H), 5.59 (dt, <i>J</i> = 17.3, 9.7 Hz, 1H), 5.20 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.13–5.03 (m, 1H), 4.52–4.29 (m, 2H), 3.97–3.84 (m, 2H), 2.98–2.84 (m, 1H), 2.52–2.48 (m, 1 H), 2.15 (q, <i>J</i> = 8.5 Hz, 2H), 1.68 (dd, <i>J</i> = 7.8, 5.3 Hz, 1H), 1.40–1.29 (m, 1H), 1.12–0.85 (m, 22H). LCMS (method D): <i>t</i><sub>R</sub> = 2.38 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>ClN<sub>5</sub>O<sub>8</sub>S, 717.26; found, 718.22 (M + H)<sup>+</sup>.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-fluoro-4-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>26</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.14 (dd, <i>J</i> = 9.2, 5.4 Hz, 1H), 7.71 (dd, <i>J</i> = 9.4, 2.6 Hz, 1H), 7.60–7.39 (m, 2H), 6.58 (d, <i>J</i> = 9.1 Hz, 1H), 5.87–5.64 (m, 2H), 5.28 (d, <i>J</i> = 16.9 Hz, 1H), 5.11 (d, <i>J</i> = 10.6 Hz, 1H), 4.52 (dd, <i>J</i> = 10.3, 7.3 Hz, 1H), 4.42 (d, <i>J</i> = 11.6 Hz, 1H), 4.25–4.17 (m, 1H), 4.06–3.95 (m, 4H), 2.97–2.89 (m, 1H), 2.59 (dd, <i>J</i> = 13.7, 6.9 Hz, 1H), 2.34–2.16 (m, 2H), 1.86 (dd, <i>J</i> = 8.1, 5.5 Hz, 1H), 1.49–1.38 (m, 1H), 1.30–0.91 (m, 22H). LCMS (method E): <i>t</i><sub>R</sub> = 3.34 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>46</sub>FN<sub>5</sub>O<sub>9</sub>S, 731.30; found, 732.35 (M + H)<sup>+</sup>.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Chloro-4-(2-methoxyethoxy)isoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.17 (d, <i>J</i> = 8.9 Hz, 1H), 8.08 (s, 1H), 7.72 (d, <i>J</i> = 8.5 Hz, 1H), 7.63 (s, 1H), 6.62 (d, <i>J</i> = 9.5 Hz, 1H), 5.90–5.70 (m, 2H), 5.33 (d, <i>J</i> = 17.1 Hz, 1H), 5.15 (d, <i>J</i> = 10.4 Hz, 1H), 4.67–4.55 (m, 2H), 4.47 (d, <i>J</i> = 11.6 Hz, 1H), 4.38–4.31 (m, 2H), 4.24–4.18 (m, 1H), 4.08 (d, <i>J</i> = 9.2 Hz, 1H), 3.94–3.82 (m, 2H), 3.50 (s, 3H), 3.05–2.89 (m, 1H), 2.63 (dd, <i>J</i> = 13.6, 6.9 Hz, 1H), 2.40–2.20 (m, 2H), 1.91 (dd, <i>J</i> = 7.9, 5.5 Hz, 1H), 1.47 (dd, <i>J</i> = 9.5, 5.2 Hz, 1H), 1.16 (s, 9H), 1.14–1.24 (m, 2H), 1.06–1.00 (m, 11H). LCMS (method B): <i>t</i><sub>R</sub> = 3.09 min). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>50</sub>ClN<sub>5</sub>O<sub>10</sub>S, 791.30; found, 792.35 (M + H)<sup>+</sup>.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Chloro-4-(dimethylamino)isoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.23–8.14 (m, 1H), 8.14–8.04 (m, 2H), 7.92–7.74 (m, 1H), 5.86 (br s, 1H), 5.73 (dt, <i>J</i> = 17.1, 9.6 Hz, 1H), 5.29 (dd, <i>J</i> = 17.2, 1.4 Hz, 1H), 5.17–5.04 (m, 1H), 4.59 (dd, <i>J</i> = 10.3, 7.1 Hz, 1H), 4.48 (d, <i>J</i> = 12.1 Hz, 1H), 4.13 (s, 1H), 4.07 (dd, <i>J</i> = 11.8, 3.3 Hz, 1H), 3.23–3.09 (m, 6H), 2.99–2.87 (m, 1H), 2.72–2.56 (m, 1H), 2.41–2.18 (m, 2H), 1.87 (dd, <i>J</i> = 8.2, 5.4 Hz, 1H), 1.43 (dd, <i>J</i> = 9.6, 5.3 Hz, 1H), 1.30–1.17 (m, 2H), 1.13–1.02 (m, 11H), 1.00 (s, 9H). LCMS (method I): <i>t</i><sub>R</sub> = 2.05 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>ClN<sub>6</sub>O<sub>8</sub>S, 760.30; found, 761.33 (M + H)<sup>+</sup>.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Chloro-4-(difluoromethoxy)isoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>29</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.16 (s, 1H), 8.07 (d, <i>J</i> = 8.9 Hz, 1H), 7.95 (s, 1H), 7.82 (d, <i>J</i> = 8.9 Hz, 1H), 7.18–6.76 (m, 1H), 6.59 (d, <i>J</i> = 9.2 Hz, 1H), 5.89 (br s, 1H), 5.83–5.72 (m, 1H), 5.33 (d, <i>J</i> = 17.1 Hz, 1H), 5.15 (d, <i>J</i> = 10.4 Hz, 1H), 4.65–4.52 (m, 1H), 4.43 (d, <i>J</i> = 12.09 Hz, 1H), 4.24–4.17 (m, 1H), 4.14–4.01 (m, 1H), 3.02–2.87 (m, 1H), 2.59 (dd, <i>J</i> = 13.85, 6.80 Hz, 1H), 2.39–2.17 (m, 2H), 1.88 (dd, <i>J</i> = 8.06, 5.54 Hz, 1H), 1.44 (dd, <i>J</i> = 9.32, 5.29 Hz, 1H), 1.16 (s, 9H), 1.14–1.24 (m, 2H), 1.06–1.00 (m, 11H). LCMS (method B): <i>t</i><sub>R</sub> = 3.13 min). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>44</sub>ClF<sub>2</sub>N<sub>5</sub>O<sub>9</sub>S, 783.25; found, 784.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> X-ray Co-crystal Structure of HCV NS3/4A Protease Complexed with <b>24</b></h3><div class="NLM_p last">Methods for protein expression and purification have been reported.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> A solution of the NS3/4A protease enzyme (20 mg/mL) in 25 mM MES buffer at pH 6.5, 500 mM NaCl, 2 mM DTT, and 5% v/v glycerol was incubated with 4.3 mM <b>24</b> (5-fold molar excess) for 2 h at room temperature. The complexed protein was centrifuged at 10000 rpm for 10 min and then 0.2 μm centrifuge filtered. Crystals were grown by the hanging drop vapor diffusion method. A 12–24% v/v PEG 1500 gradient evenly divided across 24 reservoir solutions, which also was buffered by 100 mM HEPES at pH 7.5, was used to screen for crystallization conditions. For this complex, the optimal PEG 1500 concentration was 18% v/v. Plate-like crystals were harvested after 7 days. A 20% v/v glycerol solution prepared with the reservoir solution was used as the cryoprotectant. The crystals belonged to space group <i>P</i>2<sub>1</sub> with unit cell parameters of <i>a</i> = 45.4 Å, <i>b</i> = 67.8 Å, <i>c</i> = 61.3 Å, and β = 108.5°. A data set was collected at the Bristol-Myers Squibb research facility in Princeton, NJ. A Rigaku FR-E generator and Osmic MaxFlux HR multilayer optics were used to generate the well-collimated X-ray beam. A Rigaku R-axis IV++ image plate detector was used to record the diffraction images which were processed with the HKL suite.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Diffraction data were recorded from 50.0–2.2 Å resolution. Overall, the data set was 99.4% complete with an average <i>I</i>/σ(<i>I</i>) of 12.3, <i>R</i><sub>merge</sub> of 9.3%, and redundancy of 3.5. The highest resolution shell, 2.28–2.20 Å, was 98.0% complete with an average <i>I</i>/σ(<i>I</i>) of 4.8, <i>R</i><sub>merge</sub> of 26.3%, and redundancy of 3.3. The structure was determined by molecular substitution based on another structure of this same crystal form. The structure was refined by three cycles of model building with QUANTA<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and refinement with CNX.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The current crystallographic residues, <i>R</i> and <i>R</i><sub>free</sub>, are 23.9% and 28.9%, respectively.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code for <b>1</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK">4NWK</a> and for <b>24</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWL">4NWL</a>.</p><div class="testing" data-doi="10.1021/jm500297k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul M. Scola</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#84d4e5f1e8aad7e7ebe8e5c4e6e9f7aae7ebe9"><span class="__cf_email__" data-cfemail="c595a4b0a9eb96a6aaa9a485a7a8b6eba6aaa8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Qiang Sun</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89c5e0d8e0e8e7eea7dafce7c9ebe4faa7eae6e4"><span class="__cf_email__" data-cfemail="b9f5d0e8d0d8d7de97eaccd7f9dbd4ca97dad6d4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Xiangdong Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ny Sin</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian L. Venables</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sing-Yuen Sit</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Cocuzza</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna M. Bilder</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanley V. D’Andrea</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Zheng</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piyasena Hewawasam</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Tu</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacques Friborg</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Falk</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis Hernandez</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Levine</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chaoqun Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Yu</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy K. Sheaffer</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guangzhi Zhai</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Barry</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay O. Knipe</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong-Hae Han</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Schartman</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Donoso</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Mosure</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael W. Sinz</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatyana Zvyaga</span> - <span class="hlFld-Affiliation affiliation">Department of Lead Discovery and Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew C. Good</span> - <span class="hlFld-Affiliation affiliation">Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramkumar Rajamani</span> - <span class="hlFld-Affiliation affiliation">Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Kish</span> - <span class="hlFld-Affiliation affiliation">Department of Protein Science and Structure, Bristol-Myers Squibb Research and Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey Tredup</span> - <span class="hlFld-Affiliation affiliation">Department of Protein Science and Structure, Bristol-Myers Squibb Research and Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herbert E. Klei</span> - <span class="hlFld-Affiliation affiliation">Department of Protein Science and Structure, Bristol-Myers Squibb Research and Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Gao</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Development, Bristol-Myers
Squibb Research and Development, 1 Squibb Drive, New Brunswick, New Jersey, 08903, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luciano Mueller</span> - <span class="hlFld-Affiliation affiliation">Department
of Mechanistic Biochemistry, Bristol-Myers
Squibb Research and Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard J. Colonno</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis M. Grasela</span> - <span class="hlFld-Affiliation affiliation">Department of Clinical Development Infectious
Disease, Bristol-Myers Squibb Research and
Development, PO Box 5400 Princeton, New Jersey, 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen P. Adams</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Loy</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul C. Levesque</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huabin Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Shi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucy Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Warner</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danshi Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jialong Zhu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas A. Meanwell</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fiona McPhee</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut, 06492, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d8688e7183-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Xiaohua Stella Huang of the analytical department for NMR studies and the discovery chemistry synthesis group, including Arvind Mathur and Richard Rampulla, for their support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> Abbreviations Used</h2><tr><td class="NLM_term">AV</td><td class="NLM_def"><p class="first last">atrioventricular</p></td></tr><tr><td class="NLM_term">BP</td><td class="NLM_def"><p class="first last">blood pressure</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CV</td><td class="NLM_def"><p class="first last">cardiovascular</p></td></tr><tr><td class="NLM_term">DAAs</td><td class="NLM_def"><p class="first last">direct-acting antivirals</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenylphosphoryl azide</p></td></tr><tr><td class="NLM_term">ECG</td><td class="NLM_def"><p class="first last">electrocardiogram</p></td></tr><tr><td class="NLM_term">GLP</td><td class="NLM_def"><p class="first last">good laboratory practice</p></td></tr><tr><td class="NLM_term">GT</td><td class="NLM_def"><p class="first last">genotype</p></td></tr><tr><td class="NLM_term">HCN4</td><td class="NLM_def"><p class="first last">potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">HR</td><td class="NLM_def"><p class="first last">heart rate</p></td></tr><tr><td class="NLM_term">ID</td><td class="NLM_def"><p class="first last">intraduodenal</p></td></tr><tr><td class="NLM_term">MAD</td><td class="NLM_def"><p class="first last">multiple ascending dose</p></td></tr><tr><td class="NLM_term">NHV</td><td class="NLM_def"><p class="first last">normal healthy volunteer</p></td></tr><tr><td class="NLM_term">NS3</td><td class="NLM_def"><p class="first last">nonstructural protein 3</p></td></tr><tr><td class="NLM_term">NS4A</td><td class="NLM_def"><p class="first last">nonstructural protein 4A</p></td></tr><tr><td class="NLM_term">NS5A</td><td class="NLM_def"><p class="first last">nonstructural protein 5A</p></td></tr><tr><td class="NLM_term">PegIFN</td><td class="NLM_def"><p class="first last">pegylated interferon</p></td></tr><tr><td class="NLM_term">RBV</td><td class="NLM_def"><p class="first last">ribavirin</p></td></tr><tr><td class="NLM_term">SAD</td><td class="NLM_def"><p class="first last">single ascending dose</p></td></tr><tr><td class="NLM_term">SNRT</td><td class="NLM_def"><p class="first last">sinus node recovery time</p></td></tr><tr><td class="NLM_term">SVR</td><td class="NLM_def"><p class="first last">sustained viral response</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Scola, P. M.; Wang, A.; Good, A. C; Sun, L.; Combrink, K. D.; Campbell, J. A.; Chen, J.; Tu, Y.; Sin, N.; Venables, B. L.; Sit, S. Y.; Chen, Y.; Cocuzza, A.; Bilder, D. M.; D’Andrea, S.; Zheng, B.; Hewawasam, P.; Ding, M.; Thuring, J.; Hernandez, D.; Yu, F.; Falk, P.; Zhai, G.; Sheaffer, A. K.; Chen, C.; Lee, M. S.; Barry, D.; Knipe, J. O.; Han, Y. H.; Jenkins, S.; Gesenberg, C.; Sinz, M. W.; Santone, K. S.; Zvyaga, T.; Rajamani, R.; Klei, H. E.; Colonno, R. J.; Grasela, D. M.; Hughes, E.; Chien, C.; Adams, S.; Levesque, P. C.; Li, D.; Zhu, J.; Meanwell, N. A.; McPhee, F.</span><span> </span><span class="NLM_article-title">Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1021/jm401840s</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm401840s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+M.+Scola&author=A.+Wang&author=A.+C+Good&author=L.+Sun&author=K.+D.+Combrink&author=J.+A.+Campbell&author=J.+Chen&author=Y.+Tu&author=N.+Sin&author=B.+L.+Venables&author=S.+Y.+Sit&author=Y.+Chen&author=A.+Cocuzza&author=D.+M.+Bilder&author=S.+D%E2%80%99Andrea&author=B.+Zheng&author=P.+Hewawasam&author=M.+Ding&author=J.+Thuring&author=D.+Hernandez&author=F.+Yu&author=P.+Falk&author=G.+Zhai&author=A.+K.+Sheaffer&author=C.+Chen&author=M.+S.+Lee&author=D.+Barry&author=J.+O.+Knipe&author=Y.+H.+Han&author=S.+Jenkins&author=C.+Gesenberg&author=M.+W.+Sinz&author=K.+S.+Santone&author=T.+Zvyaga&author=R.+Rajamani&author=H.+E.+Klei&author=R.+J.+Colonno&author=D.+M.+Grasela&author=E.+Hughes&author=C.+Chien&author=S.+Adams&author=P.+C.+Levesque&author=D.+Li&author=J.+Zhu&author=N.+A.+Meanwell&author=F.+McPhee&title=Discovery+and+early+clinical+evaluation+of+BMS-605339%2C+a+potent+and+orally+efficacious+tripeptidic+acylsulfonamide+NS3+protease+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection&doi=10.1021%2Fjm401840s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm401840s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401840s%26sid%3Dliteratum%253Aachs%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DDiscovery%2520and%2520early%2520clinical%2520evaluation%2520of%2520BMS-605339%252C%2520a%2520potent%2520and%2520orally%2520efficacious%2520tripeptidic%2520acylsulfonamide%2520NS3%2520protease%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm401840s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poliakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerblom, E. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2551-2568&author=A.+Johanssonauthor=A.+Poliakovauthor=E.+A+Kerblomauthor=K.+Wiklundauthor=G.+Lindebergauthor=S.+Winiwarterauthor=U.+H.+Danielsonauthor=B.+Samuelssonauthor=A.+Hallberg&title=Acyl+sulfonamides+as+potent+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3+%28protease-helicase%2FNTPase%29%3A+a+comparative+study+of+different+C-terminals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DPoliakov%26aufirst%3DA.%26aulast%3DKerblom%26aufirst%3DE.%2BA%26aulast%3DWiklund%26aufirst%3DK.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DAcyl%2520sulfonamides%2520as%2520potent%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%2520%2528protease-helicase%252FNTPase%2529%253A%2520a%2520comparative%2520study%2520of%2520different%2520C-terminals%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2551%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1448-1474&author=P.+Oertqvistauthor=S.+D.+Petersonauthor=E.+Aakerblomauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=R.+Franssonauthor=G.+Lindebergauthor=U.+H.+Danielsonauthor=A.+Karlenauthor=A.+Sandstroem&title=Phenylglycine+as+a+novel+P2+scaffold+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DS.%2BD.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DFransson%26aufirst%3DR.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DPhenylglycine%2520as%2520a%2520novel%2520P2%2520scaffold%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1448%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daoud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4057</span><span class="NLM_x">–</span> <span class="NLM_lpage">4068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=4057-4068&author=R.+Roennauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=H.+Daoudauthor=E.+Aakerblomauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Evaluation+of+a+diverse+set+of+potential+P1+carboxylic+acid+bioisosteres+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DDaoud%26aufirst%3DH.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520a%2520diverse%2520set%2520of%2520potential%2520P1%2520carboxylic%2520acid%2520bioisosteres%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D4057%26epage%3D4068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Baeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waangsell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorstensson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvarnstroem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7184</span><span class="NLM_x">–</span> <span class="NLM_lpage">7202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7184-7202&author=M.+Baeckauthor=P.-O.+Johanssonauthor=F.+Waangsellauthor=F.+Thorstenssonauthor=I.+Kvarnstroemauthor=S.+Ayesaauthor=H.+Waehlingauthor=M.+Pelcmanauthor=K.+Janssonauthor=S.+Lindstroemauthor=H.+Wallbergauthor=B.+Classonauthor=C.+Ryderg%C3%A5rdauthor=L.+Vrangauthor=E.+Hamelinkauthor=A.+Hallbergauthor=A.+Rosenquistauthor=B.+Samuelsson&title=Novel+potent+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+use+of+cyclopentane+and+cyclopentene+P2-motifs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaeck%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DWaangsell%26aufirst%3DF.%26aulast%3DThorstensson%26aufirst%3DF.%26aulast%3DKvarnstroem%26aufirst%3DI.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWallberg%26aufirst%3DH.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DNovel%2520potent%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520use%2520of%2520cyclopentane%2520and%2520cyclopentene%2520P2-motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7184%26epage%3D7202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span> </span><span class="NLM_article-title">Potent triazolyl-proline-based inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3400-3404&author=J.+Naudauthor=C.+Lemkeauthor=N.+Goudreauauthor=E.+Beaulieuauthor=P.+D.+Whiteauthor=M.+Llinas-Brunetauthor=P.+Forgione&title=Potent+triazolyl-proline-based+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DLemke%26aufirst%3DC.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DBeaulieu%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DP.%2BD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DForgione%26aufirst%3DP.%26atitle%3DPotent%2520triazolyl-proline-based%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3400%26epage%3D3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%80%93activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraznenok, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2g&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1002%2Fanie.200906696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2g&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1652-1655&author=M.+D.+Cummingsauthor=J.+Lindbergauthor=T.-I.+Linauthor=H.+de+Kockauthor=O.+Lenzauthor=E.+Liljaauthor=S.+Fellanderauthor=V.+Baraznenokauthor=S.+Nystromauthor=M.+Nilssonauthor=L.+Vrangauthor=M.+Edlundauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+Raboissonauthor=K.+Simmen&title=Induced-fit+binding+of+the+macrocyclic+noncovalent+inhibitor+TMC435+to+its+HCV+NS3%2FNS4A+protease+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2gR"><div class="casContent"><span class="casTitleNuber">2g</span><div class="casTitle"><span class="NLM_cas:atitle">Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target</span></div><div class="casAuthors">Cummings, Maxwell D.; Lindberg, Jimmy; Lin, Tse-I.; de Kock, Herman; Lenz, Oliver; Lilja, Elisabet; Fellander, Sara; Baraznenok, Vera; Nystrom, Susanne; Nilsson, Magnus; Vrang, Lotta; Edlund, Michael; Rosenquist, Asa; Samuelsson, Bertil; Raboisson, Pierre; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1652-1655, S1652/1-S1652/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of the macrocyclic inhibitor TMC435 bound to its HCV NS3/4A protease target at a resoln. of 2.4 Å, providing at. detail of induced fit to an extended S2 subsite.  The complex structure helps to rationalize the impact of key modifications in the optimization path that led to 1, and is guiding our understanding of resistance patterns.  Future modeling and structure-based design efforts aimed at NS3/NS4A protease should benefit from the new structure, which represents the first example of a noncovalent NS3/NS4A protease-inhibitor complex deposited in the PDB and details the induced fit involved in accommodating a large P2 substituent.  Inhibitors with large P2 groups that occupy the extended S2 subsite probe the crystallog. obsd. helicase-protease interface, and it is hoped that future studies will clarify the relevance of interfacial contacts to protease activity and protease inhibitor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEYqCPA57hLVg90H21EOLACvtfcHk0liHOIrrao3nbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D&md5=535b340784d1af62df32e8cf3bd3fe87</span></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906696%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DLilja%26aufirst%3DE.%26aulast%3DFellander%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DInduced-fit%2520binding%2520of%2520the%2520macrocyclic%2520noncovalent%2520inhibitor%2520TMC435%2520to%2520its%2520HCV%2520NS3%252FNS4A%2520protease%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1652%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5095</span><span class="NLM_x">–</span> <span class="NLM_lpage">5100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5095-5100&author=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=M.+Nilssonauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmen&title=Discovery+of+novel+potent+and+selective+dipeptide+hepatitis+C+virus+NS3%2F4A+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520potent%2520and%2520selective%2520dipeptide%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5095%26epage%3D5100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dooren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindermans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span> </span><span class="NLM_article-title">Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6189</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6189-6193&author=S.+Vendevilleauthor=M.+Nilssonauthor=H.+de+Kockauthor=T.-I.+Linauthor=D.+Antonovauthor=B.+Classonauthor=S.+Ayesaauthor=V.+Ivanovauthor=P.-O.+Johanssonauthor=P.+Kahnbergauthor=A.+Enerothauthor=K.+Wikstromauthor=L.+Vrangauthor=M.+Edlundauthor=S.+Lindstr%C3%B6mauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=M.+Van+Doorenauthor=N.+Kindermansauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmenauthor=P.+Raboisson&title=Discovery+of+novel%2C+potent+and+bioavailable+proline-urea+based+macrocyclic+HCV+NS3%2F4A+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DAntonov%26aufirst%3DD.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DWikstrom%26aufirst%3DK.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DVan%2BDooren%26aufirst%3DM.%26aulast%3DKindermans%26aufirst%3DN.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520novel%252C%2520potent%2520and%2520bioavailable%2520proline-urea%2520based%2520macrocyclic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6189%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belfrage, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agback, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terelius, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of potent inhibitors of the hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4004</span><span class="NLM_x">–</span> <span class="NLM_lpage">4011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4004-4011&author=M.+Nilssonauthor=A.+K.+Belfrageauthor=S.+Lindstroemauthor=H.+Waehlingauthor=C.+Lindquistauthor=S.+Ayesaauthor=P.+Kahnbergauthor=M.+Pelcmanauthor=K.+Benkestockauthor=T.+Agbackauthor=L.+Vrangauthor=Y.+Tereliusauthor=K.+Wikstr%C3%B6mauthor=E.+Hamelinkauthor=C.+Ryderg%C3%A5rdauthor=M.+Edlundauthor=A.+Enerothauthor=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=P.+Wigerinckauthor=K.+Simmenauthor=B.+Samuelssonauthor=A.+Rosenquist&title=Synthesis+and+SAR+of+potent+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease%3A+exploration+of+P2+quinazoline+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DBelfrage%26aufirst%3DA.%2BK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DLindquist%26aufirst%3DC.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DAgback%26aufirst%3DT.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DTerelius%26aufirst%3DY.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRosenquist%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520potent%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%253A%2520exploration%2520of%2520P2%2520quinazoline%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4004%26epage%3D4011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Lampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5413</span><span class="NLM_x">–</span> <span class="NLM_lpage">5424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2k&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1016%2Fj.bmc.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2k&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=20541424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2k&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5413-5424&author=A.+Lampaauthor=A.+E.+Ehrenbergauthor=S.+S.+Gustafssonauthor=A.+Vemaauthor=E.+Aakerblomauthor=G.+Lindebergauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Improved+P2+phenylglycine-based+hepatitis+C+virus+NS3+protease+inhibitors+with+alkenylic+prime-side+substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2kR"><div class="casContent"><span class="casTitleNuber">2k</span><div class="casTitle"><span class="NLM_cas:atitle">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span></div><div class="casAuthors">Lampa, Anna; Ehrenberg, Angelica E.; Gustafsson, Sofia S.; Vema, Aparna; Aakerblom, Eva; Lindeberg, Gunnar; Karlen, Anders; Danielson, U. Helena; Sandstroem, Anja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5413-5424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phenylglycine has proven to be a useful P2 residue in HCV NS3 protease inhibitors.  A novel π-π-interaction between the phenylglycine and the catalytic H57 residue of the protease was postulated, and it was hypothesized that the introduction of a vinyl on the phenylglycine might strengthen this π-π-interaction.  Thus, a series of acyclic vinylated phenylglycine-based HCV NS3 protease inhibitors, e.g., I, was synthesized and their inhibitory potency evaluated.  Surprisingly, inhibitors based on both D- and L-phenylglycine were found to be effective inhibitors, with a slight preference for the D-epimers.  Furthermore, prime-side alkenylic extension of the C-terminal acylsulfonamide group gave significantly improved inhibitors with potencies in the nanomolar range (∼35 nM), potencies which were retained on mutant variants of the protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1S6r1UZnWFrVg90H21EOLACvtfcHk0lhO9VNNDOD4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D&md5=53f795b5eba3e0b2d27e74fd504229a0</span></div><a href="/servlet/linkout?suffix=cit2k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DLampa%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DGustafsson%26aufirst%3DS.%2BS.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DImproved%2520P2%2520phenylglycine-based%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%2520with%2520alkenylic%2520prime-side%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5413%26epage%3D5424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gising, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larhed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1<i>H</i>)-pyrazinones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6512-6525&author=P.+Oertqvistauthor=J.+Gisingauthor=A.+E.+Ehrenbergauthor=A.+Vemaauthor=A.+Borgauthor=A.+Karlenauthor=M.+Larhedauthor=U.+H+Danielsonauthor=A.+Sandstroem&title=Discovery+of+achiral+inhibitors+of+the+hepatitis+C+virus+NS3+protease+based+on+2%281H%29-pyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DGising%26aufirst%3DJ.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DBorg%26aufirst%3DA.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DDanielson%26aufirst%3DU.%2BH%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520achiral%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520based%2520on%25202%25281H%2529-pyrazinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6512%26epage%3D6525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aekerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=841-852&author=P.+Oertqvistauthor=A.+Vemaauthor=A.+E.+Ehrenbergauthor=G.+Dahlauthor=R.+Roennauthor=E.+Aekerblomauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Structure%E2%80%93activity+relationships+of+HCV+NS3+protease+inhibitors+evaluated+on+the+drug-resistant+variants+A156T+and+D168V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DAekerblom%26aufirst%3DE.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%2520evaluated%2520on%2520the%2520drug-resistant%2520variants%2520A156T%2520and%2520D168V%26jtitle%3DAntiviral%2520Ther.%26date%3D2010%26volume%3D15%26spage%3D841%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7317</span><span class="NLM_x">–</span> <span class="NLM_lpage">7322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7317-7322&author=C.+Z.+Dingauthor=Y.-K.+Zhangauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=L.+Liuauthor=M.+Duanauthor=R.+L.+Jarvestauthor=J.+Jiauthor=W.+M.+Kazmierskiauthor=M.+D.+Tallantauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+M.+Crosbyauthor=A.+A.+Wangauthor=Z.-J.+Niauthor=W.+Zoueauthor=J.+Wright&title=Synthesis+and+biological+evaluations+of+P4-benzoxaborole-substituted+macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DA.%2BA.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DZoue%26aufirst%3DW.%26aulast%3DWright%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%2520P4-benzoxaborole-substituted%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7317%26epage%3D7322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2993</span><span class="NLM_x">–</span> <span class="NLM_lpage">2996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2993-2996&author=M.+Duanauthor=W.+Kazmierskiauthor=R.+Crosbyauthor=M.+Gartlandauthor=J.+Jiauthor=M.+Tallantauthor=A.+Wangauthor=R.+Hamatakeauthor=L.+Wrightauthor=M.+Wuauthor=Y.-K.+Zhangauthor=C.+Z.+Dingauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Baker&title=Discovery+of+novel+P3-oxo+inhibitor+of+hepatitis+C+virus+NS3%2F4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DCrosby%26aufirst%3DR.%26aulast%3DGartland%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DTallant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520P3-oxo%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2993%26epage%3D2996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3021</span><span class="NLM_x">–</span> <span class="NLM_lpage">3026</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201278q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2p&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3021-3026&author=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wangauthor=X.+Liauthor=S.+Zhangauthor=Y.-Y.+Zhangauthor=Y.+Liuauthor=C.+Z.+Dingauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liu&title=Discovery+of+novel+urea-based+hepatitis+C+protease+inhibitors+with+high+potency+against+protease-inhibitor-resistant+mutants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2pR"><div class="casContent"><span class="casTitleNuber">2p</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Hamatake, Robert; Duan, Maosheng; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Wang, Amy; Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3021-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors were prepd. and characterized in replicase HCV protease-resistant mutants assay.  Several compds., exemplified by I, were found to be more potent in HCV replicon assays than leading second generation inhibitors such as danoprevir and TMC-435350.  Addnl., following oral administration, inhibitor I was found in rat liver in significantly higher concns. than those reported for both danoprevir and TMC-435350, suggesting that inhibitor I has the combination of anti-HCV and pharmacokinetic properties that warrants further development of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZf8snkMwqSrVg90H21EOLACvtfcHk0lh0nstDq6eU5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D&md5=43f9016626357a5fea8d6d1e9784e2d8</span></div><a href="/servlet/linkout?suffix=cit2p&amp;dbid=16384&amp;doi=10.1021%2Fjm201278q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201278q%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.-Y.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520urea-based%2520hepatitis%2520C%2520protease%2520inhibitors%2520with%2520high%2520potency%2520against%2520protease-inhibitor-resistant%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3021%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2q&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.-S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2qR"><div class="casContent"><span class="casTitleNuber">2q</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">McCauley, John A.; McIntyre, Charles J.; Rudd, Michael T.; Nguyen, Kevin T.; Romano, Joseph J.; Butcher, John W.; Gilbert, Kevin F.; Bush, Kimberly J.; Holloway, M. Katharine; Swestock, John; Wan, Bang-Lin; Carroll, Steven S.; DiMuzio, Jillian M.; Graham, Donald J.; Ludmerer, Steven W.; Mao, Shi-Shan; Stahlhut, Mark W.; Fandozzi, Christine M.; Trainor, Nicole; Olsen, David B.; Vacca, Joseph P.; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2443-2463</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a mol.-modeling derived strategy.  Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compds. via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate vaniprevir, MK-7009, which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_2CVs9I1H_7Vg90H21EOLACvtfcHk0lj-8N5ZRFyfUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D&md5=dc820c588d5482f6913091a87eaf9af1</span></div><a href="/servlet/linkout?suffix=cit2q&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2443%26epage%3D2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2–P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2%E2%80%93P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2r&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2%25E2%2580%2593P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, I. I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bismacrocyclic, N. J.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=I.+I.+I.+Carrollauthor=S.+S.+DiMuzioauthor=J.+Stahlhutauthor=M.+W.+Olsenauthor=D.+B.+Lyleauthor=T.+A.+Vaccaauthor=J.+P.+Livertonauthor=N.+J.+Bismacrocyclic&title=Inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DI.%2BI.%2BI.%26aulast%3DDiMuzio%26aufirst%3DS.%2BS.%26aulast%3DStahlhut%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DM.%2BW.%26aulast%3DLyle%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DT.%2BA.%26aulast%3DLiverton%26aufirst%3DJ.%2BP.%26aulast%3DBismacrocyclic%26aufirst%3DN.%2BJ.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the hepatitis C virus NS3 protease with basic amine functionality at the P3-amino acid N-terminus: discovery and optimization of a new series of P2–P4 macrocycles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4820</span><span class="NLM_x">–</span> <span class="NLM_lpage">4837</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900372w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4820-4837&author=S.+Harperauthor=M.+Ferraraauthor=B.+Crescenziauthor=M.+Pompeiauthor=M.+C.+Palumbiauthor=J.+M.+Di+Muzioauthor=M.+Donghiauthor=F.+Fioreauthor=U.+Kochauthor=N.+J.+Livertonauthor=S.+Pesciauthor=A.+Petrocchiauthor=M.+Rowleyauthor=V.+Summaauthor=C.+Gardelli&title=Inhibitors+of+the+hepatitis+C+virus+NS3+protease+with+basic+amine+functionality+at+the+P3-amino+acid+N-terminus%3A+discovery+and+optimization+of+a+new+series+of+P2%E2%80%93P4+macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2t&amp;dbid=16384&amp;doi=10.1021%2Fjm900372w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900372w%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DPalumbi%26aufirst%3DM.%2BC.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%2BM.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520with%2520basic%2520amine%2520functionality%2520at%2520the%2520P3-amino%2520acid%2520N-terminus%253A%2520discovery%2520and%2520optimization%2520of%2520a%2520new%2520series%2520of%2520P2%25E2%2580%2593P4%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4820%26epage%3D4837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Di Francesco, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessole, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7014</span><span class="NLM_x">–</span> <span class="NLM_lpage">7028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900524b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2u&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7014-7028&author=M.+E.+Di+Francescoauthor=G.+Dessoleauthor=E.+Niziauthor=P.+Paceauthor=U.+Kochauthor=F.+Fioreauthor=S.+Pesciauthor=J.+Di+Muzioauthor=E.+Monteagudoauthor=M.+Rowleyauthor=V.+Summa&title=Novel+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease+featuring+a+2-amino-1%2C3-thiazole+as+a+P4+carbamate+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2uR"><div class="casContent"><span class="casTitleNuber">2u</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement</span></div><div class="casAuthors">Di Francesco, M. Emilia; Dessole, Gabriella; Nizi, Emanuela; Pace, Paola; Koch, Uwe; Fiore, Fabrizio; Pesci, Silvia; Di Muzio, Jillian; Monteagudo, Edith; Rowley, Michael; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7014-7028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of P2-P4 macrocyclic inhibitors of HCV NS3/4A protease characterized by high levels of potency and liver exposure was recently reported.  Within this novel class of inhibitors, a structurally diverse series of compds. I [X = isoquinoline-1,7-diyl, 2-phenylquinoline-4,6-diyl, 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)2, (CH2)3, CH2CMe2; Z = thiazol-2,4-diyl, 1,3,4-oxadiazol-2,5-diyl; R1 = i-Pr, t-Bu, cyclohexyl, (S)-EtCHMe, cyclopentyl; R2 = H2C:CH, Et] featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4 was identified.  Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogs characterized by excellent levels of enzyme and cellular activity.  Among these, I [double bond; X = 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)3; Z = thiazol-2,4-diyl; R1 = (S)-EtCHMe; R2 = H2C:CH] displayed an attractive pharmacokinetic profile in preclin. species and showed sustained liver levels following oral administration in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFtigQW8FUrVg90H21EOLACvtfcHk0ljS9bwDIbM9Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN&md5=76e409fa1d0e9812ee78c4eeabca21ce</span></div><a href="/servlet/linkout?suffix=cit2u&amp;dbid=16384&amp;doi=10.1021%2Fjm900524b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900524b%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DDessole%26aufirst%3DG.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DNovel%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%2520featuring%2520a%25202-amino-1%252C3-thiazole%2520as%2520a%2520P4%2520carbamate%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7014%26epage%3D7028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-1220: a macrocyclic inhibitor of hepatitis C virus NS3/4A protease with improved preclinical plasma exposure</span> <span class="citation_source-journal">ACS Med. Chem. Lett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1002426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+MK-1220%3A+a+macrocyclic+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease+with+improved+preclinical+plasma+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2v&amp;dbid=16384&amp;doi=10.1021%2Fml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002426%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-1220%253A%2520a%2520macrocyclic%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520with%2520improved%2520preclinical%2520plasma%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett%26date%3D2011%26volume%3D2%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiFilippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2w&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=332-336&author=S.+Harperauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=M.+Ferraraauthor=M.+DiFilippoauthor=B.+Crescenziauthor=U.+Kochauthor=A.+Petrocchiauthor=M.+K.+Hollowayauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=K.+F.+Gilbertauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=E.+Niziauthor=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=C.+M.+McHaleauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=E.+Monteagudoauthor=S.+Cianettiauthor=C.+Giulianoauthor=V.+Pucciauthor=N.+Trainorauthor=C.+M.+Fandozziauthor=M.+Rowleyauthor=P.+J.+Colemanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=N.+J.+Liverton&title=Discovery+of+MK-5172%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2wR"><div class="casContent"><span class="casTitleNuber">2w</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">Harper, Steven; McCauley, John A.; Rudd, Michael T.; Ferrara, Marco; DiFilippo, Marcello; Crescenzi, Benedetta; Koch, Uwe; Petrocchi, Alessia; Holloway, M. Katharine; Butcher, John W.; Romano, Joseph J.; Bush, Kimberly J.; Gilbert, Kevin F.; McIntyre, Charles J.; Nguyen, Kevin T.; Nizi, Emanuela; Carroll, Steven S.; Ludmerer, Steven W.; Burlein, Christine; DiMuzio, Jillian M.; Graham, Donald J.; McHale, Carolyn M.; Stahlhut, Mark W.; Olsen, David B.; Monteagudo, Edith; Cianetti, Simona; Giuliano, Claudio; Pucci, Vincenzo; Trainor, Nicole; Fandozzi, Christine M.; Rowley, Michael; Coleman, Paul J.; Vacca, Joseph P.; Summa, Vincenzo; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors contg. a P2 to P4 macrocyclic constraint was designed using a mol. modeling-derived strategy.  Building on the profile of previous clin. compds. and exploring the P2 and linker regions of the series allowed for optimization of broad genotype and mutant enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate 15 (MK-5172), which is active against genotype 1-3 NS3/4a and clin. relevant mutant enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAzCaAN9VqJrVg90H21EOLACvtfcHk0lhQrNLzv92Uvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D&md5=efc04ad0ad47aef13b367fc38d6bbf63</span></div><a href="/servlet/linkout?suffix=cit2w&amp;dbid=16384&amp;doi=10.1021%2Fml300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300017p%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DDiFilippo%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DMcHale%26aufirst%3DC.%2BM.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DCianetti%26aufirst%3DS.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-5172%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D332%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7201</span><span class="NLM_x">–</span> <span class="NLM_lpage">7206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7201-7206&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+Bushauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=M.+K+Hollowayauthor=B.-L.+Wanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=N.+J.+Liverton&title=Development+of+potent+macrocyclic+inhibitors+of+genotype+3a+HCV+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2x&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DHolloway%26aufirst%3DM.%2BK%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520potent%2520macrocyclic%2520inhibitors%2520of%2520genotype%25203a%2520HCV%2520NS3%252F4A%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7201%26epage%3D7206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7207</span><span class="NLM_x">–</span> <span class="NLM_lpage">7213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7207-7213&author=M.+T.+Ruddauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=M.+K.+Hollowayauthor=K.+Bushauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=N.+J.+Livertonauthor=B.-L+Wanauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=J.+P.+Vaccaauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+A.+McCauley&title=Development+of+macrocyclic+inhibitors+of+HCV+NS3%2F4A+protease+with+cyclic+constrained+P2-P4+linkers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2y&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DWan%26aufirst%3DB.-L%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%252F4A%2520protease%2520with%2520cyclic%2520constrained%2520P2-P4%2520linkers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7207%26epage%3D7213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span> </span><span class="NLM_article-title">Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7351</span><span class="NLM_x">–</span> <span class="NLM_lpage">7356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7351-7356&author=X.+Liauthor=Y.+Liuauthor=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liuauthor=Y.+Zhouauthor=C.+Z.+Dingauthor=S.+Zhangauthor=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wang&title=Synthesis+and+antiviral+activity+of+novel+HCV+NS3+protease+inhibitors+with+P4+capping+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2z&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520novel%2520HCV%2520NS3%2520protease%2520inhibitors%2520with%2520P4%2520capping%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7351%26epage%3D7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Bilodeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4267</span><span class="NLM_x">–</span> <span class="NLM_lpage">4271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4267-4271&author=F.+Bilodeauauthor=M.+D.+Baileyauthor=P.+K.+Bhardwajauthor=J.+Bordeleauauthor=P.+Forgioneauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=E.+S.+Jolicoeurauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+Naudauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunet&title=Synthesis+and+optimization+of+a+novel+series+of+HCV+NS3+protease+inhibitors%3A+4-arylproline+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2aa&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBhardwaj%26aufirst%3DP.%2BK.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DForgione%26aufirst%3DP.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DJolicoeur%26aufirst%3DE.%2BS.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%253A%25204-arylproline%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4267%26epage%3D4271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2ab"><span><span class="NLM_label">(ab) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span> </span><span class="NLM_article-title">Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4436</span><span class="NLM_x">–</span> <span class="NLM_lpage">4440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4436-4440&author=M.+D.+Baileyauthor=T.+Halmosauthor=C.+T.+Lemke&title=Discovery+of+novel+P2+substituted+4-biaryl+proline+inhibitors+of+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ab&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520novel%2520P2%2520substituted%25204-biaryl%2520proline%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4436%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2ac"><span><span class="NLM_label">(ac) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: Discovery of potent succinamide inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4447</span><span class="NLM_x">–</span> <span class="NLM_lpage">4452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4447-4452&author=M.+D.+Baileyauthor=J.+Bordeleauauthor=M.+Garneauauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llinas-Brunet&title=Peptide+backbone+replacement+of+hepatitis+C+virus+NS3+serine+protease+C-terminal+cleavage+product+analogs%3A+Discovery+of+potent+succinamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ac&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPeptide%2520backbone%2520replacement%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520C-terminal%2520cleavage%2520product%2520analogs%253A%2520Discovery%2520of%2520potent%2520succinamide%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4447%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2ad"><span><span class="NLM_label">(ad) </span><span class="NLM_contrib-group">Moreau, B.; O’Meara, J. A.; Bordeleau, J.; Garneau, M.; Godbout, C.; Gorys, V.; Leblanc, M.; Villemure, E.; White, P. W.; Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Discovery of hepatitis C Virus NS3-4A protease inhibitors with improved barrier to resistance and favorable liver distribution</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI:<span class="refDoi"> DOI: 10.1021/jm400121t</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400121t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Moreau&author=J.+A.+O%E2%80%99Meara&author=J.+Bordeleau&author=M.+Garneau&author=C.+Godbout&author=V.+Gorys&author=M.+Leblanc&author=E.+Villemure&author=P.+W.+White&author=M.+Llinas-Brunet&title=Discovery+of+hepatitis+C+Virus+NS3-4A+protease+inhibitors+with+improved+barrier+to+resistance+and+favorable+liver+distribution&doi=10.1021%2Fjm400121t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ad&amp;dbid=16384&amp;doi=10.1021%2Fjm400121t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400121t%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520hepatitis%2520C%2520Virus%2520NS3-4A%2520protease%2520inhibitors%2520with%2520improved%2520barrier%2520to%2520resistance%2520and%2520favorable%2520liver%2520distribution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm400121t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2ae"><span><span class="NLM_label">(ae) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ae&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2af"><span><span class="NLM_label">(af) </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenglowsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madduru, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span> </span><span class="NLM_article-title">Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm400164c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400164c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+Jiangauthor=S.+W.+Andrewsauthor=K.+R.+Condroskiauthor=B.+Buckmanauthor=V.+Serebryanyauthor=S.+Wenglowskyauthor=A.+L.+Kennedyauthor=M.+R.+Madduruauthor=B.+Wangauthor=M.+Lyonauthor=G.+A.+Dohertyauthor=B.+T.+Woodardauthor=C.+Lemieuxauthor=M.+Geck+Doauthor=H.+Zhangauthor=J.+Ballardauthor=G.+Vigersauthor=B.+J.+Brandhuberauthor=P.+Stengelauthor=J.+A.+Joseyauthor=L.+Beigelmanauthor=L.+Blattauthor=S.+D.+Seiwert&title=Discovery+of+danoprevir+%28ITMN-191%2FR7227%29%2C+a+highly+selective+and+potent+inhibitor+of+hepatitis+C+virus+%28HCV%29+NS3%2F4A+protease&doi=10.1021%2Fjm400164c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2af&amp;dbid=16384&amp;doi=10.1021%2Fjm400164c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400164c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DBuckman%26aufirst%3DB.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DA.%2BL.%26aulast%3DMadduru%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DWoodard%26aufirst%3DB.%2BT.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520danoprevir%2520%2528ITMN-191%252FR7227%2529%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm400164c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P.</span><span> </span><span class="NLM_article-title">Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5387</span><span class="NLM_x">–</span> <span class="NLM_lpage">5396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5387-5396&author=F.+McPheeauthor=A.+K.+Sheafferauthor=J.+Friborgauthor=D.+Hernandezauthor=P.+Falkauthor=G.+Zhaiauthor=S.+Levineauthor=S.+Chaniewskiauthor=F.+Yuauthor=D.+Barryauthor=C.+Chenauthor=M.+S.+Leeauthor=K.+Mosureauthor=L.-Q.+Sunauthor=M.+Sinzauthor=N.+A.+Meanwellauthor=R.+J.+Colonnoauthor=J.+Knipeauthor=P.+Scola&title=Preclinical+profile+and+characterization+of+the+hepatitis+C+virus+NS3+protease+inhibitor+asunaprevir+%28BMS-650032%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DG.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChaniewski%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DScola%26aufirst%3DP.%26atitle%3DPreclinical%2520profile%2520and%2520characterization%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520asunaprevir%2520%2528BMS-650032%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5387%26epage%3D5396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Langendorff, O.</span><span> </span><span class="NLM_article-title">Untersuchungen am uberleberden saugerleizen</span> <span class="citation_source-journal">Puflger’s Arch. Ges. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1895</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1007%2FBF01812150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1895&pages=291-332&author=O.+Langendorff&title=Untersuchungen+am+uberleberden+saugerleizen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF01812150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01812150%26sid%3Dliteratum%253Aachs%26aulast%3DLangendorff%26aufirst%3DO.%26atitle%3DUntersuchungen%2520am%2520uberleberden%2520saugerleizen%26jtitle%3DPuflger%25E2%2580%2599s%2520Arch.%2520Ges.%2520Physiol.%26date%3D1895%26volume%3D61%26spage%3D291%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="note"><p class="first last">Effects on HR and SNRT of less than 10% and 15% respectively were considered vehicle like.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pietschmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon system and its application to molecular studies</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=657-664&author=T.+Pietschmannauthor=R.+Bartenschlager&title=The+hepatitis+C+virus+replicon+system+and+its+application+to+molecular+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPietschmann%26aufirst%3DT.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520system%2520and%2520its%2520application%2520to%2520molecular%2520studies%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D657%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.2174%2F1389200003339270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=11467081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=67-84&author=M.+Murray&title=Mechanisms+of+inhibitory+and+regulatory+effects+of+methylenedioxyphenyl+compounds+on+cytochrome+P450-dependent+drug+oxidation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span></div><div class="casAuthors">Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 110 refs.  Cytochrome P 450 (CYP) enzymes catalyze the oxidative conversion of drugs and other lipophilic compds. to hydrophilic metabolites.  Thus, CYPs play a dominant role in the elimination of drugs from the body.  Inhibitory interactions occur when drugs compete for oxidn. by specific CYPs, whereas certain drugs increase the capacity for oxidative biotransformation by inducing the synthesis of new CYPs.  Methylenedioxyphenyl (MDP) compds. have been widely employed as com. important pesticide synergists and a no. of derivs. are found in oils and spices.  MDP compds. are of considerable toxicol. significance because of their capacity to inhibit and induce CYP enzymes in mammals; some derivs. produce neurotoxic and hepatotoxic effects.  Although there are relatively few therapeutic agents of present clin. importance that possess the MDP structural feature, the synthesis and preclin. evaluation of such agents appears to be increasing.  In the context of the existing literature surrounding MDP compds. it is noteworthy that these potential drugs also elicit significant modulatory effects on CYP activities in rat and human liver.  These developments indicate the importance of understanding the chem. mechanisms by which MDPs interact with CYPs.  Thus, the presence of the MDP structure may undermine the potential clin. value of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYAjGf6nf5ZbVg90H21EOLACvtfcHk0lib6axQs5jk5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D&md5=dcafc824c8bcd0080d256d6dd8c50ae7</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.2174%2F1389200003339270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339270%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520inhibitory%2520and%2520regulatory%2520effects%2520of%2520methylenedioxyphenyl%2520compounds%2520on%2520cytochrome%2520P450-dependent%2520drug%2520oxidation%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D67%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peterson, L. A.</span><span> </span><span class="NLM_article-title">Reactive metabolites in the biotransformation of molecules containing a furan ring</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx3003824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2qsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=6-25&author=L.+A.+Peterson&title=Reactive+metabolites+in+the+biotransformation+of+molecules+containing+a+furan+ring"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Metabolites in the Biotransformation of Molecules Containing a Furan Ring</span></div><div class="casAuthors">Peterson, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-25</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many xenobiotics contg. a furan ring are toxic and/or carcinogenic.  The harmful effects of these compds. require furan ring oxidn.  This reaction generates an electrophilic intermediate.  Depending on the furan ring substituents, the intermediate is either an epoxide or a cis-enedione with more ring substitution favoring epoxide formation.  Either intermediate reacts with cellular nucleophiles such as protein or DNA to trigger toxicities.  The reactivity of the metabolite dets. which cellular nucleophiles are targeted.  The toxicity of a particular furan is also influenced by the presence of competing metabolic pathways or efficient detoxification routes.  GSH plays an important role in modulating the harmful effects of this class of compd. by reacting with the reactive metabolite.  However, this may not represent a detoxification step in all cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp4Dr5stLUSrVg90H21EOLACvtfcHk0lib6axQs5jk5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2qsrbN&md5=fe3a280d0b7a99a436ec619abc1e1fa0</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Ftx3003824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx3003824%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BA.%26atitle%3DReactive%2520metabolites%2520in%2520the%2520biotransformation%2520of%2520molecules%2520containing%2520a%2520furan%2520ring%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2013%26volume%3D26%26spage%3D6%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span> </span><span class="NLM_article-title">Time-dependent CYP inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1517%2F17425255.3.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=17269894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=51-566&author=R.+J.+Rileyauthor=K.+Grimeauthor=R.+Weaver&title=Time-dependent+CYP+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent CYP inhibition</span></div><div class="casAuthors">Riley, Robert J.; Grime, Ken; Weaver, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of CYP refers to a change in potency during an in vitro incubation or dosing period in vivo.  Potential mechanisms include the formation of inhibitory metabolites and mechanism-based inhibition (MBI).  In vitro expts. are configured to assess TDI and MBI is inferred, at least initially.  MBI is more profound after multiple-dosing and the recovery period is independent of continued drug exposure.  Advances in in vitro-in vivo extrapolations for competitive inhibition and the potential relationship between MBI and reactive metabolite-mediated toxicity, have redirected emphasis to CYP TDI.  In contrast, with reversible inhibition, strategies for projecting the risks from TDI are less developed and the traditional I/Ki model often yields a dramatic underprediction.  This review explores the contribution of TDI to drug-drug interactions and idiosyncratic drug toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8w1eAZ9QULVg90H21EOLACvtfcHk0lib6axQs5jk5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D&md5=184636ac0768f51d65f407a0655233e4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DWeaver%26aufirst%3DR.%26atitle%3DTime-dependent%2520CYP%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D51%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">PDB code for BMS-605339 (<b>1</b>) is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK">4NWK</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unravelling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1038%2Fnature04077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=16107832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unravelling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling hepatitis C virus replication from genome to function</span></div><div class="casAuthors">Lindenbach, Brett D.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7053</span>),
    <span class="NLM_cas:pages">933-938</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the hepatitis C virus over 15 years ago, scientists have raced to develop diagnostics, study the virus and find new therapies.  Yet virtually every attempt to dissect this pathogen has met with roadblocks that impeded progress.  Its replication was restricted to humans or exptl. infected chimpanzees, and efficient growth of the virus in cell culture failed until very recently.  Nevertheless hard-fought progress has been made and the first wave of antiviral drugs is entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vc6EOs8vLVg90H21EOLACvtfcHk0lgOgYC9SYrLXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D&md5=553517cac32b797ef7a2d07f496a7b5c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature04077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04077%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnravelling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Reddy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3144-3156&author=M.+B.+Reddyauthor=P.+N.+Morcosauthor=S.+Le+Pogamauthor=Y.+Ouauthor=K.+Frankauthor=T.+Laveauthor=P.+Smith&title=Pharmacokinetic%2Fpharmacodynamic+predictors+of+clinical+potency+for+hepatitis+C+virus+nonnucleoside+polymerase+and+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BB.%26aulast%3DMorcos%26aufirst%3DP.%2BN.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DOu%26aufirst%3DY.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%26atitle%3DPharmacokinetic%252Fpharmacodynamic%2520predictors%2520of%2520clinical%2520potency%2520for%2520hepatitis%2520C%2520virus%2520nonnucleoside%2520polymerase%2520and%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3144%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">PDB code for BMS-650032 (<b>24</b>) is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWL">4NWL</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reviriego, C.</span><span> </span><span class="NLM_article-title">Asunaprevir: HCV serine protease NS3 inhibitor treatment of hepatitis C virus</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFSns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=247-254&author=C.+Reviriego&title=Asunaprevir%3A+HCV+serine+protease+NS3+inhibitor+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Asunaprevir: HCV serine protease NS3 inhibitor treatment of hepatitis C virus</span></div><div class="casAuthors">Reviriego, C.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Thomson Reuters</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus (HCV) currently affects more than 170 million people worldwide.  Over 80% of the infected individuals develop chronic hepatitis, which leads to other complications, such as cirrhosis, fibrosis or liver carcinoma.  The current std. of care (SOC), which combines pegylated interferon alfa (pegIFN-α) and ribavirin, has limited efficacy in providing a sustained virol. response, esp. in HCV genotype 1-infected individuals.  Moreover, the lengthy treatment with SOC is frequently assocd. with undesirable side effects that may be extremely debilitating.  There is therefore an urgent medical need to develop anti-HCV therapies that are safer and more effective.  Asunaprevir (BMS-650032) is an investigational, oral, selective serine protease NS3 inhibitor with pharmacokinetic parameters that suggest once- or twice-daily administration.  Its promising safety profile, in addn. to the encouraging clin. proof-of-concept results, make asunaprevir attractive for use in drug combination studies with other HCV therapeutic agents, even in interferon-free regimens and for difficult-to-treat patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprRdoGUMeeS7Vg90H21EOLACvtfcHk0lgOgYC9SYrLXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFSns7c%253D&md5=9ece17c1caf2744e907d3c20823cef36</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReviriego%26aufirst%3DC.%26atitle%3DAsunaprevir%253A%2520HCV%2520serine%2520protease%2520NS3%2520inhibitor%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DDrugs%2520Future%26date%3D2012%26volume%3D37%26spage%3D247%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevir</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3670</span><span class="NLM_x">–</span> <span class="NLM_lpage">3681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1128%2FAAC.00308-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=22508297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2is7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3670-3681&author=F.+McPheeauthor=J.+Friborgauthor=S.+Levineauthor=C.+Chenauthor=P.+Falkauthor=F.+Yuauthor=D.+Hernandezauthor=M.+S.+Leeauthor=S.+Chaniewskiauthor=A.+K.+Sheafferauthor=C.+Pasquinelli&title=Resistance+analysis+of+the+hepatitis+C+virus+NS3+protease+inhibitor+asunaprevir"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevir</span></div><div class="casAuthors">McPhee, Fiona; Friborg, Jacques; Levine, Steven; Chen, Chaoqun; Falk, Paul; Yu, Fei; Hernandez, Dennis; Lee, Min S.; Chaniewski, Susan; Sheaffer, Amy K.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3670-3681</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor demonstrating efficacy in alfa interferon-sparing, direct-acting antiviral dual-combination regimens (together with the NS5A replication complex inhibitor daclatasvir) in patients chronically infected with HCV genotype 1b.  Here, we describe a comprehensive in vitro genotypic and phenotypic anal. of asunaprevir-assocd. resistance against genotypes 1a and 1b using HCV replicons and patient samples obtained from clin. studies of short-term asunaprevir monotherapy.  During genotype 1a resistance selection using HCV replicons, the primary NS3 protease substitutions identified were R155K, D168G, and I170T, which conferred low- to moderate-level asunaprevir resistance (5- to 21-fold) in transient-transfection susceptibility assays.  For genotype 1b, a higher level of asunaprevir-assocd. resistance was obsd. at the same selection pressures, ranging from 170- to 400-fold relative to the wild-type control.  The primary NS3 protease substitutions identified occurred predominantly at amino acid residue D168 (D168A/G/H/V/Y) and were assocd. with high-level asunaprevir resistance (16- to 280-fold) and impaired replication capacity.  In asunaprevir single-ascending-dose and 3-day multiple-ascending-dose studies in HCV genotype 1a- or 1b-infected patients, the predominant pre-existing NS3 baseline polymorphism was NS3-Q80K.  This substitution impacted initial virol. response rates in a single-ascending-dose study, but its effects after multiple doses were more ambiguous.  Interestingly, for patient NS3 protease sequences contg. Q80 and those contg. K80, susceptibilities to asunaprevir were comparable when tested in an enzyme assay.  No resistance-assocd. variants emerged in these clin. studies that significantly impacted susceptibility to asunaprevir.  Importantly, asunaprevir-resistant replicons remained susceptible to an NS5A replication complex inhibitor, consistent with a role for asunaprevir in combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNf2shzFcn47Vg90H21EOLACvtfcHk0lgOgYC9SYrLXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2is7s%253D&md5=713c87d4123a5769f47eb51d52ebd044</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1128%2FAAC.00308-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00308-12%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DChaniewski%26aufirst%3DS.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DResistance%2520analysis%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520asunaprevir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3670%26epage%3D3681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Balimane, P.; Browning, M.; Chong, S.; Dai, R.; Darienzo, R.; Dalterio, C.; Davis, C.; Han, Y.-H.; Kim, S.; Knipe, J.; Malinowski, J.; Marino, T.; Mosure, K.; Sandquist, J.; Gesenberg, C.; Schartman, R.; Sinz, M.; Whiterock, V.; Zadjura, L.; Zoeckler, M.; Zvyaga, T.; Meanwell, N. A.; McPhee, F.; Scola, P. M.</span><span> </span><span class="NLM_article-title">Nonclinical pharmacokinetics of a novel HCV NS3 protease inhibitor, BMS-605339</span>. <div class="note"><p class="first last">Manuscript in preparation</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Balimane%2C+P.%3B+Browning%2C+M.%3B+Chong%2C+S.%3B+Dai%2C+R.%3B+Darienzo%2C+R.%3B+Dalterio%2C+C.%3B+Davis%2C+C.%3B+Han%2C+Y.-H.%3B+Kim%2C+S.%3B+Knipe%2C+J.%3B+Malinowski%2C+J.%3B+Marino%2C+T.%3B+Mosure%2C+K.%3B+Sandquist%2C+J.%3B+Gesenberg%2C+C.%3B+Schartman%2C+R.%3B+Sinz%2C+M.%3B+Whiterock%2C+V.%3B+Zadjura%2C+L.%3B+Zoeckler%2C+M.%3B+Zvyaga%2C+T.%3B+Meanwell%2C+N.+A.%3B+McPhee%2C+F.%3B+Scola%2C+P.+M.+Nonclinical+pharmacokinetics+of+a+novel+HCV+NS3+protease+inhibitor%2C+BMS-605339.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DBalimane%26aufirst%3DP.%26atitle%3DNonclinical%2520pharmacokinetics%2520of%2520a%2520novel%2520HCV%2520NS3%2520protease%2520inhibitor%252C%2520BMS-605339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pasquinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marbury, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwater, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMicco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Talavera, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span> </span><span class="NLM_article-title">Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1838</span><span class="NLM_x">–</span> <span class="NLM_lpage">1844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1838-1844&author=C.+Pasquinelliauthor=F.+McPheeauthor=T.+Eleyauthor=C.+Villegasauthor=K.+Sandyauthor=P.+Sheridanauthor=A.+Perssonauthor=S.-P.+Huangauthor=D.+Hernandezauthor=A.+K.+Sheafferauthor=P.+Scolaauthor=T.+Marburyauthor=E.+Lawitzauthor=R.+Goldwaterauthor=M.+Rodriguez-Torresauthor=M.+DeMiccoauthor=D.+Wrightauthor=M.+Charltonauthor=W.+K.+Kraftauthor=J.-C.+Lopez-Talaveraauthor=D.+M.+Grasela&title=Single-+and+multiple-ascending-dose+studies+of+the+NS3+protease+inhibitor+asunaprevir+in+subjects+with+or+without+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasquinelli%26aufirst%3DC.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DVillegas%26aufirst%3DC.%26aulast%3DSandy%26aufirst%3DK.%26aulast%3DSheridan%26aufirst%3DP.%26aulast%3DPersson%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DScola%26aufirst%3DP.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DGoldwater%26aufirst%3DR.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DDeMicco%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DCharlton%26aufirst%3DM.%26aulast%3DKraft%26aufirst%3DW.%2BK.%26aulast%3DLopez-Talavera%26aufirst%3DJ.-C.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26atitle%3DSingle-%2520and%2520multiple-ascending-dose%2520studies%2520of%2520the%2520NS3%2520protease%2520inhibitor%2520asunaprevir%2520in%2520subjects%2520with%2520or%2520without%2520chronic%2520hepatitis%2520C%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D1838%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bronowicki, J.-P.; Pol, S.; Thuluvath, P. J.; Larrey, D.; Martorell Claudia, T.; Rustgi Vinod, K.; Morris, D. W.; Younes, Z.; Fried, M. W.; Bourliere, M.; Hezode, C.; Reddy, K. R.; Massoud, O.; Abrams, G. A.; Ratziu, V.; He, B.; Eley, T.; Ahmad, A.; Cohen, D.; Hindes, R.; McPhee, F.; Reilly, B.; Mendez, P.; Hughes, E.</span><span> </span><span class="NLM_article-title">Randomized study of asunaprevir plus peg-interferon alfa and ribavirin for previously untreated genotype 1 chronic hepatitis C</span>.  <span class="citation_source-journal">Antivir. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=885-893&author=J.-P.+Bronowicki&author=S.+Pol&author=P.+J.+Thuluvath&author=D.+Larrey&author=T.+Martorell+Claudia&author=K.+Rustgi+Vinod&author=D.+W.+Morris&author=Z.+Younes&author=M.+W.+Fried&author=M.+Bourliere&author=C.+Hezode&author=K.+R.+Reddy&author=O.+Massoud&author=G.+A.+Abrams&author=V.+Ratziu&author=B.+He&author=T.+Eley&author=A.+Ahmad&author=D.+Cohen&author=R.+Hindes&author=F.+McPhee&author=B.+Reilly&author=P.+Mendez&author=E.+Hughes&title=Randomized+study+of+asunaprevir+plus+peg-interferon+alfa+and+ribavirin+for+previously+untreated+genotype+1+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBronowicki%26aufirst%3DJ.-P.%26atitle%3DRandomized%2520study%2520of%2520asunaprevir%2520plus%2520peg-interferon%2520alfa%2520and%2520ribavirin%2520for%2520previously%2520untreated%2520genotype%25201%2520chronic%2520hepatitis%2520C%26jtitle%3DAntivir.%2520Ther.%26date%3D2013%26volume%3D18%26spage%3D885%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lok, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Preliminary study of two antiviral agents for hepatitis C genotype 1</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1056%2FNEJMoa1104430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=22256805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=216-224&author=A.+S.+Lokauthor=D.+F.+Gardinerauthor=E.+Lawitzauthor=C.+Martorellauthor=G.+T.+Eversonauthor=R.+Ghalibauthor=R.+Reindollarauthor=V.+Rustgiauthor=F.+McPheeauthor=M.+Wind-Rotoloauthor=A.+Perssonauthor=K.+Zhuauthor=D.+I.+Dimitrovaauthor=T.+Eleyauthor=T.+Guoauthor=D.+M.+Graselaauthor=C.+Pasquinelli&title=Preliminary+study+of+two+antiviral+agents+for+hepatitis+C+genotype+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary study of two antiviral agents for hepatitis C genotype 1</span></div><div class="casAuthors">Lok, Anna S.; Gardiner, David F.; Lawitz, Eric; Martorell, Claudia; Everson, Gregory T.; Ghalib, Reem; Reindollar, Robert; Rustgi, Vinod; McPhee, Fiona; Wind-Rotolo, Megan; Persson, Anna; Zhu, Kurt; Dimitrova, Dessislava I.; Eley, Timothy; Guo, Tong; Grasela, Dennis M.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-224</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection who have not had a response to therapy with peginterferon and ribavirin may benefit from the addn. of multiple direct-acting antiviral agents to their treatment regimen.  METHODS: This open-label, phase 2a study included an exploratory cohort of 21 patients with chronic HCV genotype 1 infection who had not had a response to previous therapy (i.e., had not had ≥2 log10 decline in HCV RNA after ≥12 wk of treatment with peginterferon and ribavirin).  We randomly assigned patients to receive the NS5A replication complex inhibitor daclatasvir (60 mg once daily) and the NS3 protease inhibitor asunaprevir (600 mg twice daily) alone (group A, 11 patients) or in combination with peginterferon alfa-2a and ribavirin (group B, 10 patients) for 24 wk.  The primary end point was the percentage of patients with a sustained virol. response 12 wk after the end of the treatment period.  RESULTS: A total of 4 patients in group A (36%; 2 of 9 with HCV genotype la and 2 of 2 with genotype lb) had a sustained virol. response at 12 wk after treatment and also at 24 wk after treatment.  Six patients (all with HCV genotype la) had viral breakthrough while receiving therapy, and resistance mutations to both antiviral agents were found in all cases; 1 patient had a viral response at the end of treatment but had a relapse after the treatment period.  All 10 patients in group B had a sustained virol. response at 12 wk after treatment, and 9 had a sustained virol. response at 24 wk after treatment Diarrhea was the most common adverse event in both groups.  Six patients had transient elevations of alanine aminotransferase levels to more than 3 times the upper limit of the normal range.  CONCLUSIONS: This preliminary study involving patients with HCV genotype 1 infection who had not had a response to prior therapy showed that a sustained virol. response can be achieved with two direct-acting antiviral agents only.  In addn., a high rate of sustained virol. response was achieved when the two direct-acting antiviral agents were combined with peginterferon alfa-2a and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiY7QiDziiRbVg90H21EOLACvtfcHk0ljf3ytVPnfW4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D&md5=5b986bac6ea53144898c91e8e2eaf5bc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1104430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1104430%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DA.%2BS.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DMartorell%26aufirst%3DC.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DDimitrova%26aufirst%3DD.%2BI.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DPreliminary%2520study%2520of%2520two%2520antiviral%2520agents%2520for%2520hepatitis%2520C%2520genotype%25201%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D216%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lok, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hézode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serfaty, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Randomized trial of daclatasvir and asunaprevir with or without peginterferon/ribaviran for hepatitis C virus genotype 1 null responders</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1016%2Fj.jhep.2013.10.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=24444658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=490-499&author=A.+S.+Lokauthor=D.+F.+Gardinerauthor=C.+H%C3%A9zodeauthor=E.+J.+Lawitzauthor=M.+Bourli%C3%A8reauthor=G.+T.+Eversonauthor=P.+Marcellinauthor=M.+Rodriguez-Torresauthor=S.+Polauthor=L.+Serfatyauthor=T.+Eleyauthor=S.-P.+Huangauthor=J.+Liauthor=M.+Wind-Rotoloauthor=F.+Yuauthor=F.+McPheeauthor=D.+M.+Graselaauthor=C.+Pasquinelli&title=Randomized+trial+of+daclatasvir+and+asunaprevir+with+or+without+peginterferon%2Fribaviran+for+hepatitis+C+virus+genotype+1+null+responders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders</span></div><div class="casAuthors">Lok, Anna S.; Gardiner, David F.; Hezode, Christophe; Lawitz, Eric J.; Bourliere, Marc; Everson, Gregory T.; Marcellin, Patrick; Rodriguez-Torres, Maribel; Pol, Stanislas; Serfaty, Lawrence; Eley, Timothy; Huang, Shu-Pang; Li, Jianling; Wind-Rotolo, Megan; Yu, Fei; McPhee, Fiona; Grasela, Dennis M.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">490-499</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Patients with chronic hepatitis C virus (HCV) infection and prior null response (<2 log HCV RNA decline after ≥12 wk of PegIFN/RBV) have limited options.  We evaluated daclatasvir plus once- or twice-daily asunaprevir in non-cirrhotic genotype 1 null responders.  In this randomized, phase 2a, open-label, 24-wk treatment study, 101 patients received daclatasvir (60 mg) once-daily.  In addn., 38 genotype 1b patients received asunaprevir (200 mg) twice- (DUAL A1) or once-daily (DUAL A2); 36 genotype 1a and 5 genotype 1b patients received asunaprevir twice- (QUAD B1) or once-daily (QUAD B2) plus PegIFN/RBV; and 18 genotype 1a and 4 genotype 1b patients received asunaprevir twice-daily plus ribavirin (TRIPLE B3).  The primary endpoint was undetectable HCV RNA 12 wk post-treatment (sustained virol. response, SVR12).  Across all groups, mean HCV RNA was ≥6 log IU/mL, and 99% of patients had a non-CC IL28B genotype.  SVR12 rates were 78% (A1), 65% (A2), 95% (B1), and 95% (B2).  In B3, most genotype 1a patients experienced virol. breakthrough.  The most common adverse events were headache, diarrhea, and asthenia.  Grade 3-4 aminotransferase elevations were infrequent and not treatment-limiting.  In genotype 1 null responders, daclatasvir plus twice-daily asunaprevir DUAL therapy is effective for most genotype 1b patients, and daclatasvir, asunaprevir, and PegIFN/RBV QUAD therapy is effective for nearly all genotype 1a and 1b patients; but neither DUAL nor TRIPLE therapy is effective for genotype 1a patients.  Interferon-free regimens including daclatasvir and twice-daily asunaprevir for genotype 1 null responders should be tailored to subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmaQLpKkbNoLVg90H21EOLACvtfcHk0lhrywAHT_u8AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlartw%253D%253D&md5=d216b31a62adc838c4f2215fcfff4838</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2013.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2013.10.019%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DA.%2BS.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26aulast%3DH%25C3%25A9zode%26aufirst%3DC.%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DSerfaty%26aufirst%3DL.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DRandomized%2520trial%2520of%2520daclatasvir%2520and%2520asunaprevir%2520with%2520or%2520without%2520peginterferon%252Fribaviran%2520for%2520hepatitis%2520C%2520virus%2520genotype%25201%2520null%2520responders%26jtitle%3DJ.%2520Hepatol.%26date%3D2014%26volume%3D60%26spage%3D490%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumada, H.</span><span> </span><span class="NLM_article-title">Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=742-748&author=K.+Chayamaauthor=S.+Takahashiauthor=J.+Toyotaauthor=Y.+Karinoauthor=K.+Ikedaauthor=H.+Ishikawaauthor=H.+Watanabeauthor=F.+McPheeauthor=E.+Hughesauthor=H.+Kumada&title=Dual+therapy+with+the+nonstructural+protein+5A+inhibitor%2C+daclatasvir%2C+and+the+nonstructural+protein+3+protease+inhibitor%2C+asunaprevir%2C+in+hepatitis+C+virus+genotype+1b-infected+null+responders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChayama%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DToyota%26aufirst%3DJ.%26aulast%3DKarino%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DHughes%26aufirst%3DE.%26aulast%3DKumada%26aufirst%3DH.%26atitle%3DDual%2520therapy%2520with%2520the%2520nonstructural%2520protein%25205A%2520inhibitor%252C%2520daclatasvir%252C%2520and%2520the%2520nonstructural%2520protein%25203%2520protease%2520inhibitor%252C%2520asunaprevir%252C%2520in%2520hepatitis%2520C%2520virus%2520genotype%25201b-infected%2520null%2520responders%26jtitle%3DHepatology%26date%3D2012%26volume%3D55%26spage%3D742%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hézode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loustaud-Ratti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuluvath, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span> </span><span class="NLM_article-title">Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naı̈ve patients with HCV genotype 1 infection.</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2013&pages=420-429&author=G.+T.+Eversonauthor=K.+D.+Simsauthor=M.+Rodriguez-Torresauthor=C.+H%C3%A9zodeauthor=E.+Lawitzauthor=M.+Bourli%C3%A8reauthor=V.+Loustaud-Rattiauthor=V.+Rustgiauthor=H.+Schwartzauthor=H.+Tatumauthor=P.+Marcellinauthor=S.+Polauthor=P.+J.+Thuluvathauthor=T.+Eleyauthor=X.+Wangauthor=S.-P.+Huangauthor=F.+McPheeauthor=M.+Wind-Rotoloauthor=E.+Chungauthor=C.+Pasquinelliauthor=D.+M.+Graselaauthor=D.+F.+Gardiner&title=Efficacy+of+an+interferon-+and+ribavirin-free+regimen+of+daclatasvir%2C+asunaprevir%2C+and+BMS-791325+in+treatment-na%C4%B1%CC%88ve+patients+with+HCV+genotype+1+infection."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DSims%26aufirst%3DK.%2BD.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DH%25C3%25A9zode%26aufirst%3DC.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DLoustaud-Ratti%26aufirst%3DV.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DSchwartz%26aufirst%3DH.%26aulast%3DTatum%26aufirst%3DH.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DThuluvath%26aufirst%3DP.%2BJ.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DPasquinelli%26aufirst%3DC.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26atitle%3DEfficacy%2520of%2520an%2520interferon-%2520and%2520ribavirin-free%2520regimen%2520of%2520daclatasvir%252C%2520asunaprevir%252C%2520and%2520BMS-791325%2520in%2520treatment-na%25C4%25B1%25CC%2588ve%2520patients%2520with%2520HCV%2520genotype%25201%2520infection.%26jtitle%3DGastroenterology%26date%3D2013%26volume%3D146%26spage%3D420%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chung, R. T.</span><span> </span><span class="NLM_article-title">A watershed moment in the treatment of hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1056%2FNEJMe1113272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=22256811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=273-275&author=R.+T.+Chung&title=A+watershed+moment+in+the+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A watershed moment in the treatment of hepatitis C</span></div><div class="casAuthors">Chung, Raymond T.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-275</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3ffT6ZbaILVg90H21EOLACvtfcHk0lgd712mjajpwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gns7s%253D&md5=a0a82b76f878d91ed04bb09ed6a6339e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1113272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1113272%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DR.%2BT.%26atitle%3DA%2520watershed%2520moment%2520in%2520the%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D273%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumada, H.</span><span> </span><span class="NLM_article-title">Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1016%2Fj.jhep.2012.09.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=23183526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2jtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=655-662&author=Y.+Suzukiauthor=K.+Ikedaauthor=F.+Suzukiauthor=J.+Toyotaauthor=Y.+Karinoauthor=K.+Chayamaauthor=Y.+Kawakamiauthor=H.+Ishikawaauthor=H.+Watanabeauthor=W.+Huauthor=T.+Eleyauthor=F.+McPheeauthor=E.+Hughesauthor=H.+Kumada&title=Dual+oral+therapy+with+daclatasvir+and+asunaprevir+for+patients+with+HCV+genotype+1b+infection+and+limited+treatment+options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options</span></div><div class="casAuthors">Suzuki, Yoshiyuki; Ikeda, Kenji; Suzuki, Fumitaka; Toyota, Joji; Karino, Yoshiyasu; Chayama, Kazuaki; Kawakami, Yoshiiku; Ishikawa, Hiroki; Watanabe, Hideaki; Hu, Wenhua; Eley, Timothy; McPhee, Fiona; Hughes, Eric; Kumada, Hiromitsu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-662</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Improved therapeutic options for chronic hepatitis C virus (HCV) infection are needed for patients who are poor candidates for treatment with current regimens due to anticipated intolerability or low likelihood of response.  In this open-label, phase 2a study of Japanese patients with chronic HCV genotype 1b infection, 21 null responders (<2 log10 HCV RNA redn. after 12 wk of peginterferon/ribavirin) and 22 patients intolerant to or medically ineligible for peginterferon/ribavirin therapy received dual oral treatment for 24 wk with the NS5A replication complex inhibitor daclatasvir (DCV) and the NS3 protease inhibitor asunaprevir (ASV).  The primary efficacy end point was sustained virol. response at 12 wk post-treatment (SVR12).  Thirty-six of 43 enrolled patients completed 24 wk of therapy.  Serum HCV RNA levels declined rapidly, becoming undetectable in all patients on therapy by week 8.  Overall, 76.7% of patients achieved SVR12 and SVR24, including 90.5% of null responders and 63.6% of ineligible/intolerant patients.  There were no virol. failures among null responders.  Three ineligible/intolerant patients experienced viral breakthrough and four relapsed post-treatment.  Diarrhea, nasopharyngitis, headache, and ALT/AST increases, generally mild, were the most common adverse events; three discontinuations before week 24 were due to adverse events that included hyperbilirubinemia and transaminase elevations (two patients).  Dual therapy with daclatasvir and asunaprevir, without peginterferon/ribavirin, was well tolerated and achieved high SVR rates in two groups of difficult-to-treat patients with hepatitis C virus genotype 1b infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1ZlrHtPRHLVg90H21EOLACvtfcHk0lgd712mjajpwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2jtbw%253D&md5=48caec88fbfc444ea629aac577c2ed95</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.09.037%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DToyota%26aufirst%3DJ.%26aulast%3DKarino%26aufirst%3DY.%26aulast%3DChayama%26aufirst%3DK.%26aulast%3DKawakami%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DHughes%26aufirst%3DE.%26aulast%3DKumada%26aufirst%3DH.%26atitle%3DDual%2520oral%2520therapy%2520with%2520daclatasvir%2520and%2520asunaprevir%2520for%2520patients%2520with%2520HCV%2520genotype%25201b%2520infection%2520and%2520limited%2520treatment%2520options%26jtitle%3DJ.%2520Hepatol.%26date%3D2013%26volume%3D58%26spage%3D655%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0ljgNf3OE7-0vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Campbell, J. A.; Good, A.</span>World Patent Application WO-2002/060926 A2, <span class="NLM_day">8</span><span class="NLM_month">Aug</span><span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+A.+Campbell&author=A.+Good&title=World+Patent+Application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26jtitle%3DWorld%2520Patent%2520Application%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span>Crystal structure data has been deposited to Cambridge Structure Database (deposition number CCDC <span class="NLM_ext-link">984267</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Crystal+structure+data+has+been+deposited+to+Cambridge+Structure+Database+%28deposition+number+CCDC+984267%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Crespi, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penman, B. W.</span><span> </span><span class="NLM_article-title">Microtiter plate assay for inhibition of human, drug-metabolizing cytochromes P450</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1997&pages=188-190&author=C.+L.+Crespiauthor=V.+P.+Millerauthor=B.+W.+Penman&title=Microtiter+plate+assay+for+inhibition+of+human%2C+drug-metabolizing+cytochromes+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DV.%2BP.%26aulast%3DPenman%26aufirst%3DB.%2BW.%26atitle%3DMicrotiter%2520plate%2520assay%2520for%2520inhibition%2520of%2520human%252C%2520drug-metabolizing%2520cytochromes%2520P450%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D248%26spage%3D188%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalczyk, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahn, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, E. T.</span><span> </span><span class="NLM_article-title">Image annotation and database mining to create a novel screen for the chemotype-dependent crystallization of HCV NS3 protease</span> <span class="citation_source-journal">Cryst. Growth Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks">[<a href="/doi/10.1021/cg101353h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Sjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1143-1151&author=H.+E.+Kleiauthor=K.+Kishauthor=M.+F.+Russoauthor=S.+J.+Michalczykauthor=M.+H.+Cahnauthor=J.+Tredupauthor=C.+Y.+Changauthor=J.+Khanauthor=E.+T.+Baldwin&title=Image+annotation+and+database+mining+to+create+a+novel+screen+for+the+chemotype-dependent+crystallization+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Image Annotation and Database Mining to Create a Novel Screen for the Chemotype-Dependent Crystallization of HCV NS3 Protease</span></div><div class="casAuthors">Klei, Herbert E.; Kish, Kevin; Russo, Mark F.; Michalczyk, Steve J.; Cahn, Matthew H.; Tredup, Jeffrey; Chang, Chieh Ying; Khan, Javed; Baldwin, Eric T.</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1143-1151</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An effective process for screening, imaging, and optimizing crystn. trials using a combination of external and internal hardware and software has been deployed.  The combination of this infrastructure with a vast annotated crystn. database enables the creation of custom crystn. screening strategies.  Because of the strong chemotype-dependent crystn. obsd. with HCV NS3 protease (HCVPr), this strategy was applied to a chemotype resistant to all prior crystn. efforts.  The crystn. database was mined for ingredients used to generate earlier HCVPr/inhibitor co-crystals.  A random screen was created from the most prolific ingredients.  A previously untested combination of proven ingredients was identified that led to a successful crystn. condition for the resistant chemotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUy_4tlryROLVg90H21EOLACvtfcHk0ljgNf3OE7-0vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Sjtro%253D&md5=f6146dccfb26e5599e36c65307721040</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcg101353h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg101353h%26sid%3Dliteratum%253Aachs%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DRusso%26aufirst%3DM.%2BF.%26aulast%3DMichalczyk%26aufirst%3DS.%2BJ.%26aulast%3DCahn%26aufirst%3DM.%2BH.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26atitle%3DImage%2520annotation%2520and%2520database%2520mining%2520to%2520create%2520a%2520novel%2520screen%2520for%2520the%2520chemotype-dependent%2520crystallization%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2011%26volume%3D11%26spage%3D1143%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-Ray Diffraction Data Collected in Oscillation Mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-Ray+Diffraction+Data+Collected+in+Oscillation+Mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-Ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D263%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span>QUANTA Modeling Environment; <span class="NLM_publisher-name">Accelrys, Inc</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=QUANTA+Modeling+Environment%3B+Accelrys%2C+Inc%3A+San+Diego%2C+CA%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DQUANTA%2520Modeling%2520Environment%26pub%3DAccelrys%252C%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Brünger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLano, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography and NMR System: A New Software Suite for Macromolecular Structure Determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">D54</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D54&publication_year=1998&pages=905-921&author=A.+Br%C3%BCngerauthor=P.+Adamsauthor=G.+Cloreauthor=W.+DeLanoauthor=P.+Grosauthor=R.+Grosse-Kunstleveauthor=J.-S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+and+NMR+System%3A+A+New+Software+Suite+for+Macromolecular+Structure+Determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DP.%26aulast%3DClore%26aufirst%3DG.%26aulast%3DDeLano%26aufirst%3DW.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DJ.-S.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520and%2520NMR%2520System%253A%2520A%2520New%2520Software%2520Suite%2520for%2520Macromolecular%2520Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3DD54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e','cit2f','cit2g','cit2h','cit2i','cit2j','cit2k','cit2l','cit2m','cit2n','cit2o','cit2p','cit2q','cit2r','cit2s','cit2t','cit2u','cit2v','cit2w','cit2x','cit2y','cit2z','cit2aa','cit2ab','cit2ac','cit2ad','cit2ae','cit2af'],'ref3':['cit3'],'ref4':['cit4'],'ref5':[],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':[],'ref10':['cit10'],'ref11':['cit11'],'ref12':[],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 83 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jiong Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shigang Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Engineering L7Ae for RNA-Only Delivery Kill Switch Targeting CMS2 Type Colorectal Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Synthetic Biology</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 1095-1105. <a href="https://doi.org/10.1021/acssynbio.0c00612" title="DOI URL">https://doi.org/10.1021/acssynbio.0c00612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssynbio.0c00612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssynbio.0c00612%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Synthetic%2520Biology%26atitle%3DEngineering%252BL7Ae%252Bfor%252BRNA-Only%252BDelivery%252BKill%252BSwitch%252BTargeting%252BCMS2%252BType%252BColorectal%252BCancer%252BCells%26aulast%3DYang%26aufirst%3DJiong%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D08122020%26date%3D03052021%26volume%3D10%26issue%3D5%26spage%3D1095%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li-Qiang Sun, Eric Mull, Stanley D’Andrea, Barbara Zheng, Sheldon Hiebert, Eric Gillis, Michael Bowsher, Sarkunam Kandhasamy, Venkata Rao Baratam, Sunitha Puttaswamy, Nagalakshmi Pulicharla, Sureshbabu Vishwakrishnan, Subba Reddy, Ravi Trivedi, Sarmistha Sinha, Sankar Sivaprasad, Abhijith Rao, Salil Desai, Kaushik Ghosh, Rushith Anumula, Amit Kumar, Ramkumar Rajamani, Ying-Kai Wang, Hua Fang, Arvind Mathur, Richard Rampulla, Tatyana A. Zvyaga, Kathy Mosure, Susan Jenkins, Paul Falk, Debarati M. Tagore, Chaoqun Chen, Kishore Rendunchintala, James Loy, Nicholas A. Meanwell, Fiona McPhee, <span class="NLM_string-name hlFld-ContribAuthor">Paul M. Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14740-14760. <a href="https://doi.org/10.1021/acs.jmedchem.0c01296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBMS-986144%25252C%252Ba%252BThird-Generation%25252C%252BPan-Genotype%252BNS3%25252F4A%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DSun%26aufirst%3DLi-Qiang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24072020%26date%3D23112020%26volume%3D63%26issue%3D23%26spage%3D14740%26epage%3D14760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicholas A. Meanwell, Gunda I. Georg, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The 2020 Nobel Prize in Physiology or Medicine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13197-13204. <a href="https://doi.org/10.1021/acs.jmedchem.0c01877" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01877%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B2020%252BNobel%252BPrize%252Bin%252BPhysiology%252Bor%252BMedicine%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2020%26date%3D2020%26date%3D05112020%26volume%3D63%26issue%3D22%26spage%3D13197%26epage%3D13204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nitinchandra D. Patel, Xudong Wei, Denis Byrne, Bikshandarkoil A. Narayanan, Scott Pennino, Max Sarvestani, Anjan Saha, Nizar Haddad, Suresh Kapadia, Jon C. Lorenz, Philomen DeCroos, Andrew Ye, Heewon Lee, Nelu Grinberg, Azad Hossain, Carl A. Busacca, Nathan K. Yee, <span class="NLM_string-name hlFld-ContribAuthor">Chris H. Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfone-Mediated SNAr Reaction as a Powerful Tool for the Synthesis of 4-Quinolinyl Ethers and More—Application to the Synthesis of HCV NS3/4a Protease Inhibitor BI 201420. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (13)
                                     , 8339-8351. <a href="https://doi.org/10.1021/acs.joc.0c00554" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00554%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSulfone-Mediated%252BSNAr%252BReaction%252Bas%252Ba%252BPowerful%252BTool%252Bfor%252Bthe%252BSynthesis%252Bof%252B4-Quinolinyl%252BEthers%252Band%252BMore%2525E2%252580%252594Application%252Bto%252Bthe%252BSynthesis%252Bof%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitor%252BBI%252B201420%26aulast%3DPatel%26aufirst%3DNitinchandra%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02032020%26date%3D19062020%26date%3D28052020%26volume%3D85%26issue%3D13%26spage%3D8339%26epage%3D8351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ittipat Meewan, Xingquan Zhang, Suchismita Roy, Carlo Ballatore, Anthony J. O’Donoghue, Robert T. Schooley, <span class="NLM_string-name hlFld-ContribAuthor">Ruben Abagyan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (16)
                                     , 16999-17008. <a href="https://doi.org/10.1021/acsomega.9b02491" title="DOI URL">https://doi.org/10.1021/acsomega.9b02491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b02491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b02491%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiscovery%252Bof%252BNew%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252Band%252BIts%252BD168A%252BMutant%26aulast%3DMeewan%26aufirst%3DIttipat%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06082019%26date%3D02092019%26date%3D02102019%26volume%3D4%26issue%3D16%26spage%3D16999%26epage%3D17008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Javier
L. Baylon, Nicholas A. Cilfone, Jeffrey R. Gulcher, <span class="NLM_string-name hlFld-ContribAuthor">Thomas W. Chittenden</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing Retrosynthetic Reaction Prediction with Deep Learning Using Multiscale Reaction Classification. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (2)
                                     , 673-688. <a href="https://doi.org/10.1021/acs.jcim.8b00801" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00801%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEnhancing%252BRetrosynthetic%252BReaction%252BPrediction%252Bwith%252BDeep%252BLearning%252BUsing%252BMultiscale%252BReaction%252BClassification%26aulast%3DBaylon%26aufirst%3DJavier%2BL.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D12112018%26date%3D01022019%26date%3D14012019%26volume%3D59%26issue%3D2%26spage%3D673%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Peter  Hrnciar</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Manjula  Paruchuri</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Richard A.  Rampulla</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, and <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 143-148. <a href="https://doi.org/10.1021/acsmedchemlett.7b00503" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00503%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%25253A%252BEmployment%252Bof%252Ba%252BDifluoromethyl%252BGroup%252Bas%252Ba%252BHydrogen-Bond%252BDonor%26aulast%3DZheng%26aufirst%3DBarbara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04122017%26date%3D19012018%26date%3D24012018%26date%3D08022018%26date%3D19012018%26volume%3D9%26issue%3D2%26spage%3D143%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley N.  Matthew</span>, <span class="hlFld-ContribAuthor ">Jacqueto  Zephyr</span>, <span class="hlFld-ContribAuthor ">Caitlin. J.  Hill</span>, <span class="hlFld-ContribAuthor ">Muhammad  Jahangir</span>, <span class="hlFld-ContribAuthor ">Alicia  Newton</span>, <span class="hlFld-ContribAuthor ">Christos J.  Petropoulos</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nese  Kurt-Yilmaz</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>, and <span class="hlFld-ContribAuthor ">Akbar  Ali</span>  . </span><span class="cited-content_cbyCitation_article-title">Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5699-5716. <a href="https://doi.org/10.1021/acs.jmedchem.7b00426" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00426%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252BInhibitors%252BIncorporating%252BFlexible%252BP2%252BQuinoxalines%252BTarget%252BDrug%252BResistant%252BViral%252BVariants%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16032017%26date%3D19062017%26date%3D13072017%26date%3D08062017%26volume%3D60%26issue%3D13%26spage%3D5699%26epage%3D5716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Brett R.  Beno</span>, <span class="hlFld-ContribAuthor ">Kyle  Parcella</span>, <span class="hlFld-ContribAuthor ">John A.  Bender</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Grant-Young</span>, <span class="hlFld-ContribAuthor ">Andrew  Nickel</span>, <span class="hlFld-ContribAuthor ">Prashantha  Gunaga</span>, <span class="hlFld-ContribAuthor ">Prakash  Anjanappa</span>, <span class="hlFld-ContribAuthor ">Rajesh Onkardas  Bora</span>, <span class="hlFld-ContribAuthor ">Kumaravel  Selvakumar</span>, <span class="hlFld-ContribAuthor ">Karen  Rigat</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Mengping  Liu</span>, <span class="hlFld-ContribAuthor ">Julie  Lemm</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Changhong  Wan</span>, <span class="hlFld-ContribAuthor ">Mark  Witmer</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Umesh  Hanumegowda</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Yue-Zhong  Shu</span>, <span class="hlFld-ContribAuthor ">Dawn  Parker</span>, <span class="hlFld-ContribAuthor ">Roy  Haskell</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Colston</span>, <span class="hlFld-ContribAuthor ">Joseph  Raybon</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Kenneth  Santone</span>, <span class="hlFld-ContribAuthor ">Min  Gao</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Soars</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Susan B.  Roberts</span>, and <span class="hlFld-ContribAuthor ">John F.  Kadow</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (10)
                                     , 4369-4385. <a href="https://doi.org/10.1021/acs.jmedchem.7b00328" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00328%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BHepatitis%252BC%252BVirus%252BNS5B%252BReplicase%252BPalm%252BSite%252BAllosteric%252BInhibitor%252B%252528BMS-929075%252529%252BAdvanced%252Bto%252BPhase%252B1%252BClinical%252BStudies%26aulast%3DYeung%26aufirst%3DKap-Sun%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03032017%26date%3D04052017%26date%3D25052017%26date%3D21042017%26volume%3D60%26issue%3D10%26spage%3D4369%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Amino Acids in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10807-10836. <a href="https://doi.org/10.1021/acs.jmedchem.6b00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnusual%252BAmino%252BAcids%252Bin%252BMedicinal%252BChemistry%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D30092016%26date%3D22122016%26date%3D02092016%26volume%3D59%26issue%3D24%26spage%3D10807%26epage%3D10836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian S.  Young</span>, <span class="hlFld-ContribAuthor ">Yuping  Qiu</span>, <span class="hlFld-ContribAuthor ">Michael J.  Smith</span>, <span class="hlFld-ContribAuthor ">Michael B.  Hay</span>, and <span class="hlFld-ContribAuthor ">Wendel W.  Doubleday</span>  . </span><span class="cited-content_cbyCitation_article-title">Preparation of a Tricyclopropylamino Acid Derivative via Simmons–Smith Cyclopropanation with Downstream Intramolecular Aminoacetoxylation for Impurity Control. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (12)
                                     , 2108-2115. <a href="https://doi.org/10.1021/acs.oprd.6b00334" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00334%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPreparation%252Bof%252Ba%252BTricyclopropylamino%252BAcid%252BDerivative%252Bvia%252BSimmons%2525E2%252580%252593Smith%252BCyclopropanation%252Bwith%252BDownstream%252BIntramolecular%252BAminoacetoxylation%252Bfor%252BImpurity%252BControl%26aulast%3DYoung%26aufirst%3DIan%2BS.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08102016%26date%3D22112016%26date%3D16122016%26volume%3D20%26issue%3D12%26spage%3D2108%26epage%3D2115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth E.  Schwieter</span> and <span class="hlFld-ContribAuthor ">Jeffrey N.  Johnston</span>  . </span><span class="cited-content_cbyCitation_article-title">On-Demand Complex Peptide Synthesis: An Aspirational (and Elusive?) Goal for Peptide Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (43)
                                     , 14160-14169. <a href="https://doi.org/10.1021/jacs.6b08663" title="DOI URL">https://doi.org/10.1021/jacs.6b08663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b08663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b08663%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DOn-Demand%252BComplex%252BPeptide%252BSynthesis%25253A%252BAn%252BAspirational%252B%252528and%252BElusive%25253F%252529%252BGoal%252Bfor%252BPeptide%252BSynthesis%26aulast%3DSchwieter%26aufirst%3DKenneth%2BE.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18082016%26date%3D14102016%26date%3D02112016%26volume%3D138%26issue%3D43%26spage%3D14160%26epage%3D14169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Ramirez</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Hallow</span>, <span class="hlFld-ContribAuthor ">Michaël D. B.  Fenster</span>, <span class="hlFld-ContribAuthor ">Sha  Lou</span>, <span class="hlFld-ContribAuthor ">Nathan R.  Domagalski</span>, <span class="hlFld-ContribAuthor ">Srinivas  Tummala</span>, <span class="hlFld-ContribAuthor ">Sushil  Srivastava</span>, and <span class="hlFld-ContribAuthor ">Lindsay A.  Hobson</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Control Strategy for a Final Intermediate to Enable Impurities Control. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (10)
                                     , 1781-1791. <a href="https://doi.org/10.1021/acs.oprd.6b00253" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00253%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BControl%252BStrategy%252Bfor%252Ba%252BFinal%252BIntermediate%252Bto%252BEnable%252BImpurities%252BControl%26aulast%3DRamirez%26aufirst%3DAntonio%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29072016%26date%3D07102016%26date%3D21102016%26volume%3D20%26issue%3D10%26spage%3D1781%26epage%3D1791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Eric  Mull</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Richard  Rampulla</span>, <span class="hlFld-ContribAuthor ">Bang-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Theerthagiri  Palani</span>, <span class="hlFld-ContribAuthor ">Sivakumar  Ganesan</span>, <span class="hlFld-ContribAuthor ">Pirama Nayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Mark I.  Cockett</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, and <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8042-8060. <a href="https://doi.org/10.1021/acs.jmedchem.6b00821" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAcyclic%25252C%252BTripeptidic%25252C%252BAcyl%252BSulfonamide%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252Bas%252Ba%252BBack-up%252Bto%252BAsunaprevir%252Bwith%252Bthe%252BPotential%252Bfor%252BOnce-Daily%252BDosing%26aulast%3DSun%26aufirst%3DLi-Qiang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D26082016%26date%3D08092016%26volume%3D59%26issue%3D17%26spage%3D8042%26epage%3D8060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7311-7351. <a href="https://doi.org/10.1021/acs.jmedchem.6b00915" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00915%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2015%252BPhilip%252BS.%252BPortoghese%252BMedicinal%252BChemistry%252BLectureship.%252BCuring%252BHepatitis%252BC%252BVirus%252BInfection%252Bwith%252BDirect-Acting%252BAntiviral%252BAgents%25253A%252BThe%252BArc%252Bof%252Ba%252BMedicinal%252BChemistry%252BTriumph%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18062016%26date%3D08082016%26date%3D25082016%26volume%3D59%26issue%3D16%26spage%3D7311%26epage%3D7351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santhosh F.  Neelamkavil</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Thomas  Bara</span>, <span class="hlFld-ContribAuthor ">Chad  Bennett</span>, <span class="hlFld-ContribAuthor ">Sathesh  Bhat</span>, <span class="hlFld-ContribAuthor ">Dipshikha  Biswas</span>, <span class="hlFld-ContribAuthor ">Linda  Brockunier</span>, <span class="hlFld-ContribAuthor ">Nicole  Buist</span>, <span class="hlFld-ContribAuthor ">Duane  Burnette</span>, <span class="hlFld-ContribAuthor ">Mark  Cartwright</span>, <span class="hlFld-ContribAuthor ">Samuel  Chackalamannil</span>, <span class="hlFld-ContribAuthor ">Robert  Chase</span>, <span class="hlFld-ContribAuthor ">Mariappan  Chelliah</span>, <span class="hlFld-ContribAuthor ">Austin  Chen</span>, <span class="hlFld-ContribAuthor ">Martin  Clasby</span>, <span class="hlFld-ContribAuthor ">Vincent J.  Colandrea</span>, <span class="hlFld-ContribAuthor ">Ian W.  Davies</span>, <span class="hlFld-ContribAuthor ">Keith  Eagen</span>, <span class="hlFld-ContribAuthor ">Zhuyan  Guo</span>, <span class="hlFld-ContribAuthor ">Yongxin  Han</span>, <span class="hlFld-ContribAuthor ">John  Howe</span>, <span class="hlFld-ContribAuthor ">Charles  Jayne</span>, <span class="hlFld-ContribAuthor ">Hubert  Josien</span>, <span class="hlFld-ContribAuthor ">Stacia  Kargman</span>, <span class="hlFld-ContribAuthor ">Karen  Marcantonio</span>, <span class="hlFld-ContribAuthor ">Shouwu  Miao</span>, <span class="hlFld-ContribAuthor ">Randy  Miller</span>, <span class="hlFld-ContribAuthor ">Andrew  Nolting</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Murali  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Rebecca T.  Ruck</span>, <span class="hlFld-ContribAuthor ">Unmesh  Shah</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Donald  Sperbeck</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Yan  Xia</span>, and <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 111-116. <a href="https://doi.org/10.1021/acsmedchemlett.5b00425" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00425%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BMK-8831%25252C%252BA%252BNovel%252BSpiro-Proline%252BMacrocycle%252Bas%252Ba%252BPan-Genotypic%252BHCV-NS3%25252F4a%252BProtease%252BInhibitor%26aulast%3DNeelamkavil%26aufirst%3DSanthosh%2BF.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09112015%26date%3D22122015%26date%3D23122015%26date%3D14012016%26date%3D22122015%26volume%3D7%26issue%3D1%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajing  Tan</span> and <span class="hlFld-ContribAuthor ">Nobuyoshi  Yasuda</span>  . </span><span class="cited-content_cbyCitation_article-title">Contemporary Asymmetric Phase Transfer Catalysis: Large-Scale Industrial Applications. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (11)
                                     , 1731-1746. <a href="https://doi.org/10.1021/acs.oprd.5b00304" title="DOI URL">https://doi.org/10.1021/acs.oprd.5b00304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.5b00304%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DContemporary%252BAsymmetric%252BPhase%252BTransfer%252BCatalysis%25253A%252BLarge-Scale%252BIndustrial%252BApplications%26aulast%3DTan%26aufirst%3DJiajing%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D25092015%26date%3D27102015%26date%3D20112015%26date%3D29092015%26volume%3D19%26issue%3D11%26spage%3D1731%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yukino  Shinomoto</span>, <span class="hlFld-ContribAuthor ">Akira  Yoshimura</span>, <span class="hlFld-ContribAuthor ">Hisato  Shimizu</span>, <span class="hlFld-ContribAuthor ">Mutsumi  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Viktor V.  Zhdankin</span>, and <span class="hlFld-ContribAuthor ">Akio  Saito</span>  . </span><span class="cited-content_cbyCitation_article-title">Tetra-n-butylammonium Iodide Catalyzed C–H Azidation of Aldehydes with Thermally Stable Azidobenziodoxolone. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (21)
                                     , 5212-5215. <a href="https://doi.org/10.1021/acs.orglett.5b02543" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b02543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b02543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b02543%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTetra-n-butylammonium%252BIodide%252BCatalyzed%252BC%2525E2%252580%252593H%252BAzidation%252Bof%252BAldehydes%252Bwith%252BThermally%252BStable%252BAzidobenziodoxolone%26aulast%3DShinomoto%26aufirst%3DYukino%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D03092015%26date%3D22102015%26date%3D06112015%26volume%3D17%26issue%3D21%26spage%3D5212%26epage%3D5215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Marco  Weisshaar</span>, <span class="hlFld-ContribAuthor ">Kristen  Lamb</span>, <span class="hlFld-ContribAuthor ">Hokyung K.  Chung</span>, <span class="hlFld-ContribAuthor ">Michael Z.  Lin</span>, and <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>  . </span><span class="cited-content_cbyCitation_article-title">Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2015,</strong> <em>54 </em>
                                    (36)
                                     , 5589-5604. <a href="https://doi.org/10.1021/acs.biochem.5b00623" title="DOI URL">https://doi.org/10.1021/acs.biochem.5b00623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.5b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.5b00623%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DReplication-Competent%252BInfluenza%252BVirus%252Band%252BRespiratory%252BSyncytial%252BVirus%252BLuciferase%252BReporter%252BStrains%252BEngineered%252Bfor%252BCo-Infections%252BIdentify%252BAntiviral%252BCompounds%252Bin%252BCombination%252BScreens%26aulast%3DYan%26aufirst%3DDan%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05062015%26date%3D04082015%26date%3D01092015%26date%3D15092015%26date%3D26082015%26volume%3D54%26issue%3D36%26spage%3D5589%26epage%3D5604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan E.  Gable</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Acker</span>, and <span class="hlFld-ContribAuthor ">Charles S.  Craik</span>  . </span><span class="cited-content_cbyCitation_article-title">Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (22)
                                     , 11382-11412. <a href="https://doi.org/10.1021/cr500255e" title="DOI URL">https://doi.org/10.1021/cr500255e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500255e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500255e%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DCurrent%252Band%252BPotential%252BTreatments%252Bfor%252BUbiquitous%252Bbut%252BNeglected%252BHerpesvirus%252BInfections%26aulast%3DGable%26aufirst%3DJonathan%2BE.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13052014%26date%3D02102014%26date%3D26112014%26volume%3D114%26issue%3D22%26spage%3D11382%26epage%3D11412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Djadé I.  Soumana</span>, <span class="hlFld-ContribAuthor ">Akbar  Ali</span>, and <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , 2485-2490. <a href="https://doi.org/10.1021/cb5006118" title="DOI URL">https://doi.org/10.1021/cb5006118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb5006118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb5006118%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStructural%252BAnalysis%252Bof%252BAsunaprevir%252BResistance%252Bin%252BHCV%252BNS3%25252F4A%252BProtease%26aulast%3DSoumana%26aufirst%3DDjad%25C3%25A9%2BI.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01082014%26date%3D22092014%26date%3D30092014%26date%3D21112014%26date%3D22092014%26volume%3D9%26issue%3D11%26spage%3D2485%26epage%3D2490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Makonen  Belema</span> and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5057-5071. <a href="https://doi.org/10.1021/jm500335h" title="DOI URL">https://doi.org/10.1021/jm500335h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500335h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDaclatasvir%25252C%252Ba%252BPan-Genotypic%252BHepatitis%252BC%252BVirus%252BNS5A%252BReplication%252BComplex%252BInhibitor%252Bwith%252BPotent%252BClinical%252BEffect%26aulast%3DBelema%26aufirst%3DMakonen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03032014%26date%3D21042014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5057%26epage%3D5071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sjoerd  Slagman</span>, <span class="hlFld-ContribAuthor ">Wolf-Dieter  Fessner</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalytic routes to anti-viral agents and their synthetic intermediates. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (3)
                                     , 1968-2009. <a href="https://doi.org/10.1039/D0CS00763C" title="DOI URL">https://doi.org/10.1039/D0CS00763C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00763C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00763C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DBiocatalytic%252Broutes%252Bto%252Banti-viral%252Bagents%252Band%252Btheir%252Bsynthetic%252Bintermediates%26aulast%3DSlagman%26aufirst%3DSjoerd%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D3%26spage%3D1968%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura M.  Luh</span>, <span class="hlFld-ContribAuthor ">Ulrike  Scheib</span>, <span class="hlFld-ContribAuthor ">Katrin  Juenemann</span>, <span class="hlFld-ContribAuthor ">Lars  Wortmann</span>, <span class="hlFld-ContribAuthor ">Michael  Brands</span>, <span class="hlFld-ContribAuthor ">Philipp M.  Cromm</span>. </span><span class="cited-content_cbyCitation_article-title">Beute für das Proteasom: Gezielter Proteinabbau aus medizinalchemischer Perspektive. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (36)
                                     , 15576-15595. <a href="https://doi.org/10.1002/ange.202004310" title="DOI URL">https://doi.org/10.1002/ange.202004310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202004310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202004310%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DBeute%252Bf%2525C3%2525BCr%252Bdas%252BProteasom%25253A%252BGezielter%252BProteinabbau%252Baus%252Bmedizinalchemischer%252BPerspektive%26aulast%3DLuh%26aufirst%3DLaura%2BM.%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D36%26spage%3D15576%26epage%3D15595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura M.  Luh</span>, <span class="hlFld-ContribAuthor ">Ulrike  Scheib</span>, <span class="hlFld-ContribAuthor ">Katrin  Juenemann</span>, <span class="hlFld-ContribAuthor ">Lars  Wortmann</span>, <span class="hlFld-ContribAuthor ">Michael  Brands</span>, <span class="hlFld-ContribAuthor ">Philipp M.  Cromm</span>. </span><span class="cited-content_cbyCitation_article-title">Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (36)
                                     , 15448-15466. <a href="https://doi.org/10.1002/anie.202004310" title="DOI URL">https://doi.org/10.1002/anie.202004310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202004310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202004310%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPrey%252Bfor%252Bthe%252BProteasome%25253A%252BTargeted%252BProtein%252BDegradation%2525E2%252580%252594A%252BMedicinal%252BChemist%252527s%252BPerspective%26aulast%3DLuh%26aufirst%3DLaura%2BM.%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D36%26spage%3D15448%26epage%3D15466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Zappulo</span>, <span class="hlFld-ContribAuthor ">Riccardo  Scotto</span>, <span class="hlFld-ContribAuthor ">Antonio Riccardo  Buonomo</span>, <span class="hlFld-ContribAuthor ">Alberto Enrico  Maraolo</span>, <span class="hlFld-ContribAuthor ">Biagio  Pinchera</span>, <span class="hlFld-ContribAuthor ">Ivan  Gentile</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2020,</strong> <em>21 </em>
                                    (3)
                                     , 261-273. <a href="https://doi.org/10.1080/14656566.2019.1697674" title="DOI URL">https://doi.org/10.1080/14656566.2019.1697674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2019.1697674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2019.1697674%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DEfficacy%252Band%252Bsafety%252Bof%252Ba%252Bfixed%252Bdose%252Bcombination%252Btablet%252Bof%252Basunaprevir%252B%25252B%252Bbeclabuvir%252B%25252B%252Bdaclatasvir%252Bfor%252Bthe%252Btreatment%252Bof%252BHepatitis%252BC%26aulast%3DZappulo%26aufirst%3DEmanuela%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D3%26spage%3D261%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rishitha  Gundala</span>, <span class="hlFld-ContribAuthor ">Himani  Balutia</span>, <span class="hlFld-ContribAuthor ">R.  Lavanya</span>, <span class="hlFld-ContribAuthor ">Ravichandiran  Velayutham</span>, <span class="hlFld-ContribAuthor ">Kuldeep K.  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">HCV NS3 serine protease as a drug target for the development of drugs against hepatocellular carcinoma (liver cancer). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 243-263. <a href="https://doi.org/10.1016/B978-0-12-818168-3.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-818168-3.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818168-3.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818168-3.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DHCV%252BNS3%252Bserine%252Bprotease%252Bas%252Ba%252Bdrug%252Btarget%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bdrugs%252Bagainst%252Bhepatocellular%252Bcarcinoma%252B%252528liver%252Bcancer%252529%26aulast%3DGundala%26aufirst%3DRishitha%26date%3D2020%26spage%3D243%26epage%3D263%26pub%3DElsevier%26atitle%3DCancer-Leading%252BProteases%26date%3D2020%26volume%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Liu</span>, <span class="hlFld-ContribAuthor ">Yan-Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Bing-Feng  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino acids and peptides with bulky side chains
              via
              ligand-enabled carboxylate-directed γ-C(sp
              3
              )–H arylation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 290-294. <a href="https://doi.org/10.1039/C9SC04482E" title="DOI URL">https://doi.org/10.1039/C9SC04482E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC04482E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC04482E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DSynthesis%252Bof%252Bamino%252Bacids%252Band%252Bpeptides%252Bwith%252Bbulky%252Bside%252Bchains%252Bvia%252Bligand-enabled%252Bcarboxylate-directed%252B%2525CE%2525B3-C%252528sp%252B3%252B%252529%2525E2%252580%252593H%252Barylation%26aulast%3DLiu%26aufirst%3DLei%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D290%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jirayu  Kammarabutr</span>, <span class="hlFld-ContribAuthor ">Panupong  Mahalapbutr</span>, <span class="hlFld-ContribAuthor ">Bodee  Nutho</span>, <span class="hlFld-ContribAuthor ">Nawee  Kungwan</span>, <span class="hlFld-ContribAuthor ">Thanyada  Rungrotmongkol</span>. </span><span class="cited-content_cbyCitation_article-title">Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>89 </em>, 122-130. <a href="https://doi.org/10.1016/j.jmgm.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DLow%252Bsusceptibility%252Bof%252Basunaprevir%252Btowards%252BR155K%252Band%252BD168A%252Bpoint%252Bmutations%252Bin%252BHCV%252BNS3%25252F4A%252Bprotease%25253A%252BA%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DKammarabutr%26aufirst%3DJirayu%26date%3D2019%26volume%3D89%26spage%3D122%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Usman  Ashraf</span>, <span class="hlFld-ContribAuthor ">Kanzal  Iman</span>, <span class="hlFld-ContribAuthor ">Muhammad Farhan  Khalid</span>, <span class="hlFld-ContribAuthor ">Hafiz Muhammad  Salman</span>, <span class="hlFld-ContribAuthor ">Talha  Shafi</span>, <span class="hlFld-ContribAuthor ">Momal  Rafi</span>, <span class="hlFld-ContribAuthor ">Nida  Javaid</span>, <span class="hlFld-ContribAuthor ">Rashid  Hussain</span>, <span class="hlFld-ContribAuthor ">Fayyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Syed  Shahzad‐Ul‐Hussan</span>, <span class="hlFld-ContribAuthor ">Shaper  Mirza</span>, <span class="hlFld-ContribAuthor ">Muhammad  Shafiq</span>, <span class="hlFld-ContribAuthor ">Samia  Afzal</span>, <span class="hlFld-ContribAuthor ">Sadia  Hamera</span>, <span class="hlFld-ContribAuthor ">Saima  Anwar</span>, <span class="hlFld-ContribAuthor ">Romena  Qazi</span>, <span class="hlFld-ContribAuthor ">Muhammad  Idrees</span>, <span class="hlFld-ContribAuthor ">Sohail A.  Qureshi</span>, <span class="hlFld-ContribAuthor ">Safee Ullah  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of efficacious pangenotypic hepatitis C virus therapies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 1091-1136. <a href="https://doi.org/10.1002/med.21554" title="DOI URL">https://doi.org/10.1002/med.21554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21554%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEvolution%252Bof%252Befficacious%252Bpangenotypic%252Bhepatitis%252BC%252Bvirus%252Btherapies%26aulast%3DAshraf%26aufirst%3DMuhammad%2BUsman%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D1091%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clémence  Delalande</span>, <span class="hlFld-ContribAuthor ">Mahendra  Awale</span>, <span class="hlFld-ContribAuthor ">Matthias  Rubin</span>, <span class="hlFld-ContribAuthor ">Daniel  Probst</span>, <span class="hlFld-ContribAuthor ">Lijo C.  Ozhathil</span>, <span class="hlFld-ContribAuthor ">Jürg  Gertsch</span>, <span class="hlFld-ContribAuthor ">Hugues  Abriel</span>, <span class="hlFld-ContribAuthor ">Jean-Louis  Reymond</span>. </span><span class="cited-content_cbyCitation_article-title">Optimizing TRPM4 inhibitors in the MHFP6 chemical space. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 167-177. <a href="https://doi.org/10.1016/j.ejmech.2019.01.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimizing%252BTRPM4%252Binhibitors%252Bin%252Bthe%252BMHFP6%252Bchemical%252Bspace%26aulast%3DDelalande%26aufirst%3DCl%25C3%25A9mence%26date%3D2019%26volume%3D166%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Lung  Yu</span>, <span class="hlFld-ContribAuthor ">Chao-Hung  Hung</span>, <span class="hlFld-ContribAuthor ">Yi-Hsiang  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng-Yuan  Peng</span>, <span class="hlFld-ContribAuthor ">Chun-Yen  Lin</span>, <span class="hlFld-ContribAuthor ">Pin-Nan  Cheng</span>, <span class="hlFld-ContribAuthor ">Rong-Nan  Chien</span>, <span class="hlFld-ContribAuthor ">Shih-Jer  Hsu</span>, <span class="hlFld-ContribAuthor ">Chen-Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Chung-Feng  Huang</span>, <span class="hlFld-ContribAuthor ">Chien-Wei  Su</span>, <span class="hlFld-ContribAuthor ">Jee-Fu  Huang</span>, <span class="hlFld-ContribAuthor ">Chun-Jen  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-Horng  Kao</span>, <span class="hlFld-ContribAuthor ">Wan-Long  Chuang</span>, <span class="hlFld-ContribAuthor ">Pei-Jer  Chen</span>, <span class="hlFld-ContribAuthor ">Ding-Shinn  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Formosan Medical Association</span><span> <strong>2019,</strong> <em>118 </em>
                                    (2)
                                     , 556-564. <a href="https://doi.org/10.1016/j.jfma.2018.11.007" title="DOI URL">https://doi.org/10.1016/j.jfma.2018.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfma.2018.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfma.2018.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Formosan%2520Medical%2520Association%26atitle%3DEfficacy%252Band%252Bsafety%252Bof%252B12%252Bweeks%252Bof%252Bdaclatasvir%25252C%252Basunaprevir%252Bplus%252Bribavirin%252Bfor%252BHCV%252Bgenotype-1b%252Binfection%252Bwithout%252BNS5A%252Bresistance-associated%252Bsubstitutions%26aulast%3DYu%26aufirst%3DMing-Lung%26date%3D2019%26volume%3D118%26issue%3D2%26spage%3D556%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayşegül  Özen</span>, <span class="hlFld-ContribAuthor ">Kristina  Prachanronarong</span>, <span class="hlFld-ContribAuthor ">Ashley N.  Matthew</span>, <span class="hlFld-ContribAuthor ">Djade I.  Soumana</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Biochemistry and Molecular Biology</span><span> <strong>2019,</strong> <em>54 </em>
                                    (1)
                                     , 11-26. <a href="https://doi.org/10.1080/10409238.2019.1568962" title="DOI URL">https://doi.org/10.1080/10409238.2019.1568962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10409238.2019.1568962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10409238.2019.1568962%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DResistance%252Boutside%252Bthe%252Bsubstrate%252Benvelope%25253A%252Bhepatitis%252BC%252BNS3%25252F4A%252Bprotease%252Binhibitors%26aulast%3D%25C3%2596zen%26aufirst%3DAy%25C5%259Feg%25C3%25BCl%26date%3D2019%26date%3D2019%26volume%3D54%26issue%3D1%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidija  Senerovic</span>, <span class="hlFld-ContribAuthor ">Dejan  Opsenica</span>, <span class="hlFld-ContribAuthor ">Ivana  Moric</span>, <span class="hlFld-ContribAuthor ">Ivana  Aleksic</span>, <span class="hlFld-ContribAuthor ">Marta  Spasić</span>, <span class="hlFld-ContribAuthor ">Branka  Vasiljevic</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolines and Quinolones as Antibacterial, Antifungal, Anti-virulence, Antiviral and Anti-parasitic Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 37-69. <a href="https://doi.org/10.1007/5584_2019_428" title="DOI URL">https://doi.org/10.1007/5584_2019_428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/5584_2019_428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F5584_2019_428%26sid%3Dliteratum%253Aachs%26atitle%3DQuinolines%252Band%252BQuinolones%252Bas%252BAntibacterial%25252C%252BAntifungal%25252C%252BAnti-virulence%25252C%252BAntiviral%252Band%252BAnti-parasitic%252BAgents%26aulast%3DSenerovic%26aufirst%3DLidija%26date%3D2019%26date%3D2019%26spage%3D37%26epage%3D69%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAdvances%252Bin%252BMicrobiology%25252C%252BInfectious%252BDiseases%252Band%252BPublic%252BHealth%26aulast%3DDonelli%26aufirst%3DGianfranco%26date%3D2020%26volume%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert G.  Gentles</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Beclabuvir: A Potent Allosteric Inhibitor of the Hepatitis C Virus Polymerase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 193-228. <a href="https://doi.org/10.1007/7355_2018_38" title="DOI URL">https://doi.org/10.1007/7355_2018_38</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_38%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBeclabuvir%25253A%252BA%252BPotent%252BAllosteric%252BInhibitor%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BPolymerase%26aulast%3DGentles%26aufirst%3DRobert%2BG.%26date%3D2019%26date%3D2019%26spage%3D193%26epage%3D228%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of HCV NS3/4a Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 231-259. <a href="https://doi.org/10.1007/7355_2018_39" title="DOI URL">https://doi.org/10.1007/7355_2018_39</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_39%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitors%26aulast%3DLiverton%26aufirst%3DNigel%2BJ.%26date%3D2019%26date%3D2019%26spage%3D231%26epage%3D259%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>. </span><span class="cited-content_cbyCitation_article-title">The Invention of Grazoprevir: An HCV NS3/4a Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 355-387. <a href="https://doi.org/10.1007/7355_2018_41" title="DOI URL">https://doi.org/10.1007/7355_2018_41</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_41%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInvention%252Bof%252BGrazoprevir%25253A%252BAn%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitor%26aulast%3DMcCauley%26aufirst%3DJohn%2BA.%26date%3D2019%26date%3D2019%26spage%3D355%26epage%3D387%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Makonen  Belema</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 27-55. <a href="https://doi.org/10.1007/7355_2018_47" title="DOI URL">https://doi.org/10.1007/7355_2018_47</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_47%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BDevelopment%252Bof%252BDaclatasvir%25253A%252BAn%252BInhibitor%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS5A%252BReplication%252BComplex%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2019%26date%3D2019%26spage%3D27%26epage%3D55%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Early Clinical Evaluation of the HCV NS3/4A Protease Inhibitor Asunaprevir (BMS-650032). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 317-354. <a href="https://doi.org/10.1007/7355_2018_58" title="DOI URL">https://doi.org/10.1007/7355_2018_58</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_58%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BEarly%252BClinical%252BEvaluation%252Bof%252Bthe%252BHCV%252BNS3%25252F4A%252BProtease%252BInhibitor%252BAsunaprevir%252B%252528BMS-650032%252529%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2019%26date%3D2019%26spage%3D317%26epage%3D354%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelrahman  Hamdi</span>, <span class="hlFld-ContribAuthor ">Mathieu Y.  Laurent</span>, <span class="hlFld-ContribAuthor ">Annie  Hémon-Ribaud</span>, <span class="hlFld-ContribAuthor ">Amany S.  Mostafa</span>, <span class="hlFld-ContribAuthor ">Mohammed A.M.  Massoud</span>, <span class="hlFld-ContribAuthor ">Khalid B.  Selim</span>, <span class="hlFld-ContribAuthor ">Gilles  Dujardin</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Dipolar cycloaddition of vinyloxy quinolines with α-alkoxy carbonyl aldonitrones or cyclic surrogates: A comparative study for an asymmetric access to trans 4-quinolinoxy oxaprolines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (3)
                                     , 429-440. <a href="https://doi.org/10.1016/j.tet.2018.12.019" title="DOI URL">https://doi.org/10.1016/j.tet.2018.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D1%25252C3-Dipolar%252Bcycloaddition%252Bof%252Bvinyloxy%252Bquinolines%252Bwith%252B%2525CE%2525B1-alkoxy%252Bcarbonyl%252Baldonitrones%252Bor%252Bcyclic%252Bsurrogates%25253A%252BA%252Bcomparative%252Bstudy%252Bfor%252Ban%252Basymmetric%252Baccess%252Bto%252Btrans%252B4-quinolinoxy%252Boxaprolines%26aulast%3DHamdi%26aufirst%3DAbdelrahman%26date%3D2019%26volume%3D75%26issue%3D3%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O. A.  Tevs</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Veremeychik</span>, <span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>, <span class="hlFld-ContribAuthor ">I. A.  Litvinov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Hybrid Pharmacophores Based on Adducts of N-Sulfinylaniline and Norbornadiene. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2018,</strong> <em>88 </em>
                                    (11)
                                     , 2438-2441. <a href="https://doi.org/10.1134/S1070363218110300" title="DOI URL">https://doi.org/10.1134/S1070363218110300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363218110300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363218110300%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%252Bof%252BHybrid%252BPharmacophores%252BBased%252Bon%252BAdducts%252Bof%252BN-Sulfinylaniline%252Band%252BNorbornadiene%26aulast%3DTevs%26aufirst%3DO.%2BA.%26date%3D2018%26date%3D2018%26volume%3D88%26issue%3D11%26spage%3D2438%26epage%3D2441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. V.  Yashin</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for the preparation of 1-Aminocyclopropanecarboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">Review Journal of Chemistry</span><span> <strong>2018,</strong> <em>8 </em>
                                    (4)
                                     , 373-401. <a href="https://doi.org/10.1134/S2079978018040040" title="DOI URL">https://doi.org/10.1134/S2079978018040040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S2079978018040040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS2079978018040040%26sid%3Dliteratum%253Aachs%26jtitle%3DReview%2520Journal%2520of%2520Chemistry%26atitle%3DMethods%252Bfor%252Bthe%252Bpreparation%252Bof%252B1-Aminocyclopropanecarboxylic%252BAcids%26aulast%3DYashin%26aufirst%3DN.%2BV.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D4%26spage%3D373%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petra E de  Ruiter</span>, <span class="hlFld-ContribAuthor ">Yashna  Gadjradj</span>, <span class="hlFld-ContribAuthor ">Robert J de  Knegt</span>, <span class="hlFld-ContribAuthor ">Herold J  Metselaar</span>, <span class="hlFld-ContribAuthor ">Jan NM  Ijzermans</span>, <span class="hlFld-ContribAuthor ">Luc JW van der  Laan</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Transplantation</span><span> <strong>2018,</strong> <em>8 </em>
                                    (5)
                                     , 156-166. <a href="https://doi.org/10.5500/wjt.v8.i5.156" title="DOI URL">https://doi.org/10.5500/wjt.v8.i5.156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5500/wjt.v8.i5.156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5500%2Fwjt.v8.i5.156%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Transplantation%26atitle%3DInteraction%252Bof%252Bimmunosuppressants%252Bwith%252BHCV%252Bantivirals%252Bdaclatasvir%252Band%252Basunaprevir%25253A%252Bcombined%252Beffects%252Bwith%252Bmycophenolic%252Bacid%26aulast%3DRuiter%26aufirst%3DPetra%2BE%2Bde%26date%3D2018%26volume%3D8%26issue%3D5%26spage%3D156%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayodeji A.  Agbowuro</span>, <span class="hlFld-ContribAuthor ">Wilhelmina M.  Huston</span>, <span class="hlFld-ContribAuthor ">Allan B.  Gamble</span>, <span class="hlFld-ContribAuthor ">Joel D. A.  Tyndall</span>. </span><span class="cited-content_cbyCitation_article-title">Proteases and protease inhibitors in infectious diseases. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (4)
                                     , 1295-1331. <a href="https://doi.org/10.1002/med.21475" title="DOI URL">https://doi.org/10.1002/med.21475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21475%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DProteases%252Band%252Bprotease%252Binhibitors%252Bin%252Binfectious%252Bdiseases%26aulast%3DAgbowuro%26aufirst%3DAyodeji%2BA.%26date%3D2018%26date%3D2017%26volume%3D38%26issue%3D4%26spage%3D1295%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabella  Esposito</span>, <span class="hlFld-ContribAuthor ">Sebastián  Marciano</span>, <span class="hlFld-ContribAuthor ">Julieta  Trinks</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2018,</strong> <em>14 </em>
                                    (6)
                                     , 649-657. <a href="https://doi.org/10.1080/17425255.2018.1483336" title="DOI URL">https://doi.org/10.1080/17425255.2018.1483336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2018.1483336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2018.1483336%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DPharmacokinetic%252Band%252Bpharmacodynamic%252Bevaluation%252Bof%252Bdaclatasvir%25252C%252Basunaprevir%252Bplus%252Bbeclabuvir%252Bas%252Ba%252Bfixed-dose%252Bco-formulation%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%26aulast%3DEsposito%26aufirst%3DIsabella%26date%3D2018%26date%3D2018%26volume%3D14%26issue%3D6%26spage%3D649%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Amy  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Min  Lee</span>, <span class="hlFld-ContribAuthor ">Cindy  Dunaj</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Jay  Knipe</span>, <span class="hlFld-ContribAuthor ">Jason  Sandquist</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dawn  Parker</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1853-1859. <a href="https://doi.org/10.1016/j.bmcl.2018.04.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DP3-P4%252Bureas%252Band%252Breverse%252Bcarbamates%252Bas%252Bpotent%252BHCV%252BNS3%252Bprotease%252Binhibitors%25253A%252BEffective%252Btransposition%252Bof%252Bthe%252BP4%252Bhydrogen%252Bbond%252Bdonor%26aulast%3DVenables%26aufirst%3DBrian%2BL.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1853%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaozhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Ying  Shi</span>, <span class="hlFld-ContribAuthor ">Xinyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Guojun  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalytic Asymmetric Synthesis of (1R, 2S)-N-Boc-vinyl-ACCA Ethyl Ester with a Newly Isolated Sphingomonas aquatilis. </span><span class="cited-content_cbyCitation_journal-name">Applied Biochemistry and Biotechnology</span><span> <strong>2018,</strong> <em>184 </em>
                                    (2)
                                     , 500-512. <a href="https://doi.org/10.1007/s12010-017-2567-4" title="DOI URL">https://doi.org/10.1007/s12010-017-2567-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12010-017-2567-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12010-017-2567-4%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Biochemistry%2520and%2520Biotechnology%26atitle%3DBiocatalytic%252BAsymmetric%252BSynthesis%252Bof%252B%2525281R%25252C%252B2S%252529-N-Boc-vinyl-ACCA%252BEthyl%252BEster%252Bwith%252Ba%252BNewly%252BIsolated%252BSphingomonas%252Baquatilis%26aulast%3DZhu%26aufirst%3DShaozhou%26date%3D2018%26date%3D2017%26volume%3D184%26issue%3D2%26spage%3D500%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Bowsher</span>, <span class="hlFld-ContribAuthor ">Sheldon  Hiebert</span>, <span class="hlFld-ContribAuthor ">Rongti  Li</span>, <span class="hlFld-ContribAuthor ">Alan X.  Wang</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Herbert  Klei</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 43-48. <a href="https://doi.org/10.1016/j.bmcl.2017.11.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Band%252Boptimization%252Bof%252Bnaphthalene-linked%252BP2-P4%252BMacrocycles%252Bas%252Binhibitors%252Bof%252BHCV%252BNS3%252Bprotease%26aulast%3DBowsher%26aufirst%3DMichael%26date%3D2018%26volume%3D28%26issue%3D1%26spage%3D43%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">He-chuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-peng  Ren</span>, <span class="hlFld-ContribAuthor ">Yue  Qiu</span>, <span class="hlFld-ContribAuthor ">Jenny  Zheng</span>, <span class="hlFld-ContribAuthor ">Gai-ling  Li</span>, <span class="hlFld-ContribAuthor ">Chuan-pu  Hu</span>, <span class="hlFld-ContribAuthor ">Tian-yan  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Liang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated pharmacokinetic/viral dynamic model for daclatasvir/asunaprevir in treatment of patients with genotype 1 chronic hepatitis C. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (1)
                                     , 140-153. <a href="https://doi.org/10.1038/aps.2017.84" title="DOI URL">https://doi.org/10.1038/aps.2017.84</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.84%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DIntegrated%252Bpharmacokinetic%25252Fviral%252Bdynamic%252Bmodel%252Bfor%252Bdaclatasvir%25252Fasunaprevir%252Bin%252Btreatment%252Bof%252Bpatients%252Bwith%252Bgenotype%252B1%252Bchronic%252Bhepatitis%252BC%26aulast%3DWang%26aufirst%3DHe-chuan%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D1%26spage%3D140%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiyohiko  Omichi</span>, <span class="hlFld-ContribAuthor ">Nobuhisa  Akamatsu</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Mori</span>, <span class="hlFld-ContribAuthor ">Junichi  Togashi</span>, <span class="hlFld-ContribAuthor ">Junichi  Arita</span>, <span class="hlFld-ContribAuthor ">Junichi  Kaneko</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Norihiro  Kokudo</span>. </span><span class="cited-content_cbyCitation_article-title">Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation. </span><span class="cited-content_cbyCitation_journal-name">Hepatology Research</span><span> <strong>2017,</strong> <em>47 </em>
                                    (11)
                                     , 1093-1101. <a href="https://doi.org/10.1111/hepr.12845" title="DOI URL">https://doi.org/10.1111/hepr.12845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/hepr.12845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fhepr.12845%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%2520Research%26atitle%3DAsunaprevir%25252Fdaclatasvir%252Band%252Bsofosbuvir%25252Fledipasvir%252Bfor%252Brecurrent%252Bhepatitis%252BC%252Bfollowing%252Bliving%252Bdonor%252Bliver%252Btransplantation%26aulast%3DOmichi%26aufirst%3DKiyohiko%26date%3D2017%26date%3D2016%26volume%3D47%26issue%3D11%26spage%3D1093%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanghai  Jin</span>, <span class="hlFld-ContribAuthor ">Jisu  Lee</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical genetics-based development of small molecules targeting hepatitis C virus. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2017,</strong> <em>40 </em>
                                    (9)
                                     , 1021-1036. <a href="https://doi.org/10.1007/s12272-017-0949-3" title="DOI URL">https://doi.org/10.1007/s12272-017-0949-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-017-0949-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-017-0949-3%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DChemical%252Bgenetics-based%252Bdevelopment%252Bof%252Bsmall%252Bmolecules%252Btargeting%252Bhepatitis%252BC%252Bvirus%26aulast%3DJin%26aufirst%3DGuanghai%26date%3D2017%26date%3D2017%26volume%3D40%26issue%3D9%26spage%3D1021%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaos  Lougiakis</span>, <span class="hlFld-ContribAuthor ">Efseveia  Frakolaki</span>, <span class="hlFld-ContribAuthor ">Panagiota  Karmou</span>, <span class="hlFld-ContribAuthor ">Nicole  Pouli</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Marakos</span>, <span class="hlFld-ContribAuthor ">Vanesa  Madan</span>, <span class="hlFld-ContribAuthor ">Ralf  Bartenschlager</span>, <span class="hlFld-ContribAuthor ">Niki  Vassilaki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (3)
                                     , 352-367. <a href="https://doi.org/10.1111/cbdd.12966" title="DOI URL">https://doi.org/10.1111/cbdd.12966</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12966%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DNovel%252Bnucleoside%252Banalogues%252Btargeting%252BHCV%252Breplication%252Bthrough%252Ban%252BNS5A-dependent%252Binhibition%252Bmechanism%26aulast%3DLougiakis%26aufirst%3DNikolaos%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D3%26spage%3D352%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangdi  Li</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Current therapy for chronic hepatitis C: The role of direct-acting antivirals. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2017,</strong> <em>142 </em>, 83-122. <a href="https://doi.org/10.1016/j.antiviral.2017.02.014" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DCurrent%252Btherapy%252Bfor%252Bchronic%252Bhepatitis%252BC%25253A%252BThe%252Brole%252Bof%252Bdirect-acting%252Bantivirals%26aulast%3DLi%26aufirst%3DGuangdi%26date%3D2017%26volume%3D142%26spage%3D83%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Futatsugi</span>, <span class="hlFld-ContribAuthor ">K.  Huard</span>, <span class="hlFld-ContribAuthor ">D. W.  Kung</span>, <span class="hlFld-ContribAuthor ">J. C.  Pettersen</span>, <span class="hlFld-ContribAuthor ">D. A.  Flynn</span>, <span class="hlFld-ContribAuthor ">J. R.  Gosset</span>, <span class="hlFld-ContribAuthor ">G. E.  Aspnes</span>, <span class="hlFld-ContribAuthor ">R. J.  Barnes</span>, <span class="hlFld-ContribAuthor ">S.  Cabral</span>, <span class="hlFld-ContribAuthor ">M. S.  Dowling</span>, <span class="hlFld-ContribAuthor ">D. P.  Fernando</span>, <span class="hlFld-ContribAuthor ">T. C.  Goosen</span>, <span class="hlFld-ContribAuthor ">W. P.  Gorczyca</span>, <span class="hlFld-ContribAuthor ">D.  Hepworth</span>, <span class="hlFld-ContribAuthor ">M.  Herr</span>, <span class="hlFld-ContribAuthor ">S.  Lavergne</span>, <span class="hlFld-ContribAuthor ">Q.  Li</span>, <span class="hlFld-ContribAuthor ">M.  Niosi</span>, <span class="hlFld-ContribAuthor ">S. T. M.  Orr</span>, <span class="hlFld-ContribAuthor ">I. D.  Pardo</span>, <span class="hlFld-ContribAuthor ">S. M.  Perez</span>, <span class="hlFld-ContribAuthor ">J.  Purkal</span>, <span class="hlFld-ContribAuthor ">T. J.  Schmahai</span>, <span class="hlFld-ContribAuthor ">N.  Shirai</span>, <span class="hlFld-ContribAuthor ">A. M.  Shoieb</span>, <span class="hlFld-ContribAuthor ">J.  Zhou</span>, <span class="hlFld-ContribAuthor ">B.  Goodwin</span>. </span><span class="cited-content_cbyCitation_article-title">Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 771-779. <a href="https://doi.org/10.1039/C6MD00564K" title="DOI URL">https://doi.org/10.1039/C6MD00564K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00564K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00564K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSmall%252Bstructural%252Bchanges%252Bof%252Bthe%252Bimidazopyridine%252Bdiacylglycerol%252Bacyltransferase%252B2%252B%252528DGAT2%252529%252Binhibitors%252Bproduce%252Ban%252Bimproved%252Bsafety%252Bprofile%26aulast%3DFutatsugi%26aufirst%3DK.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D771%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyle J.  Eastman</span>, <span class="hlFld-ContribAuthor ">Kyle  Parcella</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Katharine A.  Grant-Young</span>, <span class="hlFld-ContribAuthor ">Juliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongxing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Yin</span>, <span class="hlFld-ContribAuthor ">Brett R.  Beno</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Adam G.  Jardel</span>, <span class="hlFld-ContribAuthor ">Vivek  Halan</span>, <span class="hlFld-ContribAuthor ">Kaushik  Ghosh</span>, <span class="hlFld-ContribAuthor ">Dawn  Parker</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Julie  Lemm</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Umesh  Hanumegowda</span>, <span class="hlFld-ContribAuthor ">Karen  Rigat</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Maria  Tuttle</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Zuzana  Haarhoff</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Soars</span>, <span class="hlFld-ContribAuthor ">Susan B.  Roberts</span>, <span class="hlFld-ContribAuthor ">John F.  Kadow</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 796-806. <a href="https://doi.org/10.1039/C6MD00636A" title="DOI URL">https://doi.org/10.1039/C6MD00636A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00636A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00636A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DThe%252Bdiscovery%252Bof%252Ba%252Bpan-genotypic%25252C%252Bprimer%252Bgrip%252Binhibitor%252Bof%252BHCV%252BNS5B%252Bpolymerase%26aulast%3DEastman%26aufirst%3DKyle%2BJ.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D796%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colin R.  Groom</span>, <span class="hlFld-ContribAuthor ">Jason C.  Cole</span>. </span><span class="cited-content_cbyCitation_article-title">The use of small-molecule structures to complement protein–ligand crystal structures in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Structural Biology</span><span> <strong>2017,</strong> <em>73 </em>
                                    (3)
                                     , 240-245. <a href="https://doi.org/10.1107/S2059798317000675" title="DOI URL">https://doi.org/10.1107/S2059798317000675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2059798317000675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2059798317000675%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Structural%2520Biology%26atitle%3DThe%252Buse%252Bof%252Bsmall-molecule%252Bstructures%252Bto%252Bcomplement%252Bprotein%2525E2%252580%252593ligand%252Bcrystal%252Bstructures%252Bin%252Bdrug%252Bdiscovery%26aulast%3DGroom%26aufirst%3DColin%2BR.%26date%3D2017%26date%3D2017%26volume%3D73%26issue%3D3%26spage%3D240%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (3)
                                     , 590-596. <a href="https://doi.org/10.1016/j.bmcl.2016.12.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-activity%252Brelationships%252Bof%252B4-hydroxy-4-biaryl-proline%252Bacylsulfonamide%252Btripeptides%25253A%252BA%252Bseries%252Bof%252Bpotent%252BNS3%252Bprotease%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bvirus%26aulast%3DWang%26aufirst%3DAlan%2BXiangdong%26date%3D2017%26volume%3D27%26issue%3D3%26spage%3D590%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric S.  Mull</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Betsy  Eggers</span>, <span class="hlFld-ContribAuthor ">Kevin  Pokornowski</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Melissa  Kramer</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Daniel  Tenney</span>, <span class="hlFld-ContribAuthor ">Carl J.  Baldick</span>, <span class="hlFld-ContribAuthor ">Mark I.  Cockett</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized triazines as potent HCV entry inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 1089-1093. <a href="https://doi.org/10.1016/j.bmcl.2016.12.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.12.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.12.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.12.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFunctionalized%252Btriazines%252Bas%252Bpotent%252BHCV%252Bentry%252Binhibitors%26aulast%3DMull%26aufirst%3DEric%2BS.%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D1089%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Nelson  Hayes</span>, <span class="hlFld-ContribAuthor ">Michio  Imamura</span>, <span class="hlFld-ContribAuthor ">Kazuaki  Chayama</span>. </span><span class="cited-content_cbyCitation_article-title">The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir + asunaprevir. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Gastroenterology & Hepatology</span><span> <strong>2017,</strong> <em>11 </em>
                                    (2)
                                     , 103-113. <a href="https://doi.org/10.1080/17474124.2017.1270205" title="DOI URL">https://doi.org/10.1080/17474124.2017.1270205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17474124.2017.1270205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17474124.2017.1270205%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DThe%252Bpractical%252Bmanagement%252Bof%252Bchronic%252Bhepatitis%252BC%252Binfection%252Bin%252BJapan%252B-%252Bdual%252Btherapy%252Bof%252Bdaclatasvir%252B%25252B%252Basunaprevir%26aulast%3DHayes%26aufirst%3DC.%2BNelson%26date%3D2017%26date%3D2016%26volume%3D11%26issue%3D2%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T  Rudd</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C virus NS3/4a protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2016,</strong> <em>30 </em>, 84-92. <a href="https://doi.org/10.1016/j.coph.2016.07.015" title="DOI URL">https://doi.org/10.1016/j.coph.2016.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2016.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2016.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DHepatitis%252BC%252Bvirus%252BNS3%25252F4a%252Bprotease%252Binhibitors%26aulast%3DMcCauley%26aufirst%3DJohn%2BA%26date%3D2016%26volume%3D30%26spage%3D84%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas J.  Osberger</span>, <span class="hlFld-ContribAuthor ">Donald C.  Rogness</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Kohrt</span>, <span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">M. Christina  White</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative diversification of amino acids and peptides by small-molecule iron catalysis. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2016,</strong> <em>537 </em>
                                    (7619)
                                     , 214-219. <a href="https://doi.org/10.1038/nature18941" title="DOI URL">https://doi.org/10.1038/nature18941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nature18941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnature18941%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DOxidative%252Bdiversification%252Bof%252Bamino%252Bacids%252Band%252Bpeptides%252Bby%252Bsmall-molecule%252Biron%252Bcatalysis%26aulast%3DOsberger%26aufirst%3DThomas%2BJ.%26date%3D2016%26date%3D2016%26volume%3D537%26issue%3D7619%26spage%3D214%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O. A.  Tevs</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Veremeichik</span>, <span class="hlFld-ContribAuthor ">D. N.  Shurpik</span>, <span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>. </span><span class="cited-content_cbyCitation_article-title">Acylated benzothiazinesulfoneamides: Synthesis and molecular structure. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2016,</strong> <em>86 </em>
                                    (8)
                                     , 1850-1853. <a href="https://doi.org/10.1134/S1070363216080120" title="DOI URL">https://doi.org/10.1134/S1070363216080120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363216080120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363216080120%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DAcylated%252Bbenzothiazinesulfoneamides%25253A%252BSynthesis%252Band%252Bmolecular%252Bstructure%26aulast%3DTevs%26aufirst%3DO.%2BA.%26date%3D2016%26date%3D2016%26volume%3D86%26issue%3D8%26spage%3D1850%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y.  Cheng</span>, <span class="hlFld-ContribAuthor ">L.  Ma</span>, <span class="hlFld-ContribAuthor ">S.-Y.  Chang</span>, <span class="hlFld-ContribAuthor ">W. G.  Humphreys</span>, <span class="hlFld-ContribAuthor ">W.  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Static Models to Predict Midazolam Clinical Interactions in the Presence of Single or Multiple Hepatitis C Virus Drugs. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2016,</strong> <em>44 </em>
                                    (8)
                                     , 1372-1380. <a href="https://doi.org/10.1124/dmd.116.070409" title="DOI URL">https://doi.org/10.1124/dmd.116.070409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.116.070409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.116.070409%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DApplication%252Bof%252BStatic%252BModels%252Bto%252BPredict%252BMidazolam%252BClinical%252BInteractions%252Bin%252Bthe%252BPresence%252Bof%252BSingle%252Bor%252BMultiple%252BHepatitis%252BC%252BVirus%252BDrugs%26aulast%3DCheng%26aufirst%3DY.%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1372%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">X.  Zhuo</span>, <span class="hlFld-ContribAuthor ">J. L.  Cantone</span>, <span class="hlFld-ContribAuthor ">Y.  Wang</span>, <span class="hlFld-ContribAuthor ">J. E.  Leet</span>, <span class="hlFld-ContribAuthor ">D. M.  Drexler</span>, <span class="hlFld-ContribAuthor ">K.-S.  Yeung</span>, <span class="hlFld-ContribAuthor ">X. S.  Huang</span>, <span class="hlFld-ContribAuthor ">K. J.  Eastman</span>, <span class="hlFld-ContribAuthor ">K. E.  Parcella</span>, <span class="hlFld-ContribAuthor ">K. W.  Mosure</span>, <span class="hlFld-ContribAuthor ">M. G.  Soars</span>, <span class="hlFld-ContribAuthor ">J. F.  Kadow</span>, <span class="hlFld-ContribAuthor ">B. M.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphocholine Conjugation: An Unexpected In Vivo Conjugation Pathway Associated with Hepatitis C NS5B Inhibitors Featuring A Bicyclo[1.1.1]Pentane. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2016,</strong> <em>44 </em>
                                    (8)
                                     , 1332-1340. <a href="https://doi.org/10.1124/dmd.115.069062" title="DOI URL">https://doi.org/10.1124/dmd.115.069062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.115.069062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.115.069062%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DPhosphocholine%252BConjugation%25253A%252BAn%252BUnexpected%252BIn%252BVivo%252BConjugation%252BPathway%252BAssociated%252Bwith%252BHepatitis%252BC%252BNS5B%252BInhibitors%252BFeaturing%252BA%252BBicyclo%25255B1.1.1%25255DPentane%26aulast%3DZhuo%26aufirst%3DX.%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1332%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Tailor-Made α-Amino Acids in the Pharmaceutical Industry: Synthetic Approaches to (1R,2S)-1-Amino-2-vinylcyclopropane-1-carboxylic Acid (Vinyl-ACCA). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (16)
                                     , 2757-2774. <a href="https://doi.org/10.1002/ejoc.201600112" title="DOI URL">https://doi.org/10.1002/ejoc.201600112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600112%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTailor-Made%252B%2525CE%2525B1-Amino%252BAcids%252Bin%252Bthe%252BPharmaceutical%252BIndustry%25253A%252BSynthetic%252BApproaches%252Bto%252B%2525281R%25252C2S%252529-1-Amino-2-vinylcyclopropane-1-carboxylic%252BAcid%252B%252528Vinyl-ACCA%252529%26aulast%3DSato%26aufirst%3DTatsunori%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D16%26spage%3D2757%26epage%3D2774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinod K.  Yadav</span>, <span class="hlFld-ContribAuthor ">Vishnu P.  Srivastava</span>, <span class="hlFld-ContribAuthor ">Lal Dhar S.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Visible light induced azidation of aldehydic C–H with carbon tetrabromide and sodium azide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (23)
                                     , 2502-2505. <a href="https://doi.org/10.1016/j.tetlet.2016.04.098" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.04.098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.04.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.04.098%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DVisible%252Blight%252Binduced%252Bazidation%252Bof%252Baldehydic%252BC%2525E2%252580%252593H%252Bwith%252Bcarbon%252Btetrabromide%252Band%252Bsodium%252Bazide%26aulast%3DYadav%26aufirst%3DVinod%2BK.%26date%3D2016%26volume%3D57%26issue%3D23%26spage%3D2502%26epage%3D2505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew C.  Flick</span>, <span class="hlFld-ContribAuthor ">Hong X.  Ding</span>, <span class="hlFld-ContribAuthor ">Carolyn A.  Leverett</span>, <span class="hlFld-ContribAuthor ">Robert E.  Kyne</span>, <span class="hlFld-ContribAuthor ">Kevin K.-C.  Liu</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Fink</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches to the 2014 new drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (9)
                                     , 1937-1980. <a href="https://doi.org/10.1016/j.bmc.2016.03.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Bto%252Bthe%252B2014%252Bnew%252Bdrugs%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2016%26volume%3D24%26issue%3D9%26spage%3D1937%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aki  Kawashima</span>, <span class="hlFld-ContribAuthor ">Shuangjie  Shu</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Takeda</span>, <span class="hlFld-ContribAuthor ">Akie  Kawamura</span>, <span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Hiroki  Moriwaki</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Advanced asymmetric synthesis of (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid by alkylation/cyclization of newly designed axially chiral Ni(II) complex of glycine Schiff base. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2016,</strong> <em>48 </em>
                                    (4)
                                     , 973-986. <a href="https://doi.org/10.1007/s00726-015-2138-3" title="DOI URL">https://doi.org/10.1007/s00726-015-2138-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-015-2138-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-015-2138-3%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DAdvanced%252Basymmetric%252Bsynthesis%252Bof%252B%2525281R%25252C2S%252529-1-amino-2-vinylcyclopropanecarboxylic%252Bacid%252Bby%252Balkylation%25252Fcyclization%252Bof%252Bnewly%252Bdesigned%252Baxially%252Bchiral%252BNi%252528II%252529%252Bcomplex%252Bof%252Bglycine%252BSchiff%252Bbase%26aulast%3DKawashima%26aufirst%3DAki%26date%3D2016%26date%3D2015%26volume%3D48%26issue%3D4%26spage%3D973%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingquan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Direct anti-HCV agents. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     , 26-31. <a href="https://doi.org/10.1016/j.apsb.2015.09.008" title="DOI URL">https://doi.org/10.1016/j.apsb.2015.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2015.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2015.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDirect%252Banti-HCV%252Bagents%26aulast%3DZhang%26aufirst%3DXingquan%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D26%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy  Eley</span>, <span class="hlFld-ContribAuthor ">Tushar  Garimella</span>, <span class="hlFld-ContribAuthor ">Wenying  Li</span>, <span class="hlFld-ContribAuthor ">Richard J.  Bertz</span>. </span><span class="cited-content_cbyCitation_article-title">Asunaprevir: A Review of Preclinical and Clinical Pharmacokinetics and Drug–Drug Interactions. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2015,</strong> <em>54 </em>
                                    (12)
                                     , 1205-1222. <a href="https://doi.org/10.1007/s40262-015-0299-6" title="DOI URL">https://doi.org/10.1007/s40262-015-0299-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-015-0299-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-015-0299-6%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DAsunaprevir%25253A%252BA%252BReview%252Bof%252BPreclinical%252Band%252BClinical%252BPharmacokinetics%252Band%252BDrug%2525E2%252580%252593Drug%252BInteractions%26aulast%3DEley%26aufirst%3DTimothy%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D12%26spage%3D1205%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuhisa  Akamatsu</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Sugawara</span>, <span class="hlFld-ContribAuthor ">Norihiro  Kokudo</span>. </span><span class="cited-content_cbyCitation_article-title">Asunaprevir (BMS-650032) for the treatment of hepatitis C virus. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anti-infective Therapy</span><span> <strong>2015,</strong> <em>13 </em>
                                    (11)
                                     , 1307-1317. <a href="https://doi.org/10.1586/14787210.2015.1091724" title="DOI URL">https://doi.org/10.1586/14787210.2015.1091724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14787210.2015.1091724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14787210.2015.1091724%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anti-infective%2520Therapy%26atitle%3DAsunaprevir%252B%252528BMS-650032%252529%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bvirus%26aulast%3DAkamatsu%26aufirst%3DNobuhisa%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D11%26spage%3D1307%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan  Gentile</span>, <span class="hlFld-ContribAuthor ">Emanuela  Zappulo</span>, <span class="hlFld-ContribAuthor ">Antonio Riccardo  Buonomo</span>, <span class="hlFld-ContribAuthor ">Riccardo  Scotto</span>, <span class="hlFld-ContribAuthor ">Guglielmo  Borgia</span>. </span><span class="cited-content_cbyCitation_article-title">Asunaprevir for hepatitis C: a safety evaluation. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Safety</span><span> <strong>2015,</strong> <em>14 </em>
                                    (10)
                                     , 1631-1646. <a href="https://doi.org/10.1517/14740338.2015.1084287" title="DOI URL">https://doi.org/10.1517/14740338.2015.1084287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14740338.2015.1084287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14740338.2015.1084287%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Safety%26atitle%3DAsunaprevir%252Bfor%252Bhepatitis%252BC%25253A%252Ba%252Bsafety%252Bevaluation%26aulast%3DGentile%26aufirst%3DIvan%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D10%26spage%3D1631%26epage%3D1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen W.  Mosure</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Marc  Browning</span>, <span class="hlFld-ContribAuthor ">Vinod  Arora</span>, <span class="hlFld-ContribAuthor ">Yue-Zhong  Shu</span>, <span class="hlFld-ContribAuthor ">Thomas  Phillip</span>, <span class="hlFld-ContribAuthor ">Fiona  Mcphee</span>, <span class="hlFld-ContribAuthor ">Paul  Scola</span>, <span class="hlFld-ContribAuthor ">Anand  Balakrishnan</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Soars</span>, <span class="hlFld-ContribAuthor ">Kenneth  Santone</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Sciences</span><span> <strong>2015,</strong> <em>104 </em>
                                    (9)
                                     , 2813-2823. <a href="https://doi.org/10.1002/jps.24356" title="DOI URL">https://doi.org/10.1002/jps.24356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jps.24356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjps.24356%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPreclinical%252BPharmacokinetics%252Band%252BIn%252BVitro%252BMetabolism%252Bof%252BAsunaprevir%252B%252528BMS-650032%252529%25252C%252Ba%252BPotent%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252BInhibitor%26aulast%3DMosure%26aufirst%3DKathleen%2BW.%26date%3D2015%26volume%3D104%26issue%3D9%26spage%3D2813%26epage%3D2823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-Shun  Yang</span>, <span class="hlFld-ContribAuthor ">Jia-Horng  Kao</span>. </span><span class="cited-content_cbyCitation_article-title">Asunaprevir-containing regimens for the treatment of hepatitis C virus infection. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Gastroenterology & Hepatology</span><span> <strong>2015,</strong> <em>9 </em>
                                    (1)
                                     , 9-20. <a href="https://doi.org/10.1586/17474124.2014.953930" title="DOI URL">https://doi.org/10.1586/17474124.2014.953930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17474124.2014.953930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17474124.2014.953930%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DAsunaprevir-containing%252Bregimens%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bvirus%252Binfection%26aulast%3DYang%26aufirst%3DSheng-Shun%26date%3D2015%26date%3D2014%26volume%3D9%26issue%3D1%26spage%3D9%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aki  Kawashima</span>, <span class="hlFld-ContribAuthor ">Chen  Xie</span>, <span class="hlFld-ContribAuthor ">Haibo  Mei</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Takeda</span>, <span class="hlFld-ContribAuthor ">Akie  Kawamura</span>, <span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Hiroki  Moriwaki</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">Jianlin  Han</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid by sequential S
              N
              2–S
              N
              2′ dialkylation of (R)-N-(benzyl)proline-derived glycine Schiff base Ni(
              ii
              ) complex. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (2)
                                     , 1051-1058. <a href="https://doi.org/10.1039/C4RA12658K" title="DOI URL">https://doi.org/10.1039/C4RA12658K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA12658K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA12658K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252B%2525281R%25252C2S%252529-1-amino-2-vinylcyclopropanecarboxylic%252Bacid%252Bby%252Bsequential%252BS%252BN%252B2%2525E2%252580%252593S%252BN%252B2%2525E2%252580%2525B2%252Bdialkylation%252Bof%252B%252528R%252529-N-%252528benzyl%252529proline-derived%252Bglycine%252BSchiff%252Bbase%252BNi%252528%252Bii%252B%252529%252Bcomplex%26aulast%3DKawashima%26aufirst%3DAki%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D2%26spage%3D1051%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Chandramohan</span>, <span class="hlFld-ContribAuthor ">Anubhav  Kaphle</span>, <span class="hlFld-ContribAuthor ">Mamatha  Chekuri</span>, <span class="hlFld-ContribAuthor ">Sindhu  Gangarudraiah</span>, <span class="hlFld-ContribAuthor ">Gowrishankar  Bychapur Siddaiah</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluating Andrographolide as a Potent Inhibitor of NS3-4A Protease and Its Drug-Resistant Mutants Using
              In Silico
              Approaches. </span><span class="cited-content_cbyCitation_journal-name">Advances in Virology</span><span> <strong>2015,</strong> <em>2015 </em>, 1-9. <a href="https://doi.org/10.1155/2015/972067" title="DOI URL">https://doi.org/10.1155/2015/972067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/972067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F972067%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520in%2520Virology%26atitle%3DEvaluating%252BAndrographolide%252Bas%252Ba%252BPotent%252BInhibitor%252Bof%252BNS3-4A%252BProtease%252Band%252BIts%252BDrug-Resistant%252BMutants%252BUsing%252BIn%252BSilico%252BApproaches%26aulast%3DChandramohan%26aufirst%3DVivek%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Stevenazzi</span>, <span class="hlFld-ContribAuthor ">Mattia  Marchini</span>, <span class="hlFld-ContribAuthor ">Giovanni  Sandrone</span>, <span class="hlFld-ContribAuthor ">Barbara  Vergani</span>, <span class="hlFld-ContribAuthor ">Maria  Lattanzio</span>. </span><span class="cited-content_cbyCitation_article-title">Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (23)
                                     , 5349-5356. <a href="https://doi.org/10.1016/j.bmcl.2014.10.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAmino%252Bacidic%252Bscaffolds%252Bbearing%252Bunnatural%252Bside%252Bchains%25253A%252BAn%252Bold%252Bidea%252Bgenerates%252Bnew%252Band%252Bversatile%252Btools%252Bfor%252Bthe%252Blife%252Bsciences%26aulast%3DStevenazzi%26aufirst%3DAndrea%26date%3D2014%26volume%3D24%26issue%3D23%26spage%3D5349%26epage%3D5356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan C.  Dickinson</span>, <span class="hlFld-ContribAuthor ">Michael S.  Packer</span>, <span class="hlFld-ContribAuthor ">Ahmed H.  Badran</span>, <span class="hlFld-ContribAuthor ">David R.  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A system for the continuous directed evolution of proteases rapidly reveals drug-resistance mutations. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2014,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms6352" title="DOI URL">https://doi.org/10.1038/ncomms6352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms6352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms6352%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DA%252Bsystem%252Bfor%252Bthe%252Bcontinuous%252Bdirected%252Bevolution%252Bof%252Bproteases%252Brapidly%252Breveals%252Bdrug-resistance%252Bmutations%26aulast%3DDickinson%26aufirst%3DBryan%2BC.%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  De Luca</span>, <span class="hlFld-ContribAuthor ">Claudia  Bianco</span>, <span class="hlFld-ContribAuthor ">Barbara  Rossetti</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of HCV infection with the novel NS3/4A protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2014,</strong> <em>18 </em>, 9-17. <a href="https://doi.org/10.1016/j.coph.2014.07.016" title="DOI URL">https://doi.org/10.1016/j.coph.2014.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2014.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2014.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DTreatment%252Bof%252BHCV%252Binfection%252Bwith%252Bthe%252Bnovel%252BNS3%25252F4A%252Bprotease%252Binhibitors%26aulast%3DDe%2BLuca%26aufirst%3DAndrea%26date%3D2014%26volume%3D18%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bradley Croy  Doak</span>, <span class="hlFld-ContribAuthor ">Bjӧrn  Over</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Giordanetto</span>, <span class="hlFld-ContribAuthor ">Jan  Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biology</span><span> <strong>2014,</strong> <em>21 </em>
                                    (9)
                                     , 1115-1142. <a href="https://doi.org/10.1016/j.chembiol.2014.08.013" title="DOI URL">https://doi.org/10.1016/j.chembiol.2014.08.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2014.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2014.08.013%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biology%26atitle%3DOral%252BDruggable%252BSpace%252Bbeyond%252Bthe%252BRule%252Bof%252B5%25253A%252BInsights%252Bfrom%252BDrugs%252Band%252BClinical%252BCandidates%26aulast%3DDoak%26aufirst%3DBradley%25C2%25A0Croy%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D1115%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Paul  Scola</span>, <span class="hlFld-ContribAuthor ">Fiona  Mcphee</span>, <span class="hlFld-ContribAuthor ">Jay  Knipe</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>, <span class="hlFld-ContribAuthor ">Vinod  Arora</span>, <span class="hlFld-ContribAuthor ">Gary  Pilcher</span>, <span class="hlFld-ContribAuthor ">Kenneth  Santone</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-605339: A Novel HCV NS3 Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Sciences</span><span> <strong>2014,</strong> <em>103 </em>
                                    (6)
                                     , 1891-1902. <a href="https://doi.org/10.1002/jps.23959" title="DOI URL">https://doi.org/10.1002/jps.23959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jps.23959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjps.23959%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPreclinical%252BPharmacokinetics%252Band%252BIn%252BVitro%252BMetabolism%252Bof%252BBMS-605339%25253A%252BA%252BNovel%252BHCV%252BNS3%252BProtease%252BInhibitor%26aulast%3DJenkins%26aufirst%3DSusan%26date%3D2014%26volume%3D103%26issue%3D6%26spage%3D1891%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of BMS-605339 (<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of BMS-605339 (<b>1</b>) on heart rate (A), sinus node recovery time (B), and PR interval (C) in anesthetized rabbits administered 1, 3, and 10 mg/kg by IV infusion. Plasma concentrations are depicted in (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of BMS-605339 (<b>1</b>) on HR and SNRT in a isolated rabbit heart preparation perfused with 0.3, 1, 3, and 10 μM of drug in protein-free medium. Hearts were perfused with each concentration of <b>1</b> (unbound) for ∼12 min. Mean ± SEM, <i>n</i> = 4 hearts/group. *<i>P</i> < 0.05, **<i>P</i> < 0.01 versus vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect on HR and SNRT in an isolated rabbit heart preparation perfused with a single concentration ≤1 μM of BMS-605339 (<b>1</b>) for 60 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a–d) Compounds <b>9</b>, <b>10</b>, <b>1</b>, and <b>8</b> bound to NS3/4A. (c) Crystal structure representation of the P2* region of compound <b>1</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> with the NS3/4A enzyme, whereas (a), (b), and (d) are computationally derived models of the bound modes of compounds <b>9</b>, <b>10</b>, and 8.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A comparison of results in the isolated heart model for compounds <b>1</b> and <b>24</b>. Compounds were perfused for 60 min at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Depiction of observed interproton NOE contacts in <b>24</b> (a) and <b>1</b> (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Crystal structure of <b>1</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and <b>24</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> bound to the HCV NS3/4A enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Key Fragments in the Synthesis of <b>24</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fragment <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DPPA, Et<sub>3</sub>N, benzene, rt; (b) Ph<sub>2</sub>CH<sub>2</sub>, reflux, 53% overall for two steps; (c) NBS, MeCN, reflux, 90%; (d) POCl<sub>3</sub>, reflux, 73%; (e) (1) <i>n</i>-Bu-Li, THF, −78 °C, (2) (<i>i</i>-PrO)<sub>3</sub>B, −78 °C; (3) 50% H<sub>2</sub>O<sub>2</sub>, Na<sub>2</sub>SO<sub>3</sub> −78 °C, 82% overall three steps; (f) MeOH, MeCN, TMSCHN<sub>2</sub>, 0 °C–rt, 66% or MeI, NaH, DMF, 4 °C, 96%; (g) <i>N</i>-Boc-3-(<i>R</i>)-hydroxy-<span class="smallcaps smallerCapital">l</span>-proline, <i>t</i>-BuOK, DMSO, 10 °C.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Coupling of Fragments for the Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, Hunig’s base <i>i</i>-Pr<sub>2</sub>Net, (1<i>R</i>,2<i>S</i>)-1-amino-<i>N</i>-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide (TsOH salt, <b>35</b>), rt, 88%; (b) HCl (conc), MeOH, reflux, 100%; (c) HATU, Hunig’s base, <i>N</i>-Boc-<i>t</i>-butyl-<span class="smallcaps smallerCapital">l</span>-glycine (<b>33</b>), DCM, 0 °C–rt, 94%.</p></p></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Single crystal X-ray structure of the hydrate of <b>24</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In the preparation of crystalline <b>24</b>, amorphous material was dissolved in methanol and water was added as an antisolvent. Prism or plate-shaped crystals were obtained which provided monohydrate crystals upon standing under ambient conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/medium/jm-2014-00297k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0010.jpeg" id="rightTab-GRAPHIC-d8688e2432-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Expanded regions of 2d-NOE spectra for <b>24</b> (a) and <b>1</b> (b). Sample solutions were ∼0.2 mM of compound 24 (a) and 1 (b) in 70% H<sub>2</sub>O (NaPO<sub>4</sub> buffer of 10 mM, pH = 6.3) and 30% DMSO-<i>d</i><sub>6</sub>. Spectra were acquired on a Bruker 700 MHz spectrometer equipped with a TCI cryo-probe, the sample temperature was 20.0 °C. The proton spectral traces along the borders of the NOESY spectral panel are from imported proton spectra. All spectra were processed in topspin with cosine apodizations in both time domains. NOESY spectra were acquired in a block-averaged mode of four times four scans per per t1-increment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm500297k/production/images/large/jm-2014-00297k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500297k&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Scola, P. M.; Wang, A.; Good, A. C; Sun, L.; Combrink, K. D.; Campbell, J. A.; Chen, J.; Tu, Y.; Sin, N.; Venables, B. L.; Sit, S. Y.; Chen, Y.; Cocuzza, A.; Bilder, D. M.; D’Andrea, S.; Zheng, B.; Hewawasam, P.; Ding, M.; Thuring, J.; Hernandez, D.; Yu, F.; Falk, P.; Zhai, G.; Sheaffer, A. K.; Chen, C.; Lee, M. S.; Barry, D.; Knipe, J. O.; Han, Y. H.; Jenkins, S.; Gesenberg, C.; Sinz, M. W.; Santone, K. S.; Zvyaga, T.; Rajamani, R.; Klei, H. E.; Colonno, R. J.; Grasela, D. M.; Hughes, E.; Chien, C.; Adams, S.; Levesque, P. C.; Li, D.; Zhu, J.; Meanwell, N. A.; McPhee, F.</span><span> </span><span class="NLM_article-title">Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1021/jm401840s</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm401840s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+M.+Scola&author=A.+Wang&author=A.+C+Good&author=L.+Sun&author=K.+D.+Combrink&author=J.+A.+Campbell&author=J.+Chen&author=Y.+Tu&author=N.+Sin&author=B.+L.+Venables&author=S.+Y.+Sit&author=Y.+Chen&author=A.+Cocuzza&author=D.+M.+Bilder&author=S.+D%E2%80%99Andrea&author=B.+Zheng&author=P.+Hewawasam&author=M.+Ding&author=J.+Thuring&author=D.+Hernandez&author=F.+Yu&author=P.+Falk&author=G.+Zhai&author=A.+K.+Sheaffer&author=C.+Chen&author=M.+S.+Lee&author=D.+Barry&author=J.+O.+Knipe&author=Y.+H.+Han&author=S.+Jenkins&author=C.+Gesenberg&author=M.+W.+Sinz&author=K.+S.+Santone&author=T.+Zvyaga&author=R.+Rajamani&author=H.+E.+Klei&author=R.+J.+Colonno&author=D.+M.+Grasela&author=E.+Hughes&author=C.+Chien&author=S.+Adams&author=P.+C.+Levesque&author=D.+Li&author=J.+Zhu&author=N.+A.+Meanwell&author=F.+McPhee&title=Discovery+and+early+clinical+evaluation+of+BMS-605339%2C+a+potent+and+orally+efficacious+tripeptidic+acylsulfonamide+NS3+protease+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection&doi=10.1021%2Fjm401840s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm401840s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401840s%26sid%3Dliteratum%253Aachs%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DDiscovery%2520and%2520early%2520clinical%2520evaluation%2520of%2520BMS-605339%252C%2520a%2520potent%2520and%2520orally%2520efficacious%2520tripeptidic%2520acylsulfonamide%2520NS3%2520protease%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm401840s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poliakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerblom, E. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2551-2568&author=A.+Johanssonauthor=A.+Poliakovauthor=E.+A+Kerblomauthor=K.+Wiklundauthor=G.+Lindebergauthor=S.+Winiwarterauthor=U.+H.+Danielsonauthor=B.+Samuelssonauthor=A.+Hallberg&title=Acyl+sulfonamides+as+potent+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3+%28protease-helicase%2FNTPase%29%3A+a+comparative+study+of+different+C-terminals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DPoliakov%26aufirst%3DA.%26aulast%3DKerblom%26aufirst%3DE.%2BA%26aulast%3DWiklund%26aufirst%3DK.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DAcyl%2520sulfonamides%2520as%2520potent%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%2520%2528protease-helicase%252FNTPase%2529%253A%2520a%2520comparative%2520study%2520of%2520different%2520C-terminals%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2551%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1448-1474&author=P.+Oertqvistauthor=S.+D.+Petersonauthor=E.+Aakerblomauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=R.+Franssonauthor=G.+Lindebergauthor=U.+H.+Danielsonauthor=A.+Karlenauthor=A.+Sandstroem&title=Phenylglycine+as+a+novel+P2+scaffold+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DS.%2BD.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DFransson%26aufirst%3DR.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DPhenylglycine%2520as%2520a%2520novel%2520P2%2520scaffold%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1448%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daoud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4057</span><span class="NLM_x">–</span> <span class="NLM_lpage">4068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=4057-4068&author=R.+Roennauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=H.+Daoudauthor=E.+Aakerblomauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Evaluation+of+a+diverse+set+of+potential+P1+carboxylic+acid+bioisosteres+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DDaoud%26aufirst%3DH.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520a%2520diverse%2520set%2520of%2520potential%2520P1%2520carboxylic%2520acid%2520bioisosteres%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D4057%26epage%3D4068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Baeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waangsell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorstensson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvarnstroem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7184</span><span class="NLM_x">–</span> <span class="NLM_lpage">7202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7184-7202&author=M.+Baeckauthor=P.-O.+Johanssonauthor=F.+Waangsellauthor=F.+Thorstenssonauthor=I.+Kvarnstroemauthor=S.+Ayesaauthor=H.+Waehlingauthor=M.+Pelcmanauthor=K.+Janssonauthor=S.+Lindstroemauthor=H.+Wallbergauthor=B.+Classonauthor=C.+Ryderg%C3%A5rdauthor=L.+Vrangauthor=E.+Hamelinkauthor=A.+Hallbergauthor=A.+Rosenquistauthor=B.+Samuelsson&title=Novel+potent+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+use+of+cyclopentane+and+cyclopentene+P2-motifs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaeck%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DWaangsell%26aufirst%3DF.%26aulast%3DThorstensson%26aufirst%3DF.%26aulast%3DKvarnstroem%26aufirst%3DI.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWallberg%26aufirst%3DH.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DNovel%2520potent%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520use%2520of%2520cyclopentane%2520and%2520cyclopentene%2520P2-motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7184%26epage%3D7202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span> </span><span class="NLM_article-title">Potent triazolyl-proline-based inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3400-3404&author=J.+Naudauthor=C.+Lemkeauthor=N.+Goudreauauthor=E.+Beaulieuauthor=P.+D.+Whiteauthor=M.+Llinas-Brunetauthor=P.+Forgione&title=Potent+triazolyl-proline-based+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DLemke%26aufirst%3DC.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DBeaulieu%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DP.%2BD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DForgione%26aufirst%3DP.%26atitle%3DPotent%2520triazolyl-proline-based%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3400%26epage%3D3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%80%93activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraznenok, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2g&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1002%2Fanie.200906696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2g&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1652-1655&author=M.+D.+Cummingsauthor=J.+Lindbergauthor=T.-I.+Linauthor=H.+de+Kockauthor=O.+Lenzauthor=E.+Liljaauthor=S.+Fellanderauthor=V.+Baraznenokauthor=S.+Nystromauthor=M.+Nilssonauthor=L.+Vrangauthor=M.+Edlundauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+Raboissonauthor=K.+Simmen&title=Induced-fit+binding+of+the+macrocyclic+noncovalent+inhibitor+TMC435+to+its+HCV+NS3%2FNS4A+protease+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2gR"><div class="casContent"><span class="casTitleNuber">2g</span><div class="casTitle"><span class="NLM_cas:atitle">Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target</span></div><div class="casAuthors">Cummings, Maxwell D.; Lindberg, Jimmy; Lin, Tse-I.; de Kock, Herman; Lenz, Oliver; Lilja, Elisabet; Fellander, Sara; Baraznenok, Vera; Nystrom, Susanne; Nilsson, Magnus; Vrang, Lotta; Edlund, Michael; Rosenquist, Asa; Samuelsson, Bertil; Raboisson, Pierre; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1652-1655, S1652/1-S1652/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of the macrocyclic inhibitor TMC435 bound to its HCV NS3/4A protease target at a resoln. of 2.4 Å, providing at. detail of induced fit to an extended S2 subsite.  The complex structure helps to rationalize the impact of key modifications in the optimization path that led to 1, and is guiding our understanding of resistance patterns.  Future modeling and structure-based design efforts aimed at NS3/NS4A protease should benefit from the new structure, which represents the first example of a noncovalent NS3/NS4A protease-inhibitor complex deposited in the PDB and details the induced fit involved in accommodating a large P2 substituent.  Inhibitors with large P2 groups that occupy the extended S2 subsite probe the crystallog. obsd. helicase-protease interface, and it is hoped that future studies will clarify the relevance of interfacial contacts to protease activity and protease inhibitor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEYqCPA57hLVg90H21EOLACvtfcHk0li_MZwNzLGdSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D&md5=535b340784d1af62df32e8cf3bd3fe87</span></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906696%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DLilja%26aufirst%3DE.%26aulast%3DFellander%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DInduced-fit%2520binding%2520of%2520the%2520macrocyclic%2520noncovalent%2520inhibitor%2520TMC435%2520to%2520its%2520HCV%2520NS3%252FNS4A%2520protease%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1652%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5095</span><span class="NLM_x">–</span> <span class="NLM_lpage">5100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5095-5100&author=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=M.+Nilssonauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmen&title=Discovery+of+novel+potent+and+selective+dipeptide+hepatitis+C+virus+NS3%2F4A+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520potent%2520and%2520selective%2520dipeptide%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5095%26epage%3D5100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dooren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindermans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span> </span><span class="NLM_article-title">Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6189</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6189-6193&author=S.+Vendevilleauthor=M.+Nilssonauthor=H.+de+Kockauthor=T.-I.+Linauthor=D.+Antonovauthor=B.+Classonauthor=S.+Ayesaauthor=V.+Ivanovauthor=P.-O.+Johanssonauthor=P.+Kahnbergauthor=A.+Enerothauthor=K.+Wikstromauthor=L.+Vrangauthor=M.+Edlundauthor=S.+Lindstr%C3%B6mauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=M.+Van+Doorenauthor=N.+Kindermansauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmenauthor=P.+Raboisson&title=Discovery+of+novel%2C+potent+and+bioavailable+proline-urea+based+macrocyclic+HCV+NS3%2F4A+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DAntonov%26aufirst%3DD.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DWikstrom%26aufirst%3DK.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DVan%2BDooren%26aufirst%3DM.%26aulast%3DKindermans%26aufirst%3DN.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520novel%252C%2520potent%2520and%2520bioavailable%2520proline-urea%2520based%2520macrocyclic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6189%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belfrage, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agback, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terelius, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of potent inhibitors of the hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4004</span><span class="NLM_x">–</span> <span class="NLM_lpage">4011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4004-4011&author=M.+Nilssonauthor=A.+K.+Belfrageauthor=S.+Lindstroemauthor=H.+Waehlingauthor=C.+Lindquistauthor=S.+Ayesaauthor=P.+Kahnbergauthor=M.+Pelcmanauthor=K.+Benkestockauthor=T.+Agbackauthor=L.+Vrangauthor=Y.+Tereliusauthor=K.+Wikstr%C3%B6mauthor=E.+Hamelinkauthor=C.+Ryderg%C3%A5rdauthor=M.+Edlundauthor=A.+Enerothauthor=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=P.+Wigerinckauthor=K.+Simmenauthor=B.+Samuelssonauthor=A.+Rosenquist&title=Synthesis+and+SAR+of+potent+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease%3A+exploration+of+P2+quinazoline+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DBelfrage%26aufirst%3DA.%2BK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DLindquist%26aufirst%3DC.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DAgback%26aufirst%3DT.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DTerelius%26aufirst%3DY.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRosenquist%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520potent%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%253A%2520exploration%2520of%2520P2%2520quinazoline%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4004%26epage%3D4011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Lampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5413</span><span class="NLM_x">–</span> <span class="NLM_lpage">5424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2k&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1016%2Fj.bmc.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2k&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=20541424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2k&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5413-5424&author=A.+Lampaauthor=A.+E.+Ehrenbergauthor=S.+S.+Gustafssonauthor=A.+Vemaauthor=E.+Aakerblomauthor=G.+Lindebergauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Improved+P2+phenylglycine-based+hepatitis+C+virus+NS3+protease+inhibitors+with+alkenylic+prime-side+substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2kR"><div class="casContent"><span class="casTitleNuber">2k</span><div class="casTitle"><span class="NLM_cas:atitle">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span></div><div class="casAuthors">Lampa, Anna; Ehrenberg, Angelica E.; Gustafsson, Sofia S.; Vema, Aparna; Aakerblom, Eva; Lindeberg, Gunnar; Karlen, Anders; Danielson, U. Helena; Sandstroem, Anja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5413-5424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phenylglycine has proven to be a useful P2 residue in HCV NS3 protease inhibitors.  A novel π-π-interaction between the phenylglycine and the catalytic H57 residue of the protease was postulated, and it was hypothesized that the introduction of a vinyl on the phenylglycine might strengthen this π-π-interaction.  Thus, a series of acyclic vinylated phenylglycine-based HCV NS3 protease inhibitors, e.g., I, was synthesized and their inhibitory potency evaluated.  Surprisingly, inhibitors based on both D- and L-phenylglycine were found to be effective inhibitors, with a slight preference for the D-epimers.  Furthermore, prime-side alkenylic extension of the C-terminal acylsulfonamide group gave significantly improved inhibitors with potencies in the nanomolar range (∼35 nM), potencies which were retained on mutant variants of the protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1S6r1UZnWFrVg90H21EOLACvtfcHk0lhdJYmvXArw-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D&md5=53f795b5eba3e0b2d27e74fd504229a0</span></div><a href="/servlet/linkout?suffix=cit2k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DLampa%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DGustafsson%26aufirst%3DS.%2BS.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DImproved%2520P2%2520phenylglycine-based%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%2520with%2520alkenylic%2520prime-side%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5413%26epage%3D5424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gising, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larhed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1<i>H</i>)-pyrazinones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6512-6525&author=P.+Oertqvistauthor=J.+Gisingauthor=A.+E.+Ehrenbergauthor=A.+Vemaauthor=A.+Borgauthor=A.+Karlenauthor=M.+Larhedauthor=U.+H+Danielsonauthor=A.+Sandstroem&title=Discovery+of+achiral+inhibitors+of+the+hepatitis+C+virus+NS3+protease+based+on+2%281H%29-pyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DGising%26aufirst%3DJ.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DBorg%26aufirst%3DA.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DDanielson%26aufirst%3DU.%2BH%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520achiral%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520based%2520on%25202%25281H%2529-pyrazinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6512%26epage%3D6525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aekerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=841-852&author=P.+Oertqvistauthor=A.+Vemaauthor=A.+E.+Ehrenbergauthor=G.+Dahlauthor=R.+Roennauthor=E.+Aekerblomauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Structure%E2%80%93activity+relationships+of+HCV+NS3+protease+inhibitors+evaluated+on+the+drug-resistant+variants+A156T+and+D168V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DAekerblom%26aufirst%3DE.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%2520evaluated%2520on%2520the%2520drug-resistant%2520variants%2520A156T%2520and%2520D168V%26jtitle%3DAntiviral%2520Ther.%26date%3D2010%26volume%3D15%26spage%3D841%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7317</span><span class="NLM_x">–</span> <span class="NLM_lpage">7322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7317-7322&author=C.+Z.+Dingauthor=Y.-K.+Zhangauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=L.+Liuauthor=M.+Duanauthor=R.+L.+Jarvestauthor=J.+Jiauthor=W.+M.+Kazmierskiauthor=M.+D.+Tallantauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+M.+Crosbyauthor=A.+A.+Wangauthor=Z.-J.+Niauthor=W.+Zoueauthor=J.+Wright&title=Synthesis+and+biological+evaluations+of+P4-benzoxaborole-substituted+macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DA.%2BA.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DZoue%26aufirst%3DW.%26aulast%3DWright%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%2520P4-benzoxaborole-substituted%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7317%26epage%3D7322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2993</span><span class="NLM_x">–</span> <span class="NLM_lpage">2996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2993-2996&author=M.+Duanauthor=W.+Kazmierskiauthor=R.+Crosbyauthor=M.+Gartlandauthor=J.+Jiauthor=M.+Tallantauthor=A.+Wangauthor=R.+Hamatakeauthor=L.+Wrightauthor=M.+Wuauthor=Y.-K.+Zhangauthor=C.+Z.+Dingauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Baker&title=Discovery+of+novel+P3-oxo+inhibitor+of+hepatitis+C+virus+NS3%2F4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DCrosby%26aufirst%3DR.%26aulast%3DGartland%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DTallant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520P3-oxo%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2993%26epage%3D2996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3021</span><span class="NLM_x">–</span> <span class="NLM_lpage">3026</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201278q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2p&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3021-3026&author=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wangauthor=X.+Liauthor=S.+Zhangauthor=Y.-Y.+Zhangauthor=Y.+Liuauthor=C.+Z.+Dingauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liu&title=Discovery+of+novel+urea-based+hepatitis+C+protease+inhibitors+with+high+potency+against+protease-inhibitor-resistant+mutants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2pR"><div class="casContent"><span class="casTitleNuber">2p</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Hamatake, Robert; Duan, Maosheng; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Wang, Amy; Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3021-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors were prepd. and characterized in replicase HCV protease-resistant mutants assay.  Several compds., exemplified by I, were found to be more potent in HCV replicon assays than leading second generation inhibitors such as danoprevir and TMC-435350.  Addnl., following oral administration, inhibitor I was found in rat liver in significantly higher concns. than those reported for both danoprevir and TMC-435350, suggesting that inhibitor I has the combination of anti-HCV and pharmacokinetic properties that warrants further development of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZf8snkMwqSrVg90H21EOLACvtfcHk0lhVlZhouh55JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D&md5=43f9016626357a5fea8d6d1e9784e2d8</span></div><a href="/servlet/linkout?suffix=cit2p&amp;dbid=16384&amp;doi=10.1021%2Fjm201278q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201278q%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.-Y.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520urea-based%2520hepatitis%2520C%2520protease%2520inhibitors%2520with%2520high%2520potency%2520against%2520protease-inhibitor-resistant%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3021%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2q&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.-S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2qR"><div class="casContent"><span class="casTitleNuber">2q</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">McCauley, John A.; McIntyre, Charles J.; Rudd, Michael T.; Nguyen, Kevin T.; Romano, Joseph J.; Butcher, John W.; Gilbert, Kevin F.; Bush, Kimberly J.; Holloway, M. Katharine; Swestock, John; Wan, Bang-Lin; Carroll, Steven S.; DiMuzio, Jillian M.; Graham, Donald J.; Ludmerer, Steven W.; Mao, Shi-Shan; Stahlhut, Mark W.; Fandozzi, Christine M.; Trainor, Nicole; Olsen, David B.; Vacca, Joseph P.; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2443-2463</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a mol.-modeling derived strategy.  Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compds. via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate vaniprevir, MK-7009, which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_2CVs9I1H_7Vg90H21EOLACvtfcHk0lhVlZhouh55JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D&md5=dc820c588d5482f6913091a87eaf9af1</span></div><a href="/servlet/linkout?suffix=cit2q&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2443%26epage%3D2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2–P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2%E2%80%93P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2r&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2%25E2%2580%2593P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, I. I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bismacrocyclic, N. J.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=I.+I.+I.+Carrollauthor=S.+S.+DiMuzioauthor=J.+Stahlhutauthor=M.+W.+Olsenauthor=D.+B.+Lyleauthor=T.+A.+Vaccaauthor=J.+P.+Livertonauthor=N.+J.+Bismacrocyclic&title=Inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DI.%2BI.%2BI.%26aulast%3DDiMuzio%26aufirst%3DS.%2BS.%26aulast%3DStahlhut%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DM.%2BW.%26aulast%3DLyle%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DT.%2BA.%26aulast%3DLiverton%26aufirst%3DJ.%2BP.%26aulast%3DBismacrocyclic%26aufirst%3DN.%2BJ.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the hepatitis C virus NS3 protease with basic amine functionality at the P3-amino acid N-terminus: discovery and optimization of a new series of P2–P4 macrocycles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4820</span><span class="NLM_x">–</span> <span class="NLM_lpage">4837</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900372w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4820-4837&author=S.+Harperauthor=M.+Ferraraauthor=B.+Crescenziauthor=M.+Pompeiauthor=M.+C.+Palumbiauthor=J.+M.+Di+Muzioauthor=M.+Donghiauthor=F.+Fioreauthor=U.+Kochauthor=N.+J.+Livertonauthor=S.+Pesciauthor=A.+Petrocchiauthor=M.+Rowleyauthor=V.+Summaauthor=C.+Gardelli&title=Inhibitors+of+the+hepatitis+C+virus+NS3+protease+with+basic+amine+functionality+at+the+P3-amino+acid+N-terminus%3A+discovery+and+optimization+of+a+new+series+of+P2%E2%80%93P4+macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2t&amp;dbid=16384&amp;doi=10.1021%2Fjm900372w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900372w%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DPalumbi%26aufirst%3DM.%2BC.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%2BM.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520with%2520basic%2520amine%2520functionality%2520at%2520the%2520P3-amino%2520acid%2520N-terminus%253A%2520discovery%2520and%2520optimization%2520of%2520a%2520new%2520series%2520of%2520P2%25E2%2580%2593P4%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4820%26epage%3D4837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Di Francesco, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessole, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7014</span><span class="NLM_x">–</span> <span class="NLM_lpage">7028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900524b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2u&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7014-7028&author=M.+E.+Di+Francescoauthor=G.+Dessoleauthor=E.+Niziauthor=P.+Paceauthor=U.+Kochauthor=F.+Fioreauthor=S.+Pesciauthor=J.+Di+Muzioauthor=E.+Monteagudoauthor=M.+Rowleyauthor=V.+Summa&title=Novel+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease+featuring+a+2-amino-1%2C3-thiazole+as+a+P4+carbamate+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2uR"><div class="casContent"><span class="casTitleNuber">2u</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement</span></div><div class="casAuthors">Di Francesco, M. Emilia; Dessole, Gabriella; Nizi, Emanuela; Pace, Paola; Koch, Uwe; Fiore, Fabrizio; Pesci, Silvia; Di Muzio, Jillian; Monteagudo, Edith; Rowley, Michael; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7014-7028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of P2-P4 macrocyclic inhibitors of HCV NS3/4A protease characterized by high levels of potency and liver exposure was recently reported.  Within this novel class of inhibitors, a structurally diverse series of compds. I [X = isoquinoline-1,7-diyl, 2-phenylquinoline-4,6-diyl, 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)2, (CH2)3, CH2CMe2; Z = thiazol-2,4-diyl, 1,3,4-oxadiazol-2,5-diyl; R1 = i-Pr, t-Bu, cyclohexyl, (S)-EtCHMe, cyclopentyl; R2 = H2C:CH, Et] featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4 was identified.  Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogs characterized by excellent levels of enzyme and cellular activity.  Among these, I [double bond; X = 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)3; Z = thiazol-2,4-diyl; R1 = (S)-EtCHMe; R2 = H2C:CH] displayed an attractive pharmacokinetic profile in preclin. species and showed sustained liver levels following oral administration in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFtigQW8FUrVg90H21EOLACvtfcHk0lhkLvIJnPSDjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN&md5=76e409fa1d0e9812ee78c4eeabca21ce</span></div><a href="/servlet/linkout?suffix=cit2u&amp;dbid=16384&amp;doi=10.1021%2Fjm900524b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900524b%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DDessole%26aufirst%3DG.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DNovel%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%2520featuring%2520a%25202-amino-1%252C3-thiazole%2520as%2520a%2520P4%2520carbamate%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7014%26epage%3D7028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-1220: a macrocyclic inhibitor of hepatitis C virus NS3/4A protease with improved preclinical plasma exposure</span> <span class="citation_source-journal">ACS Med. Chem. Lett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1002426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+MK-1220%3A+a+macrocyclic+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease+with+improved+preclinical+plasma+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2v&amp;dbid=16384&amp;doi=10.1021%2Fml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002426%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-1220%253A%2520a%2520macrocyclic%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520with%2520improved%2520preclinical%2520plasma%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett%26date%3D2011%26volume%3D2%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiFilippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2w&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=332-336&author=S.+Harperauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=M.+Ferraraauthor=M.+DiFilippoauthor=B.+Crescenziauthor=U.+Kochauthor=A.+Petrocchiauthor=M.+K.+Hollowayauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=K.+F.+Gilbertauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=E.+Niziauthor=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=C.+M.+McHaleauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=E.+Monteagudoauthor=S.+Cianettiauthor=C.+Giulianoauthor=V.+Pucciauthor=N.+Trainorauthor=C.+M.+Fandozziauthor=M.+Rowleyauthor=P.+J.+Colemanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=N.+J.+Liverton&title=Discovery+of+MK-5172%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2wR"><div class="casContent"><span class="casTitleNuber">2w</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">Harper, Steven; McCauley, John A.; Rudd, Michael T.; Ferrara, Marco; DiFilippo, Marcello; Crescenzi, Benedetta; Koch, Uwe; Petrocchi, Alessia; Holloway, M. Katharine; Butcher, John W.; Romano, Joseph J.; Bush, Kimberly J.; Gilbert, Kevin F.; McIntyre, Charles J.; Nguyen, Kevin T.; Nizi, Emanuela; Carroll, Steven S.; Ludmerer, Steven W.; Burlein, Christine; DiMuzio, Jillian M.; Graham, Donald J.; McHale, Carolyn M.; Stahlhut, Mark W.; Olsen, David B.; Monteagudo, Edith; Cianetti, Simona; Giuliano, Claudio; Pucci, Vincenzo; Trainor, Nicole; Fandozzi, Christine M.; Rowley, Michael; Coleman, Paul J.; Vacca, Joseph P.; Summa, Vincenzo; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors contg. a P2 to P4 macrocyclic constraint was designed using a mol. modeling-derived strategy.  Building on the profile of previous clin. compds. and exploring the P2 and linker regions of the series allowed for optimization of broad genotype and mutant enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate 15 (MK-5172), which is active against genotype 1-3 NS3/4a and clin. relevant mutant enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAzCaAN9VqJrVg90H21EOLACvtfcHk0lhR1GRrWBEtPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D&md5=efc04ad0ad47aef13b367fc38d6bbf63</span></div><a href="/servlet/linkout?suffix=cit2w&amp;dbid=16384&amp;doi=10.1021%2Fml300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300017p%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DDiFilippo%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DMcHale%26aufirst%3DC.%2BM.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DCianetti%26aufirst%3DS.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-5172%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D332%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7201</span><span class="NLM_x">–</span> <span class="NLM_lpage">7206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7201-7206&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+Bushauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=M.+K+Hollowayauthor=B.-L.+Wanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=N.+J.+Liverton&title=Development+of+potent+macrocyclic+inhibitors+of+genotype+3a+HCV+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2x&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DHolloway%26aufirst%3DM.%2BK%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520potent%2520macrocyclic%2520inhibitors%2520of%2520genotype%25203a%2520HCV%2520NS3%252F4A%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7201%26epage%3D7206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7207</span><span class="NLM_x">–</span> <span class="NLM_lpage">7213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7207-7213&author=M.+T.+Ruddauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=M.+K.+Hollowayauthor=K.+Bushauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=N.+J.+Livertonauthor=B.-L+Wanauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=J.+P.+Vaccaauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+A.+McCauley&title=Development+of+macrocyclic+inhibitors+of+HCV+NS3%2F4A+protease+with+cyclic+constrained+P2-P4+linkers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2y&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DWan%26aufirst%3DB.-L%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%252F4A%2520protease%2520with%2520cyclic%2520constrained%2520P2-P4%2520linkers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7207%26epage%3D7213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span> </span><span class="NLM_article-title">Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7351</span><span class="NLM_x">–</span> <span class="NLM_lpage">7356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7351-7356&author=X.+Liauthor=Y.+Liuauthor=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liuauthor=Y.+Zhouauthor=C.+Z.+Dingauthor=S.+Zhangauthor=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wang&title=Synthesis+and+antiviral+activity+of+novel+HCV+NS3+protease+inhibitors+with+P4+capping+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2z&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520novel%2520HCV%2520NS3%2520protease%2520inhibitors%2520with%2520P4%2520capping%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7351%26epage%3D7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Bilodeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4267</span><span class="NLM_x">–</span> <span class="NLM_lpage">4271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4267-4271&author=F.+Bilodeauauthor=M.+D.+Baileyauthor=P.+K.+Bhardwajauthor=J.+Bordeleauauthor=P.+Forgioneauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=E.+S.+Jolicoeurauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+Naudauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunet&title=Synthesis+and+optimization+of+a+novel+series+of+HCV+NS3+protease+inhibitors%3A+4-arylproline+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2aa&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBhardwaj%26aufirst%3DP.%2BK.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DForgione%26aufirst%3DP.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DJolicoeur%26aufirst%3DE.%2BS.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%253A%25204-arylproline%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4267%26epage%3D4271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2ab"><span><span class="NLM_label">(ab) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span> </span><span class="NLM_article-title">Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4436</span><span class="NLM_x">–</span> <span class="NLM_lpage">4440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4436-4440&author=M.+D.+Baileyauthor=T.+Halmosauthor=C.+T.+Lemke&title=Discovery+of+novel+P2+substituted+4-biaryl+proline+inhibitors+of+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ab&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520novel%2520P2%2520substituted%25204-biaryl%2520proline%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4436%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2ac"><span><span class="NLM_label">(ac) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: Discovery of potent succinamide inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4447</span><span class="NLM_x">–</span> <span class="NLM_lpage">4452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4447-4452&author=M.+D.+Baileyauthor=J.+Bordeleauauthor=M.+Garneauauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llinas-Brunet&title=Peptide+backbone+replacement+of+hepatitis+C+virus+NS3+serine+protease+C-terminal+cleavage+product+analogs%3A+Discovery+of+potent+succinamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ac&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPeptide%2520backbone%2520replacement%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520C-terminal%2520cleavage%2520product%2520analogs%253A%2520Discovery%2520of%2520potent%2520succinamide%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4447%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2ad"><span><span class="NLM_label">(ad) </span><span class="NLM_contrib-group">Moreau, B.; O’Meara, J. A.; Bordeleau, J.; Garneau, M.; Godbout, C.; Gorys, V.; Leblanc, M.; Villemure, E.; White, P. W.; Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Discovery of hepatitis C Virus NS3-4A protease inhibitors with improved barrier to resistance and favorable liver distribution</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI:<span class="refDoi"> DOI: 10.1021/jm400121t</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400121t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Moreau&author=J.+A.+O%E2%80%99Meara&author=J.+Bordeleau&author=M.+Garneau&author=C.+Godbout&author=V.+Gorys&author=M.+Leblanc&author=E.+Villemure&author=P.+W.+White&author=M.+Llinas-Brunet&title=Discovery+of+hepatitis+C+Virus+NS3-4A+protease+inhibitors+with+improved+barrier+to+resistance+and+favorable+liver+distribution&doi=10.1021%2Fjm400121t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ad&amp;dbid=16384&amp;doi=10.1021%2Fjm400121t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400121t%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520hepatitis%2520C%2520Virus%2520NS3-4A%2520protease%2520inhibitors%2520with%2520improved%2520barrier%2520to%2520resistance%2520and%2520favorable%2520liver%2520distribution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm400121t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2ae"><span><span class="NLM_label">(ae) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2ae&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2af"><span><span class="NLM_label">(af) </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenglowsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madduru, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span> </span><span class="NLM_article-title">Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm400164c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400164c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+Jiangauthor=S.+W.+Andrewsauthor=K.+R.+Condroskiauthor=B.+Buckmanauthor=V.+Serebryanyauthor=S.+Wenglowskyauthor=A.+L.+Kennedyauthor=M.+R.+Madduruauthor=B.+Wangauthor=M.+Lyonauthor=G.+A.+Dohertyauthor=B.+T.+Woodardauthor=C.+Lemieuxauthor=M.+Geck+Doauthor=H.+Zhangauthor=J.+Ballardauthor=G.+Vigersauthor=B.+J.+Brandhuberauthor=P.+Stengelauthor=J.+A.+Joseyauthor=L.+Beigelmanauthor=L.+Blattauthor=S.+D.+Seiwert&title=Discovery+of+danoprevir+%28ITMN-191%2FR7227%29%2C+a+highly+selective+and+potent+inhibitor+of+hepatitis+C+virus+%28HCV%29+NS3%2F4A+protease&doi=10.1021%2Fjm400164c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2af&amp;dbid=16384&amp;doi=10.1021%2Fjm400164c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400164c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DBuckman%26aufirst%3DB.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DA.%2BL.%26aulast%3DMadduru%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DWoodard%26aufirst%3DB.%2BT.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520danoprevir%2520%2528ITMN-191%252FR7227%2529%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm400164c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P.</span><span> </span><span class="NLM_article-title">Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5387</span><span class="NLM_x">–</span> <span class="NLM_lpage">5396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5387-5396&author=F.+McPheeauthor=A.+K.+Sheafferauthor=J.+Friborgauthor=D.+Hernandezauthor=P.+Falkauthor=G.+Zhaiauthor=S.+Levineauthor=S.+Chaniewskiauthor=F.+Yuauthor=D.+Barryauthor=C.+Chenauthor=M.+S.+Leeauthor=K.+Mosureauthor=L.-Q.+Sunauthor=M.+Sinzauthor=N.+A.+Meanwellauthor=R.+J.+Colonnoauthor=J.+Knipeauthor=P.+Scola&title=Preclinical+profile+and+characterization+of+the+hepatitis+C+virus+NS3+protease+inhibitor+asunaprevir+%28BMS-650032%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DG.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChaniewski%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DScola%26aufirst%3DP.%26atitle%3DPreclinical%2520profile%2520and%2520characterization%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520asunaprevir%2520%2528BMS-650032%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5387%26epage%3D5396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Langendorff, O.</span><span> </span><span class="NLM_article-title">Untersuchungen am uberleberden saugerleizen</span> <span class="citation_source-journal">Puflger’s Arch. Ges. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1895</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1007%2FBF01812150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1895&pages=291-332&author=O.+Langendorff&title=Untersuchungen+am+uberleberden+saugerleizen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF01812150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01812150%26sid%3Dliteratum%253Aachs%26aulast%3DLangendorff%26aufirst%3DO.%26atitle%3DUntersuchungen%2520am%2520uberleberden%2520saugerleizen%26jtitle%3DPuflger%25E2%2580%2599s%2520Arch.%2520Ges.%2520Physiol.%26date%3D1895%26volume%3D61%26spage%3D291%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="note"><p class="first last">Effects on HR and SNRT of less than 10% and 15% respectively were considered vehicle like.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pietschmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon system and its application to molecular studies</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=657-664&author=T.+Pietschmannauthor=R.+Bartenschlager&title=The+hepatitis+C+virus+replicon+system+and+its+application+to+molecular+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPietschmann%26aufirst%3DT.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520system%2520and%2520its%2520application%2520to%2520molecular%2520studies%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D657%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.2174%2F1389200003339270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=11467081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=67-84&author=M.+Murray&title=Mechanisms+of+inhibitory+and+regulatory+effects+of+methylenedioxyphenyl+compounds+on+cytochrome+P450-dependent+drug+oxidation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span></div><div class="casAuthors">Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 110 refs.  Cytochrome P 450 (CYP) enzymes catalyze the oxidative conversion of drugs and other lipophilic compds. to hydrophilic metabolites.  Thus, CYPs play a dominant role in the elimination of drugs from the body.  Inhibitory interactions occur when drugs compete for oxidn. by specific CYPs, whereas certain drugs increase the capacity for oxidative biotransformation by inducing the synthesis of new CYPs.  Methylenedioxyphenyl (MDP) compds. have been widely employed as com. important pesticide synergists and a no. of derivs. are found in oils and spices.  MDP compds. are of considerable toxicol. significance because of their capacity to inhibit and induce CYP enzymes in mammals; some derivs. produce neurotoxic and hepatotoxic effects.  Although there are relatively few therapeutic agents of present clin. importance that possess the MDP structural feature, the synthesis and preclin. evaluation of such agents appears to be increasing.  In the context of the existing literature surrounding MDP compds. it is noteworthy that these potential drugs also elicit significant modulatory effects on CYP activities in rat and human liver.  These developments indicate the importance of understanding the chem. mechanisms by which MDPs interact with CYPs.  Thus, the presence of the MDP structure may undermine the potential clin. value of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYAjGf6nf5ZbVg90H21EOLACvtfcHk0ljerSnboiIjKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D&md5=dcafc824c8bcd0080d256d6dd8c50ae7</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.2174%2F1389200003339270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339270%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520inhibitory%2520and%2520regulatory%2520effects%2520of%2520methylenedioxyphenyl%2520compounds%2520on%2520cytochrome%2520P450-dependent%2520drug%2520oxidation%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D67%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peterson, L. A.</span><span> </span><span class="NLM_article-title">Reactive metabolites in the biotransformation of molecules containing a furan ring</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx3003824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2qsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=6-25&author=L.+A.+Peterson&title=Reactive+metabolites+in+the+biotransformation+of+molecules+containing+a+furan+ring"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Metabolites in the Biotransformation of Molecules Containing a Furan Ring</span></div><div class="casAuthors">Peterson, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-25</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many xenobiotics contg. a furan ring are toxic and/or carcinogenic.  The harmful effects of these compds. require furan ring oxidn.  This reaction generates an electrophilic intermediate.  Depending on the furan ring substituents, the intermediate is either an epoxide or a cis-enedione with more ring substitution favoring epoxide formation.  Either intermediate reacts with cellular nucleophiles such as protein or DNA to trigger toxicities.  The reactivity of the metabolite dets. which cellular nucleophiles are targeted.  The toxicity of a particular furan is also influenced by the presence of competing metabolic pathways or efficient detoxification routes.  GSH plays an important role in modulating the harmful effects of this class of compd. by reacting with the reactive metabolite.  However, this may not represent a detoxification step in all cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp4Dr5stLUSrVg90H21EOLACvtfcHk0ljerSnboiIjKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2qsrbN&md5=fe3a280d0b7a99a436ec619abc1e1fa0</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Ftx3003824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx3003824%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BA.%26atitle%3DReactive%2520metabolites%2520in%2520the%2520biotransformation%2520of%2520molecules%2520containing%2520a%2520furan%2520ring%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2013%26volume%3D26%26spage%3D6%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span> </span><span class="NLM_article-title">Time-dependent CYP inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1517%2F17425255.3.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=17269894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=51-566&author=R.+J.+Rileyauthor=K.+Grimeauthor=R.+Weaver&title=Time-dependent+CYP+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent CYP inhibition</span></div><div class="casAuthors">Riley, Robert J.; Grime, Ken; Weaver, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of CYP refers to a change in potency during an in vitro incubation or dosing period in vivo.  Potential mechanisms include the formation of inhibitory metabolites and mechanism-based inhibition (MBI).  In vitro expts. are configured to assess TDI and MBI is inferred, at least initially.  MBI is more profound after multiple-dosing and the recovery period is independent of continued drug exposure.  Advances in in vitro-in vivo extrapolations for competitive inhibition and the potential relationship between MBI and reactive metabolite-mediated toxicity, have redirected emphasis to CYP TDI.  In contrast, with reversible inhibition, strategies for projecting the risks from TDI are less developed and the traditional I/Ki model often yields a dramatic underprediction.  This review explores the contribution of TDI to drug-drug interactions and idiosyncratic drug toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8w1eAZ9QULVg90H21EOLACvtfcHk0ljerSnboiIjKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D&md5=184636ac0768f51d65f407a0655233e4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DWeaver%26aufirst%3DR.%26atitle%3DTime-dependent%2520CYP%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D51%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">PDB code for BMS-605339 (<b>1</b>) is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK">4NWK</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unravelling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1038%2Fnature04077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=16107832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unravelling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling hepatitis C virus replication from genome to function</span></div><div class="casAuthors">Lindenbach, Brett D.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7053</span>),
    <span class="NLM_cas:pages">933-938</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the hepatitis C virus over 15 years ago, scientists have raced to develop diagnostics, study the virus and find new therapies.  Yet virtually every attempt to dissect this pathogen has met with roadblocks that impeded progress.  Its replication was restricted to humans or exptl. infected chimpanzees, and efficient growth of the virus in cell culture failed until very recently.  Nevertheless hard-fought progress has been made and the first wave of antiviral drugs is entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vc6EOs8vLVg90H21EOLACvtfcHk0lhc94xKbmGE1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D&md5=553517cac32b797ef7a2d07f496a7b5c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature04077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04077%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnravelling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Reddy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3144-3156&author=M.+B.+Reddyauthor=P.+N.+Morcosauthor=S.+Le+Pogamauthor=Y.+Ouauthor=K.+Frankauthor=T.+Laveauthor=P.+Smith&title=Pharmacokinetic%2Fpharmacodynamic+predictors+of+clinical+potency+for+hepatitis+C+virus+nonnucleoside+polymerase+and+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BB.%26aulast%3DMorcos%26aufirst%3DP.%2BN.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DOu%26aufirst%3DY.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%26atitle%3DPharmacokinetic%252Fpharmacodynamic%2520predictors%2520of%2520clinical%2520potency%2520for%2520hepatitis%2520C%2520virus%2520nonnucleoside%2520polymerase%2520and%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3144%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">PDB code for BMS-650032 (<b>24</b>) is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWL">4NWL</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reviriego, C.</span><span> </span><span class="NLM_article-title">Asunaprevir: HCV serine protease NS3 inhibitor treatment of hepatitis C virus</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFSns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=247-254&author=C.+Reviriego&title=Asunaprevir%3A+HCV+serine+protease+NS3+inhibitor+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Asunaprevir: HCV serine protease NS3 inhibitor treatment of hepatitis C virus</span></div><div class="casAuthors">Reviriego, C.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Thomson Reuters</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus (HCV) currently affects more than 170 million people worldwide.  Over 80% of the infected individuals develop chronic hepatitis, which leads to other complications, such as cirrhosis, fibrosis or liver carcinoma.  The current std. of care (SOC), which combines pegylated interferon alfa (pegIFN-α) and ribavirin, has limited efficacy in providing a sustained virol. response, esp. in HCV genotype 1-infected individuals.  Moreover, the lengthy treatment with SOC is frequently assocd. with undesirable side effects that may be extremely debilitating.  There is therefore an urgent medical need to develop anti-HCV therapies that are safer and more effective.  Asunaprevir (BMS-650032) is an investigational, oral, selective serine protease NS3 inhibitor with pharmacokinetic parameters that suggest once- or twice-daily administration.  Its promising safety profile, in addn. to the encouraging clin. proof-of-concept results, make asunaprevir attractive for use in drug combination studies with other HCV therapeutic agents, even in interferon-free regimens and for difficult-to-treat patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprRdoGUMeeS7Vg90H21EOLACvtfcHk0lhc94xKbmGE1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFSns7c%253D&md5=9ece17c1caf2744e907d3c20823cef36</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReviriego%26aufirst%3DC.%26atitle%3DAsunaprevir%253A%2520HCV%2520serine%2520protease%2520NS3%2520inhibitor%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DDrugs%2520Future%26date%3D2012%26volume%3D37%26spage%3D247%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevir</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3670</span><span class="NLM_x">–</span> <span class="NLM_lpage">3681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1128%2FAAC.00308-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=22508297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2is7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3670-3681&author=F.+McPheeauthor=J.+Friborgauthor=S.+Levineauthor=C.+Chenauthor=P.+Falkauthor=F.+Yuauthor=D.+Hernandezauthor=M.+S.+Leeauthor=S.+Chaniewskiauthor=A.+K.+Sheafferauthor=C.+Pasquinelli&title=Resistance+analysis+of+the+hepatitis+C+virus+NS3+protease+inhibitor+asunaprevir"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevir</span></div><div class="casAuthors">McPhee, Fiona; Friborg, Jacques; Levine, Steven; Chen, Chaoqun; Falk, Paul; Yu, Fei; Hernandez, Dennis; Lee, Min S.; Chaniewski, Susan; Sheaffer, Amy K.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3670-3681</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor demonstrating efficacy in alfa interferon-sparing, direct-acting antiviral dual-combination regimens (together with the NS5A replication complex inhibitor daclatasvir) in patients chronically infected with HCV genotype 1b.  Here, we describe a comprehensive in vitro genotypic and phenotypic anal. of asunaprevir-assocd. resistance against genotypes 1a and 1b using HCV replicons and patient samples obtained from clin. studies of short-term asunaprevir monotherapy.  During genotype 1a resistance selection using HCV replicons, the primary NS3 protease substitutions identified were R155K, D168G, and I170T, which conferred low- to moderate-level asunaprevir resistance (5- to 21-fold) in transient-transfection susceptibility assays.  For genotype 1b, a higher level of asunaprevir-assocd. resistance was obsd. at the same selection pressures, ranging from 170- to 400-fold relative to the wild-type control.  The primary NS3 protease substitutions identified occurred predominantly at amino acid residue D168 (D168A/G/H/V/Y) and were assocd. with high-level asunaprevir resistance (16- to 280-fold) and impaired replication capacity.  In asunaprevir single-ascending-dose and 3-day multiple-ascending-dose studies in HCV genotype 1a- or 1b-infected patients, the predominant pre-existing NS3 baseline polymorphism was NS3-Q80K.  This substitution impacted initial virol. response rates in a single-ascending-dose study, but its effects after multiple doses were more ambiguous.  Interestingly, for patient NS3 protease sequences contg. Q80 and those contg. K80, susceptibilities to asunaprevir were comparable when tested in an enzyme assay.  No resistance-assocd. variants emerged in these clin. studies that significantly impacted susceptibility to asunaprevir.  Importantly, asunaprevir-resistant replicons remained susceptible to an NS5A replication complex inhibitor, consistent with a role for asunaprevir in combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNf2shzFcn47Vg90H21EOLACvtfcHk0lhc94xKbmGE1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2is7s%253D&md5=713c87d4123a5769f47eb51d52ebd044</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1128%2FAAC.00308-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00308-12%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DChaniewski%26aufirst%3DS.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DResistance%2520analysis%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520asunaprevir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3670%26epage%3D3681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Balimane, P.; Browning, M.; Chong, S.; Dai, R.; Darienzo, R.; Dalterio, C.; Davis, C.; Han, Y.-H.; Kim, S.; Knipe, J.; Malinowski, J.; Marino, T.; Mosure, K.; Sandquist, J.; Gesenberg, C.; Schartman, R.; Sinz, M.; Whiterock, V.; Zadjura, L.; Zoeckler, M.; Zvyaga, T.; Meanwell, N. A.; McPhee, F.; Scola, P. M.</span><span> </span><span class="NLM_article-title">Nonclinical pharmacokinetics of a novel HCV NS3 protease inhibitor, BMS-605339</span>. <div class="note"><p class="first last">Manuscript in preparation</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Balimane%2C+P.%3B+Browning%2C+M.%3B+Chong%2C+S.%3B+Dai%2C+R.%3B+Darienzo%2C+R.%3B+Dalterio%2C+C.%3B+Davis%2C+C.%3B+Han%2C+Y.-H.%3B+Kim%2C+S.%3B+Knipe%2C+J.%3B+Malinowski%2C+J.%3B+Marino%2C+T.%3B+Mosure%2C+K.%3B+Sandquist%2C+J.%3B+Gesenberg%2C+C.%3B+Schartman%2C+R.%3B+Sinz%2C+M.%3B+Whiterock%2C+V.%3B+Zadjura%2C+L.%3B+Zoeckler%2C+M.%3B+Zvyaga%2C+T.%3B+Meanwell%2C+N.+A.%3B+McPhee%2C+F.%3B+Scola%2C+P.+M.+Nonclinical+pharmacokinetics+of+a+novel+HCV+NS3+protease+inhibitor%2C+BMS-605339.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DBalimane%26aufirst%3DP.%26atitle%3DNonclinical%2520pharmacokinetics%2520of%2520a%2520novel%2520HCV%2520NS3%2520protease%2520inhibitor%252C%2520BMS-605339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pasquinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marbury, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwater, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMicco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Talavera, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span> </span><span class="NLM_article-title">Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1838</span><span class="NLM_x">–</span> <span class="NLM_lpage">1844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1838-1844&author=C.+Pasquinelliauthor=F.+McPheeauthor=T.+Eleyauthor=C.+Villegasauthor=K.+Sandyauthor=P.+Sheridanauthor=A.+Perssonauthor=S.-P.+Huangauthor=D.+Hernandezauthor=A.+K.+Sheafferauthor=P.+Scolaauthor=T.+Marburyauthor=E.+Lawitzauthor=R.+Goldwaterauthor=M.+Rodriguez-Torresauthor=M.+DeMiccoauthor=D.+Wrightauthor=M.+Charltonauthor=W.+K.+Kraftauthor=J.-C.+Lopez-Talaveraauthor=D.+M.+Grasela&title=Single-+and+multiple-ascending-dose+studies+of+the+NS3+protease+inhibitor+asunaprevir+in+subjects+with+or+without+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasquinelli%26aufirst%3DC.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DVillegas%26aufirst%3DC.%26aulast%3DSandy%26aufirst%3DK.%26aulast%3DSheridan%26aufirst%3DP.%26aulast%3DPersson%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DScola%26aufirst%3DP.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DGoldwater%26aufirst%3DR.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DDeMicco%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DCharlton%26aufirst%3DM.%26aulast%3DKraft%26aufirst%3DW.%2BK.%26aulast%3DLopez-Talavera%26aufirst%3DJ.-C.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26atitle%3DSingle-%2520and%2520multiple-ascending-dose%2520studies%2520of%2520the%2520NS3%2520protease%2520inhibitor%2520asunaprevir%2520in%2520subjects%2520with%2520or%2520without%2520chronic%2520hepatitis%2520C%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D1838%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bronowicki, J.-P.; Pol, S.; Thuluvath, P. J.; Larrey, D.; Martorell Claudia, T.; Rustgi Vinod, K.; Morris, D. W.; Younes, Z.; Fried, M. W.; Bourliere, M.; Hezode, C.; Reddy, K. R.; Massoud, O.; Abrams, G. A.; Ratziu, V.; He, B.; Eley, T.; Ahmad, A.; Cohen, D.; Hindes, R.; McPhee, F.; Reilly, B.; Mendez, P.; Hughes, E.</span><span> </span><span class="NLM_article-title">Randomized study of asunaprevir plus peg-interferon alfa and ribavirin for previously untreated genotype 1 chronic hepatitis C</span>.  <span class="citation_source-journal">Antivir. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=885-893&author=J.-P.+Bronowicki&author=S.+Pol&author=P.+J.+Thuluvath&author=D.+Larrey&author=T.+Martorell+Claudia&author=K.+Rustgi+Vinod&author=D.+W.+Morris&author=Z.+Younes&author=M.+W.+Fried&author=M.+Bourliere&author=C.+Hezode&author=K.+R.+Reddy&author=O.+Massoud&author=G.+A.+Abrams&author=V.+Ratziu&author=B.+He&author=T.+Eley&author=A.+Ahmad&author=D.+Cohen&author=R.+Hindes&author=F.+McPhee&author=B.+Reilly&author=P.+Mendez&author=E.+Hughes&title=Randomized+study+of+asunaprevir+plus+peg-interferon+alfa+and+ribavirin+for+previously+untreated+genotype+1+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBronowicki%26aufirst%3DJ.-P.%26atitle%3DRandomized%2520study%2520of%2520asunaprevir%2520plus%2520peg-interferon%2520alfa%2520and%2520ribavirin%2520for%2520previously%2520untreated%2520genotype%25201%2520chronic%2520hepatitis%2520C%26jtitle%3DAntivir.%2520Ther.%26date%3D2013%26volume%3D18%26spage%3D885%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lok, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Preliminary study of two antiviral agents for hepatitis C genotype 1</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1056%2FNEJMoa1104430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=22256805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=216-224&author=A.+S.+Lokauthor=D.+F.+Gardinerauthor=E.+Lawitzauthor=C.+Martorellauthor=G.+T.+Eversonauthor=R.+Ghalibauthor=R.+Reindollarauthor=V.+Rustgiauthor=F.+McPheeauthor=M.+Wind-Rotoloauthor=A.+Perssonauthor=K.+Zhuauthor=D.+I.+Dimitrovaauthor=T.+Eleyauthor=T.+Guoauthor=D.+M.+Graselaauthor=C.+Pasquinelli&title=Preliminary+study+of+two+antiviral+agents+for+hepatitis+C+genotype+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary study of two antiviral agents for hepatitis C genotype 1</span></div><div class="casAuthors">Lok, Anna S.; Gardiner, David F.; Lawitz, Eric; Martorell, Claudia; Everson, Gregory T.; Ghalib, Reem; Reindollar, Robert; Rustgi, Vinod; McPhee, Fiona; Wind-Rotolo, Megan; Persson, Anna; Zhu, Kurt; Dimitrova, Dessislava I.; Eley, Timothy; Guo, Tong; Grasela, Dennis M.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-224</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection who have not had a response to therapy with peginterferon and ribavirin may benefit from the addn. of multiple direct-acting antiviral agents to their treatment regimen.  METHODS: This open-label, phase 2a study included an exploratory cohort of 21 patients with chronic HCV genotype 1 infection who had not had a response to previous therapy (i.e., had not had ≥2 log10 decline in HCV RNA after ≥12 wk of treatment with peginterferon and ribavirin).  We randomly assigned patients to receive the NS5A replication complex inhibitor daclatasvir (60 mg once daily) and the NS3 protease inhibitor asunaprevir (600 mg twice daily) alone (group A, 11 patients) or in combination with peginterferon alfa-2a and ribavirin (group B, 10 patients) for 24 wk.  The primary end point was the percentage of patients with a sustained virol. response 12 wk after the end of the treatment period.  RESULTS: A total of 4 patients in group A (36%; 2 of 9 with HCV genotype la and 2 of 2 with genotype lb) had a sustained virol. response at 12 wk after treatment and also at 24 wk after treatment.  Six patients (all with HCV genotype la) had viral breakthrough while receiving therapy, and resistance mutations to both antiviral agents were found in all cases; 1 patient had a viral response at the end of treatment but had a relapse after the treatment period.  All 10 patients in group B had a sustained virol. response at 12 wk after treatment, and 9 had a sustained virol. response at 24 wk after treatment Diarrhea was the most common adverse event in both groups.  Six patients had transient elevations of alanine aminotransferase levels to more than 3 times the upper limit of the normal range.  CONCLUSIONS: This preliminary study involving patients with HCV genotype 1 infection who had not had a response to prior therapy showed that a sustained virol. response can be achieved with two direct-acting antiviral agents only.  In addn., a high rate of sustained virol. response was achieved when the two direct-acting antiviral agents were combined with peginterferon alfa-2a and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiY7QiDziiRbVg90H21EOLACvtfcHk0lieFTdfF7z08g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D&md5=5b986bac6ea53144898c91e8e2eaf5bc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1104430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1104430%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DA.%2BS.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DMartorell%26aufirst%3DC.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DDimitrova%26aufirst%3DD.%2BI.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DPreliminary%2520study%2520of%2520two%2520antiviral%2520agents%2520for%2520hepatitis%2520C%2520genotype%25201%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D216%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lok, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hézode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serfaty, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Randomized trial of daclatasvir and asunaprevir with or without peginterferon/ribaviran for hepatitis C virus genotype 1 null responders</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1016%2Fj.jhep.2013.10.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=24444658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=490-499&author=A.+S.+Lokauthor=D.+F.+Gardinerauthor=C.+H%C3%A9zodeauthor=E.+J.+Lawitzauthor=M.+Bourli%C3%A8reauthor=G.+T.+Eversonauthor=P.+Marcellinauthor=M.+Rodriguez-Torresauthor=S.+Polauthor=L.+Serfatyauthor=T.+Eleyauthor=S.-P.+Huangauthor=J.+Liauthor=M.+Wind-Rotoloauthor=F.+Yuauthor=F.+McPheeauthor=D.+M.+Graselaauthor=C.+Pasquinelli&title=Randomized+trial+of+daclatasvir+and+asunaprevir+with+or+without+peginterferon%2Fribaviran+for+hepatitis+C+virus+genotype+1+null+responders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders</span></div><div class="casAuthors">Lok, Anna S.; Gardiner, David F.; Hezode, Christophe; Lawitz, Eric J.; Bourliere, Marc; Everson, Gregory T.; Marcellin, Patrick; Rodriguez-Torres, Maribel; Pol, Stanislas; Serfaty, Lawrence; Eley, Timothy; Huang, Shu-Pang; Li, Jianling; Wind-Rotolo, Megan; Yu, Fei; McPhee, Fiona; Grasela, Dennis M.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">490-499</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Patients with chronic hepatitis C virus (HCV) infection and prior null response (<2 log HCV RNA decline after ≥12 wk of PegIFN/RBV) have limited options.  We evaluated daclatasvir plus once- or twice-daily asunaprevir in non-cirrhotic genotype 1 null responders.  In this randomized, phase 2a, open-label, 24-wk treatment study, 101 patients received daclatasvir (60 mg) once-daily.  In addn., 38 genotype 1b patients received asunaprevir (200 mg) twice- (DUAL A1) or once-daily (DUAL A2); 36 genotype 1a and 5 genotype 1b patients received asunaprevir twice- (QUAD B1) or once-daily (QUAD B2) plus PegIFN/RBV; and 18 genotype 1a and 4 genotype 1b patients received asunaprevir twice-daily plus ribavirin (TRIPLE B3).  The primary endpoint was undetectable HCV RNA 12 wk post-treatment (sustained virol. response, SVR12).  Across all groups, mean HCV RNA was ≥6 log IU/mL, and 99% of patients had a non-CC IL28B genotype.  SVR12 rates were 78% (A1), 65% (A2), 95% (B1), and 95% (B2).  In B3, most genotype 1a patients experienced virol. breakthrough.  The most common adverse events were headache, diarrhea, and asthenia.  Grade 3-4 aminotransferase elevations were infrequent and not treatment-limiting.  In genotype 1 null responders, daclatasvir plus twice-daily asunaprevir DUAL therapy is effective for most genotype 1b patients, and daclatasvir, asunaprevir, and PegIFN/RBV QUAD therapy is effective for nearly all genotype 1a and 1b patients; but neither DUAL nor TRIPLE therapy is effective for genotype 1a patients.  Interferon-free regimens including daclatasvir and twice-daily asunaprevir for genotype 1 null responders should be tailored to subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmaQLpKkbNoLVg90H21EOLACvtfcHk0lieFTdfF7z08g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlartw%253D%253D&md5=d216b31a62adc838c4f2215fcfff4838</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2013.10.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2013.10.019%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DA.%2BS.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26aulast%3DH%25C3%25A9zode%26aufirst%3DC.%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DSerfaty%26aufirst%3DL.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DRandomized%2520trial%2520of%2520daclatasvir%2520and%2520asunaprevir%2520with%2520or%2520without%2520peginterferon%252Fribaviran%2520for%2520hepatitis%2520C%2520virus%2520genotype%25201%2520null%2520responders%26jtitle%3DJ.%2520Hepatol.%26date%3D2014%26volume%3D60%26spage%3D490%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumada, H.</span><span> </span><span class="NLM_article-title">Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=742-748&author=K.+Chayamaauthor=S.+Takahashiauthor=J.+Toyotaauthor=Y.+Karinoauthor=K.+Ikedaauthor=H.+Ishikawaauthor=H.+Watanabeauthor=F.+McPheeauthor=E.+Hughesauthor=H.+Kumada&title=Dual+therapy+with+the+nonstructural+protein+5A+inhibitor%2C+daclatasvir%2C+and+the+nonstructural+protein+3+protease+inhibitor%2C+asunaprevir%2C+in+hepatitis+C+virus+genotype+1b-infected+null+responders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChayama%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DToyota%26aufirst%3DJ.%26aulast%3DKarino%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DHughes%26aufirst%3DE.%26aulast%3DKumada%26aufirst%3DH.%26atitle%3DDual%2520therapy%2520with%2520the%2520nonstructural%2520protein%25205A%2520inhibitor%252C%2520daclatasvir%252C%2520and%2520the%2520nonstructural%2520protein%25203%2520protease%2520inhibitor%252C%2520asunaprevir%252C%2520in%2520hepatitis%2520C%2520virus%2520genotype%25201b-infected%2520null%2520responders%26jtitle%3DHepatology%26date%3D2012%26volume%3D55%26spage%3D742%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hézode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loustaud-Ratti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuluvath, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span> </span><span class="NLM_article-title">Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naı̈ve patients with HCV genotype 1 infection.</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2013&pages=420-429&author=G.+T.+Eversonauthor=K.+D.+Simsauthor=M.+Rodriguez-Torresauthor=C.+H%C3%A9zodeauthor=E.+Lawitzauthor=M.+Bourli%C3%A8reauthor=V.+Loustaud-Rattiauthor=V.+Rustgiauthor=H.+Schwartzauthor=H.+Tatumauthor=P.+Marcellinauthor=S.+Polauthor=P.+J.+Thuluvathauthor=T.+Eleyauthor=X.+Wangauthor=S.-P.+Huangauthor=F.+McPheeauthor=M.+Wind-Rotoloauthor=E.+Chungauthor=C.+Pasquinelliauthor=D.+M.+Graselaauthor=D.+F.+Gardiner&title=Efficacy+of+an+interferon-+and+ribavirin-free+regimen+of+daclatasvir%2C+asunaprevir%2C+and+BMS-791325+in+treatment-na%C4%B1%CC%88ve+patients+with+HCV+genotype+1+infection."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DSims%26aufirst%3DK.%2BD.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DH%25C3%25A9zode%26aufirst%3DC.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DLoustaud-Ratti%26aufirst%3DV.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DSchwartz%26aufirst%3DH.%26aulast%3DTatum%26aufirst%3DH.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DThuluvath%26aufirst%3DP.%2BJ.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DPasquinelli%26aufirst%3DC.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26atitle%3DEfficacy%2520of%2520an%2520interferon-%2520and%2520ribavirin-free%2520regimen%2520of%2520daclatasvir%252C%2520asunaprevir%252C%2520and%2520BMS-791325%2520in%2520treatment-na%25C4%25B1%25CC%2588ve%2520patients%2520with%2520HCV%2520genotype%25201%2520infection.%26jtitle%3DGastroenterology%26date%3D2013%26volume%3D146%26spage%3D420%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chung, R. T.</span><span> </span><span class="NLM_article-title">A watershed moment in the treatment of hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1056%2FNEJMe1113272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=22256811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=273-275&author=R.+T.+Chung&title=A+watershed+moment+in+the+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A watershed moment in the treatment of hepatitis C</span></div><div class="casAuthors">Chung, Raymond T.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-275</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3ffT6ZbaILVg90H21EOLACvtfcHk0lgiOolD_OPorw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gns7s%253D&md5=a0a82b76f878d91ed04bb09ed6a6339e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1113272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1113272%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DR.%2BT.%26atitle%3DA%2520watershed%2520moment%2520in%2520the%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D273%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumada, H.</span><span> </span><span class="NLM_article-title">Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1016%2Fj.jhep.2012.09.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=23183526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2jtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=655-662&author=Y.+Suzukiauthor=K.+Ikedaauthor=F.+Suzukiauthor=J.+Toyotaauthor=Y.+Karinoauthor=K.+Chayamaauthor=Y.+Kawakamiauthor=H.+Ishikawaauthor=H.+Watanabeauthor=W.+Huauthor=T.+Eleyauthor=F.+McPheeauthor=E.+Hughesauthor=H.+Kumada&title=Dual+oral+therapy+with+daclatasvir+and+asunaprevir+for+patients+with+HCV+genotype+1b+infection+and+limited+treatment+options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options</span></div><div class="casAuthors">Suzuki, Yoshiyuki; Ikeda, Kenji; Suzuki, Fumitaka; Toyota, Joji; Karino, Yoshiyasu; Chayama, Kazuaki; Kawakami, Yoshiiku; Ishikawa, Hiroki; Watanabe, Hideaki; Hu, Wenhua; Eley, Timothy; McPhee, Fiona; Hughes, Eric; Kumada, Hiromitsu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-662</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Improved therapeutic options for chronic hepatitis C virus (HCV) infection are needed for patients who are poor candidates for treatment with current regimens due to anticipated intolerability or low likelihood of response.  In this open-label, phase 2a study of Japanese patients with chronic HCV genotype 1b infection, 21 null responders (<2 log10 HCV RNA redn. after 12 wk of peginterferon/ribavirin) and 22 patients intolerant to or medically ineligible for peginterferon/ribavirin therapy received dual oral treatment for 24 wk with the NS5A replication complex inhibitor daclatasvir (DCV) and the NS3 protease inhibitor asunaprevir (ASV).  The primary efficacy end point was sustained virol. response at 12 wk post-treatment (SVR12).  Thirty-six of 43 enrolled patients completed 24 wk of therapy.  Serum HCV RNA levels declined rapidly, becoming undetectable in all patients on therapy by week 8.  Overall, 76.7% of patients achieved SVR12 and SVR24, including 90.5% of null responders and 63.6% of ineligible/intolerant patients.  There were no virol. failures among null responders.  Three ineligible/intolerant patients experienced viral breakthrough and four relapsed post-treatment.  Diarrhea, nasopharyngitis, headache, and ALT/AST increases, generally mild, were the most common adverse events; three discontinuations before week 24 were due to adverse events that included hyperbilirubinemia and transaminase elevations (two patients).  Dual therapy with daclatasvir and asunaprevir, without peginterferon/ribavirin, was well tolerated and achieved high SVR rates in two groups of difficult-to-treat patients with hepatitis C virus genotype 1b infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1ZlrHtPRHLVg90H21EOLACvtfcHk0lgiOolD_OPorw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2jtbw%253D&md5=48caec88fbfc444ea629aac577c2ed95</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.09.037%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DToyota%26aufirst%3DJ.%26aulast%3DKarino%26aufirst%3DY.%26aulast%3DChayama%26aufirst%3DK.%26aulast%3DKawakami%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DHughes%26aufirst%3DE.%26aulast%3DKumada%26aufirst%3DH.%26atitle%3DDual%2520oral%2520therapy%2520with%2520daclatasvir%2520and%2520asunaprevir%2520for%2520patients%2520with%2520HCV%2520genotype%25201b%2520infection%2520and%2520limited%2520treatment%2520options%26jtitle%3DJ.%2520Hepatol.%26date%3D2013%26volume%3D58%26spage%3D655%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500297k&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500297k&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0lh_rd-k3aH6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Campbell, J. A.; Good, A.</span>World Patent Application WO-2002/060926 A2, <span class="NLM_day">8</span><span class="NLM_month">Aug</span><span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+A.+Campbell&author=A.+Good&title=World+Patent+Application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26jtitle%3DWorld%2520Patent%2520Application%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span>Crystal structure data has been deposited to Cambridge Structure Database (deposition number CCDC <span class="NLM_ext-link">984267</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Crystal+structure+data+has+been+deposited+to+Cambridge+Structure+Database+%28deposition+number+CCDC+984267%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Crespi, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penman, B. W.</span><span> </span><span class="NLM_article-title">Microtiter plate assay for inhibition of human, drug-metabolizing cytochromes P450</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1997&pages=188-190&author=C.+L.+Crespiauthor=V.+P.+Millerauthor=B.+W.+Penman&title=Microtiter+plate+assay+for+inhibition+of+human%2C+drug-metabolizing+cytochromes+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DV.%2BP.%26aulast%3DPenman%26aufirst%3DB.%2BW.%26atitle%3DMicrotiter%2520plate%2520assay%2520for%2520inhibition%2520of%2520human%252C%2520drug-metabolizing%2520cytochromes%2520P450%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D248%26spage%3D188%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalczyk, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahn, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, E. T.</span><span> </span><span class="NLM_article-title">Image annotation and database mining to create a novel screen for the chemotype-dependent crystallization of HCV NS3 protease</span> <span class="citation_source-journal">Cryst. Growth Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks">[<a href="/doi/10.1021/cg101353h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500297k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Sjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1143-1151&author=H.+E.+Kleiauthor=K.+Kishauthor=M.+F.+Russoauthor=S.+J.+Michalczykauthor=M.+H.+Cahnauthor=J.+Tredupauthor=C.+Y.+Changauthor=J.+Khanauthor=E.+T.+Baldwin&title=Image+annotation+and+database+mining+to+create+a+novel+screen+for+the+chemotype-dependent+crystallization+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Image Annotation and Database Mining to Create a Novel Screen for the Chemotype-Dependent Crystallization of HCV NS3 Protease</span></div><div class="casAuthors">Klei, Herbert E.; Kish, Kevin; Russo, Mark F.; Michalczyk, Steve J.; Cahn, Matthew H.; Tredup, Jeffrey; Chang, Chieh Ying; Khan, Javed; Baldwin, Eric T.</div><div class="citationInfo"><span class="NLM_cas:title">Crystal Growth & Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1143-1151</span>CODEN:
                <span class="NLM_cas:coden">CGDEFU</span>;
        ISSN:<span class="NLM_cas:issn">1528-7483</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An effective process for screening, imaging, and optimizing crystn. trials using a combination of external and internal hardware and software has been deployed.  The combination of this infrastructure with a vast annotated crystn. database enables the creation of custom crystn. screening strategies.  Because of the strong chemotype-dependent crystn. obsd. with HCV NS3 protease (HCVPr), this strategy was applied to a chemotype resistant to all prior crystn. efforts.  The crystn. database was mined for ingredients used to generate earlier HCVPr/inhibitor co-crystals.  A random screen was created from the most prolific ingredients.  A previously untested combination of proven ingredients was identified that led to a successful crystn. condition for the resistant chemotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUy_4tlryROLVg90H21EOLACvtfcHk0lh_rd-k3aH6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Sjtro%253D&md5=f6146dccfb26e5599e36c65307721040</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcg101353h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcg101353h%26sid%3Dliteratum%253Aachs%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DRusso%26aufirst%3DM.%2BF.%26aulast%3DMichalczyk%26aufirst%3DS.%2BJ.%26aulast%3DCahn%26aufirst%3DM.%2BH.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26atitle%3DImage%2520annotation%2520and%2520database%2520mining%2520to%2520create%2520a%2520novel%2520screen%2520for%2520the%2520chemotype-dependent%2520crystallization%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DCryst.%2520Growth%2520Des.%26date%3D2011%26volume%3D11%26spage%3D1143%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-Ray Diffraction Data Collected in Oscillation Mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-Ray+Diffraction+Data+Collected+in+Oscillation+Mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-Ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D263%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span>QUANTA Modeling Environment; <span class="NLM_publisher-name">Accelrys, Inc</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=QUANTA+Modeling+Environment%3B+Accelrys%2C+Inc%3A+San+Diego%2C+CA%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DQUANTA%2520Modeling%2520Environment%26pub%3DAccelrys%252C%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Brünger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLano, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, G. L.</span><span> </span><span class="NLM_article-title">Crystallography and NMR System: A New Software Suite for Macromolecular Structure Determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">D54</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D54&publication_year=1998&pages=905-921&author=A.+Br%C3%BCngerauthor=P.+Adamsauthor=G.+Cloreauthor=W.+DeLanoauthor=P.+Grosauthor=R.+Grosse-Kunstleveauthor=J.-S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+and+NMR+System%3A+A+New+Software+Suite+for+Macromolecular+Structure+Determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DP.%26aulast%3DClore%26aufirst%3DG.%26aulast%3DDeLano%26aufirst%3DW.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DJ.-S.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520and%2520NMR%2520System%253A%2520A%2520New%2520Software%2520Suite%2520for%2520Macromolecular%2520Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3DD54%26spage%3D905%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK','PDB','4NWK'); return false;">PDB: 4NWK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWL','PDB','4NWL'); return false;">PDB: 4NWL</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500297k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-5%3Barticle%3Aarticle%3A10.1021%2Fjm500297k%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500297k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a7e191e2a3d60","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
